propranolol has been researched along with Cardiovascular Stroke in 856 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Changes in C-reactive protein (CRP) between days 1 and 5 after myocardial infarction were evaluated in 189 patients treated with simvastatin alone (S), beta blockers alone (B; propranolol or metoprolol), S + B, or neither of these 2 medications (N) in a prospective observational cohort." | 9.14 | Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarction. ( Gurgel, A; Macedo, AC; Morato, TN; Munhoz, DB; Quinaglia e Silva, JC; Sever, P; Sposito, AC, 2009) |
| "This study evaluated the effects of propranolol on recovery of heart rate variability (HRV) after acute myocardial infarction and its relation to outcome in the Beta-blocker Heart Attack Trial (BHAT)." | 9.10 | Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. ( Horwitz, RI; Ickovics, JR; Lampert, R; Lee, FA; Viscoli, CJ, 2003) |
| "At 32-month follow-up of older patients with prior myocardial infarction, congestive heart failure, and a left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors, and also with digoxin if atrial fibrillation was present, propranolol caused a 35% significant reduction in total mortality and a 37% significant decrease in total mortality plus nonfatal myocardial infarction compared with no propranolol." | 9.08 | Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus ( Ahn, C; Aronow, WS; Kronzon, I, 1997) |
| "A total of 266 patients entered into a study comparing the effect of intravenous magnesium and propranolol following acute myocardial infarction." | 9.07 | A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction. ( Abraham, AS; Balkin, J; Ilan, M; Klutstein, M; Rosenmann, D; Zion, MM, 1994) |
| "3837 Men and women randomised 5-21 days after an acute myocardial infarction to treatment with placebo or propranolol for up to 40 months." | 9.06 | Long term propranolol treatment and changes in body weight after myocardial infarction. ( Byington, RP; Furberg, CD; Rössner, S; Taylor, CL, 1990) |
| "The effect of propranolol on mortality and reinfarction after acute myocardial infarction (AMI) in cigarette smokers and nonsmokers was studied in the Beta Blocker Heart Attack Trial." | 9.06 | Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. ( Goldstein, S; Jafri, SM; Peters, R; Schultz, LR; Tilley, BC, 1990) |
| "Beta-blockers are known to be effective against post-infarction ventricular arrhythmias and amiodarone has recently been shown to have this property." | 9.06 | [Comparative efficacy of amiodarone and propranolol on ventricular arrhythmia in the post-infarction period]. ( Blondeau, M; Brunet, M; Fedorowsky, A; Fournier, C; Gensous, D; Kindermans, M; Tournadre, P, 1989) |
| "The purpose of this prospective randomized trial was to compare the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias during the first 6 months following myocardial infarction (MI)." | 9.06 | Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction. ( Bah, M; Blondeau, M; Boujon, B; Brunet, M; Fournier, C; Giudicelli, JF; Kindermans, M; Tournadre, P, 1989) |
| "4 years) with uncomplicated acute myocardial infarction were randomly assigned to propranolol therapy (n = 25) or placebo (n = 25) in a double-blind manner within 24 hours of their presentation with acute symptoms." | 9.06 | Early intervention with propranolol after acute myocardial infarction: serial left ventricular function determined by M-mode and cross-sectional echocardiography. ( Garg, KC; Kaul, UA; Verma, R, 1988) |
| "The Beta-Blocker Heart Attack Trial was a placebo-controlled, randomized, double-blind clinical trial of the long-term administration of propranolol hydrochloride to patients who had had at least one myocardial infarction." | 9.06 | Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia. ( Byington, RP; Capone, RJ; Friedman, LM; Furberg, CD; Goldstein, S; Lichstein, E, 1986) |
| "The present study compared the relative efficacy of a behavioral stress-management procedure versus a pharmacologic method (the beta-blocker propranolol) in reducing psychophysiological reactivity in post-myocardial infarction (MI) patients." | 9.06 | Comparative efficacy of behavioral stress management versus propranolol in reducing psychophysiological reactivity in post-myocardial infarction patients. ( Gaffney, FA; Gatchel, RJ; Smith, JE, 1986) |
| "The effect of the beta-adrenergic blocking agent propranolol on morbidity and mortality risk after acute myocardial infarction was studied relative to coronary anatomy and left ventricular (LV) ejection fraction in a subset of 406 patients participating in a randomized study of 3,837 patients in the Beta Blocker Heart Attack Trial (BHAT)." | 9.06 | Efficacy of propranolol therapy after acute myocardial infarction related to coronary arterial anatomy and left ventricular function. ( Capone, R; Dahdah, S; Edmiston, WA; Goldstein, S; Haywood, J; Jafri, SM; Khaja, F; McFarland, T; Schultz, L; Tilley, B, 1987) |
| "The incidence of congestive heart failure was studied in the Beta Blocker Heart Attack Trial in which postmyocardial infarction patients between the ages of 30 and 69 years, with no contraindication to propranolol, were randomly assigned to receive placebo (n = 1921) or propranolol 180 or 240 mg daily (n = 1916) 5 to 21 days after admission to the hospital for the event." | 9.06 | Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. ( Byington, R; Chadda, K; Curb, JD; Goldstein, S, 1986) |
| "The value of beta-blockade and of disopyramide phosphate in the immediate treatment of patients with suspected acute myocardial infarction was assessed in two placebo controlled trials." | 9.05 | Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate. ( Wilcox, RG, 1981) |
| "A trial of intravenous followed by oral propranolol, started within 4 h of onset of suspected myocardial infarction and continued over 27 h, was carried out in 735 patients; 364 received propranolol, 371 were controls." | 9.05 | Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. ( Barnaby, PF; Brown, MA; Clarke, ED; Geary, GG; Logan, RL; Norris, RM; Sharpe, DN, 1984) |
| "The Beta-Blocker Heart Attack Trial (BHAT) was a multicenter, randomized, double-blind, placebo-controlled trial that tested the effectiveness of propranolol in reducing the mortality rate in patients after myocardial infarction (MI)." | 9.05 | Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience. ( Harrist, R; Hubble, E; Lichstein, E; Morganroth, J, 1983) |
| "A randomized, double-blind, placebo-controlled trial of propranolol was carried out in 560 high-risk survivors of myocardial infarction enrolled at 12 Norwegian hospitals." | 9.05 | Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients. ( Hansteen, V, 1983) |
| "The Beta-Blocker Heart Attack Trial was a multicenter, randomized, double-blind, placebo-controlled trial of propranolol therapy in 3837 men and women with acute myocardial infarction." | 9.05 | Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial. ( Goldstein, S, 1983) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a placebo-controlled, randomized, double-blind clinical trial of the long-term administration of propranolol hydrochloride to persons who had had at least one confirmed myocardial infarction." | 9.05 | A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. ( , 1983) |
| "The relevance of the ancillary pharmacological properties of intrinsic sympathomimetic activity (ISA) and cardioselectivity to the haemodynamic profile following intravenous beta-blockade was examined in a randomised study of propranolol (16 mg), acebutolol (160 mg) or penbutolol (4 mg) in 30 patients with stable angina pectoris." | 9.05 | Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris. ( Ahuja, RC; Hussain, M; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "A prospective, randomised, double-blind study was performed to compare the effects of propranolol and placebo on sudden cardiac death in a high-risk group of patients who survived acute myocardial infarction." | 9.05 | One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. ( Andersen, A; Bakken, J; Dyrbekk, D; Eika, C; Hansteen, V; Hoff, PI; Knudsen, K; Lorentsen, E; Møinichen, E; Refsum, AM; Smith, P; Strøm, O; Søiland, K; Tromsdal, A, 1982) |
| "The effects of propranolol on lipids and lipoproteins were investigated in survivors of a recent myocardial infarction who were enrolled in the double-blind Beta-Blocker Heart Attack Trial." | 9.05 | Effects of propranolol on blood lipids and lipoproteins in myocardial infarction. ( Campbell, J; Capone, RJ; Hawkins, CM; Henderson, LO; Herbert, PN; McClure, D; Saritelli, A; Shulman, RS, 1983) |
| "The value of beta-blockade for suspected acute myocardial infarction was assessed by determining the six-week and one-year mortality rates in patients started on propranolol, atenolol, or placebo immediately on entry to a coronary care unit." | 9.05 | Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Wilcox, RG, 1980) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a National Heart, Lung, and Blood Institute-sponsored, multicenter, randomized, double-blind, and placebo-controlled trial designed to test whether the regular administration of propranolol hydrochloride to men and women who had experienced at least one myocardial infarction would result in a significant reduction in total mortality during a two- to four-year period." | 9.05 | A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. ( , 1982) |
| "The natural history of and the effect of propranolol on ventricular arrhythmias post-myocardial infarction were analyzed using data from the Beta-Blocker Heart Attack Trial (BHAT)." | 9.05 | Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias. ( Byington, R; Lichstein, E; Morganroth, J, 1985) |
| "Left ventricular function and exercise capacity were assessed in 79 patients randomised to receive intravenous and oral propranolol (n = 44) or conventional therapy (n = 35) within four hours of onset of their first myocardial infarction." | 9.05 | Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction. ( Barnaby, PF; Brandt, PW; Brown, MA; Geary, GG; Norris, RM, 1985) |
| "Propranolol is known to decrease ischaemic damage in developing myocardial infarction." | 8.75 | Propranolol and experimental myocardial infarction: substrate effects. ( Opie, LH; Thomas, M, 1976) |
| "Considering the recognized role of thyroid hormones on the cardiovascular system during health and disease, we hypothesized that type 2 deiodinase (D2) activity, the main activation pathway of thyroxine (T4)-to-triiodothyronine (T3), could be an important site to modulate thyroid hormone status, which would then constitute a possible target for β-adrenergic blocking agents in a myocardial infarction (MI) model induced by left coronary occlusion in rats." | 7.91 | Propranolol inhibits myocardial infarction-induced brown adipose tissue D2 activation and maintains a low thyroid hormone state in rats. ( Araujo, IG; Império, GE; Marassi, MP; Mecawi, AS; Olivares, EL; Reis, LC; Seara, FAC; Silva, ACM, 2019) |
| "We demonstrated that propranolol reduced the incidence of arrhythmias in a rat model of myocardial infarction by coronary artery occlusion." | 7.75 | MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. ( Dong, D; Li, B; Li, X; Lu, Y; Pan, Z; Qiao, G; Shan, H; Song, W; Xu, C; Yang, B; Zhang, B; Zhang, F; Zhang, Y, 2009) |
| "193 patients with their first non-Q-wave myocardial infarction (NQMI) were examined with the aim of studying the functional features of NQMI and estimate the influence of pre-hospital treatment with propranalol (PP), heparin and aspirin." | 7.73 | [Functional features of acute non-Q-wave myocardial infarction and the influence of pre-hospital treatment with propranalol, heparin and aspirin on the prognosis of the disease]. ( Baltabaev, TB; Beĭshenkulov, MT; Kudaĭbergenova, NT, 2005) |
| "Echocardiography, Doppler echocardiography and ECG mapping were used in 40 patients aged 30-70 years with first anterior Q-wave myocardial infarction (MI) for the study of effects of combination of fosinopril and propranolol (20 patients) in comparison with propranolol alone (20 patients) on hemodynamics and size of myocardial damage." | 7.72 | [Efficacy of combined use of fosinopril and propranolol in acute myocardial infarction]. ( Agaev, MM; Azizov, VA, 2003) |
| "Using microelectrode techniques, we investigated the electrophysiologic effects of cocaine on endocardial canine Purkinje fibers that survived 1 day of myocardial infarction." | 7.69 | Electrophysiologic effects of cocaine on subendocardial Purkinje fibers surviving 1 day of myocardial infarction. ( Assadi, M; Boutjdir, M; el-Sherif, N, 1995) |
| "We studied the effects of fluvoxamine and amitriptyline on epicardial activation delay of premature excitations, the effective refractory period, and the incidence of ventricular arrhythmias by programmed electrical ventricular stimulation in the canine heart after myocardial infarction." | 7.69 | Comparative electrophysiological effects of the antidepressants fluvoxamine and amitriptyline in the canine heart after myocardial infarction. ( Hashimoto, H; Ikeda, Y; Nakashima, M; Nishimoto, M; Shimazu, Y; Umemura, K, 1996) |
| "Myocardial infarction causes reversible depression of resting function and beta-adrenergic responsiveness in the remote and border zone areas, which is not prevented by metabolic therapy with orotic acid." | 7.69 | Depressed function in remote myocardium after myocardial infarction: influence of orotic acid. ( Cochrane, AD; Conyers, RA; Pathik, S; Rosenfeldt, FL; Smolich, JJ, 1996) |
| "By using receptor autoradiography to observe the distribution and density of receptors, the effects of propranolol, a beta-blocker, on beta-adrenergic receptor of experimental acute myocardial infarction (AMI) were studied." | 7.69 | Effects of propranolol on beta-adrenergic receptor of experimental acute myocardial infarction in rats. ( Guan, X; Liu, X; Liu, Z; Ouyang, X; Zhang, J, 1997) |
| "In the test with saline solution, 100% of the dogs developed ventricular fibrillation; this occurred in only 10% of the tests with propranolol (95% confidence interval 0." | 7.68 | Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. ( De Ferrari, GM; Grossoni, M; Patrono, C; Salvati, P; Schwartz, PJ; Ukmar, G; Vaga, L, 1993) |
| "The effects of halothane on the effective refractory period (ERP) and the ventricular activation were examined in a canine myocardial infarction model, and compared with those of propranolol." | 7.68 | Comparison of the effects of halothane and propranolol on the effective refractory period and the ventricular activation in a canine myocardial infarction model. ( Hashimoto, H; Ikeda, K; Imamura, S; Nakashima, M, 1992) |
| "In rats with chronic myocardial infarction (MI), we have examined the effects of prolonged beta-adrenergic blockade with propranolol on left ventricular (LV) performance, weight, and volumes." | 7.68 | Chronic propranolol treatment promotes left ventricular dilation without altering systolic function after large myocardial infarction in rats. ( Gay, RG; Goldman, S; Raya, TE, 1990) |
| "The effect of propranolol on precordial ST-segment elevation was studied in 24 patients with acute anterior myocardial infarction." | 7.67 | Usefulness of intravenous propranolol in predicting left anterior descending blood flow during anterior myocardial infarction. ( Gold, HK; Harper, RW; Leinbach, RC, 1984) |
| "Serum propranolol concentration, elimination t 1/2, and protein binding were studied after a combined intravenous/oral regimen in 20 subjects with myocardial infarction (MI) and 15 with chest pain (CP)." | 7.67 | Propranolol disposition after acute myocardial infarction. ( Norris, RM; Paxton, JW, 1984) |
| "Timolol and propranolol reduce the incidence of cardiac death after myocardial infarction (MI)." | 7.67 | Effects of timolol and propranolol on inducible sustained ventricular tachyarrhythmias in dogs with subacute myocardial infarction. ( Bigger, JT; Gang, ES; Uhl, EW, 1984) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 7.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| "The effects of treatment with L-thyroxine (T4) for 10-12 days on left ventricular (LV) function and myosin isoenzyme content in rats with LV dysfunction after myocardial infarction were studied." | 7.67 | Effects of 10- to 12-day treatment with L-thyroxine in rats with myocardial infarction. ( Aguirre, M; Gay, RG; Goldman, S; Graham, S; Morkin, E, 1988) |
| " Seven days later, the animals were challenged with a dose of isoproterenol which would produce massive myocardial infarction and 50-60% mortality in non-treated animals." | 7.67 | Prolonged protective effects following propranolol withdrawal against isoproterenol-induced myocardial infarction in normotensive and hypertensive rats. ( Wexler, BC, 1985) |
| "Prophylactic effects of sulfinpyrazone (100 mg/Kg), aspirin (5 mg/Kg, 50 mg/Kg), and propranolol (2 mg/Kg, 10 mg/Kg) on myocardial necrosis and hypertrophy induced by isoproterenol were examined." | 7.66 | Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis. ( Hashimoto, H; Ogawa, K, 1981) |
| "The experiments on anaesthetized dogs have shown that with artificial ventilation and open chest adrenalin in arrhythmogenic and nonarrythmogenic doses enhances glycogenolysis in the heart proportionally to the dose used Block of beta-adrenergic receptors by propranolol decreased the activation of glycogenolysis in the ischaemic zone and the frequency of ventricular fibrillation after occlusion of the coronary artery." | 7.66 | [Role of catecholamine in activating glycogenolysis in experimental myocardial infarct complicated by ventricular fibrillation]. ( Dolgova, NP, 1982) |
| "Hemodynamic effects of combined nitroglycerin and propranolol administration were investigated in patients with acute myocardial infarction." | 7.66 | Combined administration of nitroglycerin and propranolol to patients with acute myocardial infarction. ( Becker, LC; Come, PC; Flaherty, JT; Greene, HL; Pitt, B; Weisfeldt, ML; Weiss, JL, 1981) |
| "In the present study, the effects of morphine and pethidine on coronary vessel resistance (CPP), blood pressure (BP), and experimental myocardial infarction-induced cardiac arrhythmia were investigated." | 7.66 | Effects of morphine and pethidine on coronary vascular resistance, blood pressure, and myocardial infarction-induced cardiac arrhythmias. ( Bhargava, KP; Mishra, N; Pant, KK; Singh, N; Sinha, JN; Verma, VK, 1983) |
| "The effects of propranolol on myocardial perfusion and metabolism during acute myocardial infarction were studied in 18 mongrel dogs." | 7.66 | Myocardial infarction in the dog: effects of intravenous propranolol. ( Fox, K; Selwyn, A; Welman, E, 1980) |
| "The hemodynamic effects of a single oral dose of 20 mg of nifedipine were studied in 21 stable patients after an acute myocardial infarction before withdrawal of Swan-Ganz and intra-arterial catheters." | 7.66 | Hemodynamic effects of a single oral dose of nifedipine following acute myocardial infarction. ( Debaisieux, JC; Mizgala, HF; Theroux, P; Waters, DD, 1980) |
| "Propranolol was administered intravenously to 12 patients with presumed acute myocardial infarction in the attempt to limit infarct size." | 7.66 | Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and serial creatine kinase assessment. ( Cairns, JA; Klassen, GA, 1981) |
| "The ability of practolol and propranolol of prevent ventricular fibrillation in experimental anterior myocardial infarction was compared in dogs subjected to ligation of the left anterior descending and first septal coronary arteries." | 7.66 | Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion. ( Gillis, RA; Pearle, DL; Williford, D, 1978) |
| " Propranolol, 0-1 mg/kg intravenously, was administered to 20 patients with acute myocardial infarction without clinical evidence of left ventricular failure." | 7.65 | Propranolol in acute myocardial infarction in man: effects of haemodynamics and myocardial oxygenation. ( Ayres, SM; Mueller, H, 1976) |
| "The effect of intravenous administration of propranolol (3 to 10 mg) was studied in 12 patients with acute anterior transmural myocardial infarction within the first 8 hours from the onset of pain." | 7.65 | Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction. ( Gold, HK; Leinbach, RC; Maroko, PR, 1976) |
| "The haemodynamic effects of intravenous propranolol at low dosage (1 and 2 mg) have been evaluated on 14 patients in the acute stage of myocardial infarction." | 7.65 | Evaluation of haemodynamic effects of intravenous propranolol at low dosage (1 and 2 mg) in acute myocardial infarction. ( Letac, B; Letournel, J, 1975) |
| "Isoproterenol (ISO), a drug which causes an increased strength of myocardial contraction when administered to animals in mug/kg doses, causes myocardial necrosis when given mg/kg doses." | 7.65 | Calcium as mediator of isoproterenol-induced myocardial necrosis. ( Bloom, S; Davis, DL, 1972) |
| "The results from the Beta-Blocker Heart Attack Trial for patients ages 60-69 years indicate a significant beneficial effect of propranolol and an overall reduction in mortality of 33%." | 6.65 | Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience. ( Hawkins, CM; Richardson, DW; Vokonas, PS, 1983) |
| "Propranolol did not cause significant additional changes in plasma catecholamine contents during the subsequent 3 d." | 6.65 | Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. ( Ayres, SM; Mueller, HS, 1980) |
| "Treatment with propranolol had a negative chronotropic effect throughout the observation period of 72 h." | 5.32 | Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats. ( Briest, W; Deten, A; Holzl, A; Volz, HC; Zimmer, HG, 2003) |
| "Pretreatment with propranolol or labetalol counteracted the appearance of the myocardial histological alterations and the associated ECG and biochemical lesions." | 5.32 | Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure. ( Accinni, R; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S, 2004) |
| "In propranolol-treated rats, hypertrophy of the LV septum, papillary muscle, and right ventricle were similar to those of the infarcted control." | 5.31 | Effects of prolonged propranolol treatment on left ventricular remodeling and oxidative stress after myocardial infarction in rats. ( Bonnefont-Rousselot, D; Komajda, M; Lechat, P; Mansuy, P; Mougenot, N; Raillecove, F; Ramirez-Gil, JF, 2000) |
| "The nipradilol-treated and captopril-treated rats had significantly smaller LVEDVI than did the vehicle-treated rats with both moderate and large infarction (large infarct: 2." | 5.30 | Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats. ( Nakamura, M; Sonoki, H; Takeshita, A, 1997) |
| "The propranolol treated animals had higher LV end-diastolic pressures (27+/-2* vs 20+/(-3 mmHg) and a more restricted LV diastolic filling pattern (increased ratio of early to late filling velocities and more rapid E wave deceleration rate)." | 5.30 | Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. ( Douglas, PS; Katz, SE; Litwin, SE; Morgan, JP, 1999) |
| "In the basal state, rats with congestive heart failure had significantly (p less than 0." | 5.27 | Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure. ( Brenner, BM; Duchin, KL; Ichikawa, I; Pfeffer, J; Pfeffer, M, 1984) |
| "To evaluate the possible influence of sympathetic activation on the haemodynamic response to intravenous beta-blockade, the dose-response characteristics of three boluses of propranolol were evaluated in 8 patients with uncomplicated infarction and compared in a similar number of patients with stable angina." | 5.27 | Enhanced haemodynamic effects of propranolol in acute myocardial infarction. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP; Walker, C, 1984) |
| "The arrhythmias were prevented by higher doses of the calcium antagonist verapamil which, however, decreased the survival times." | 5.26 | Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction. ( Bernauer, W, 1982) |
| "Nitroglycerin has a reducing influence on these changes, but not down to the initial level." | 5.26 | [The treatment of acute myocardial infarctions with beta-receptor-blockers. II. Hemodynamic effects of propranolol with and without combination therapy with nitroglycerin (author's transl)]. ( Hochrein, H; Lehmann, HU; Oeff, M; Witt, E, 1981) |
| "6) were given propranolol- because of its alleged myocardium-protecting properties - intravenously at a dosage of 0." | 5.26 | [Treatment of acute myocardial infarction with betareceptor blocking agents. I. Hemodynamic effects of Propranolol in combination with digitalis (author's transl)]. ( Hochrein, H; Lehmann, HU; Oeff, M; Witt, E, 1981) |
| "1 The effects of propranolol and practolol, at equivalent myocardial beta-adrenoceptor blocking doses, (as assessed by the degree of shift of isoprenaline dose-response curves) were investigated in anaesthetized greyhounds before and after acute coronary artery ligation." | 5.26 | Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. ( Marshall, RJ; Parratt, JR, 1976) |
| "Treatment with propranolol resulted in a significant reduction in the infarct size." | 5.26 | Prolonged epicardial mapping in myocardial infarction: the effects of propranolol and intra-aortic balloon pumping following coronary artery occlusion. ( Butt, KM; Dastgir, G; Ergin, MA; Stuckey, JH, 1976) |
| "When procainamide was reinfuse after propranolol (1 mg/kg), its hemodynamic effects were not significantly different from those observed before propranolol in both groups IA and IIA." | 5.25 | Hemodynamic effects of procainamide and quinidine and the influence of beta-blockade before and after experimental myocardial infarction. ( Côté, P; Harrison, DC; Schook, J; Schroeder, JS, 1975) |
| " Changes in C-reactive protein (CRP) between days 1 and 5 after myocardial infarction were evaluated in 189 patients treated with simvastatin alone (S), beta blockers alone (B; propranolol or metoprolol), S + B, or neither of these 2 medications (N) in a prospective observational cohort." | 5.14 | Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarction. ( Gurgel, A; Macedo, AC; Morato, TN; Munhoz, DB; Quinaglia e Silva, JC; Sever, P; Sposito, AC, 2009) |
| "We have previously shown that administration of a relatively large weight-based IC dose of the beta blocker propranolol before PCI decreases the incidence of post-PCI myocardial infarction (MI) and improves short- and long-term outcome." | 5.13 | Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. ( Akhtar, A; Anzuini, A; Birnbaum, Y; Chamoun, A; Gupta, R; Kumar, D; Lev, E; Lui, C; McGehee, T; Osman, A; Paniagua, O; Pohwani, A; Schwarz, ER; Uretsky, BF; Wang, FW, 2008) |
| "Studying of influence of monopril, propranolol and heparin on central hemodynamics, cardiodynamics, volume of defeat and clinical current of myocardial infarction (MI) in the early and late hospital period of disease." | 5.13 | [Clinical efficiency of the use of monopril, propanolol and heparinum in stationary rehabilitation of patients with myocardial infarction]. ( Agaev, MM, 2008) |
| "This study evaluated the effects of propranolol on recovery of heart rate variability (HRV) after acute myocardial infarction and its relation to outcome in the Beta-blocker Heart Attack Trial (BHAT)." | 5.10 | Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. ( Horwitz, RI; Ickovics, JR; Lampert, R; Lee, FA; Viscoli, CJ, 2003) |
| "The Danish Verapamil Infarction Trial II (DAVIT II) demonstrated from the second postinfarction week, that long term treatment with verapamil significantly improved reinfarction free survival after an acute myocardial infarction (AMI)." | 5.08 | Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II). ( Hagerup, L; Hansen, JF; Mellemgaard, K; Sigurd, B; Steinmetz, E; Vaage-Nilsen, M, 1995) |
| "At 32-month follow-up of older patients with prior myocardial infarction, congestive heart failure, and a left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors, and also with digoxin if atrial fibrillation was present, propranolol caused a 35% significant reduction in total mortality and a 37% significant decrease in total mortality plus nonfatal myocardial infarction compared with no propranolol." | 5.08 | Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus ( Ahn, C; Aronow, WS; Kronzon, I, 1997) |
| "A total of 266 patients entered into a study comparing the effect of intravenous magnesium and propranolol following acute myocardial infarction." | 5.07 | A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction. ( Abraham, AS; Balkin, J; Ilan, M; Klutstein, M; Rosenmann, D; Zion, MM, 1994) |
| "Random assignment to propranolol hydrochloride or placebo 5 to 21 days following a myocardial infarction." | 5.07 | The relationship of treatment adherence to the risk of death after myocardial infarction in women. ( Gallagher, EJ; Horwitz, RI; Viscoli, CM, 1993) |
| "To develop a strategy for evaluating drug efficacy over time that accounts for heterogeneous clinical courses evolving after initiation of therapy and to demonstrate its use in assessing the long-term therapeutic benefit of propranolol after myocardial infarction." | 5.07 | Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness. ( Horwitz, RI; Singer, BH; Viscoli, CM, 1993) |
| "We studied the effect of propranolol administration on risk assessment based on submaximal exercise testing performed early after myocardial infarction." | 5.07 | Propranolol therapy alters estimation of potential cardiovascular risk derived from submaximal postinfarction exercise testing. ( Adams, KF; Bradley, DA; Curtis, JL; Houghton, JL; Koch, G; Patterson, JH, 1991) |
| "3837 Men and women randomised 5-21 days after an acute myocardial infarction to treatment with placebo or propranolol for up to 40 months." | 5.06 | Long term propranolol treatment and changes in body weight after myocardial infarction. ( Byington, RP; Furberg, CD; Rössner, S; Taylor, CL, 1990) |
| "To provide insight into the protective effect of propranolol on mortality after myocardial infarction observed in the beta-Blocker Heart Attack Trial, the time of occurrence of sudden cardiac death was examined in this population." | 5.06 | Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience). ( Peters, RW, 1990) |
| "The effect of propranolol on mortality and reinfarction after acute myocardial infarction (AMI) in cigarette smokers and nonsmokers was studied in the Beta Blocker Heart Attack Trial." | 5.06 | Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. ( Goldstein, S; Jafri, SM; Peters, R; Schultz, LR; Tilley, BC, 1990) |
| "In the Beta Blocker Heart Attack Trial (BHAT), 3837 patients were randomized to propranolol (180-240 mg/day) or placebo 5-21 days after a documented myocardial infarction and were followed in a double blind manner for a mean period of 25 months." | 5.06 | Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group. ( Barker, A; Byington, RP; Peters, RW; Yusuf, S, 1990) |
| "Beta-blockers are known to be effective against post-infarction ventricular arrhythmias and amiodarone has recently been shown to have this property." | 5.06 | [Comparative efficacy of amiodarone and propranolol on ventricular arrhythmia in the post-infarction period]. ( Blondeau, M; Brunet, M; Fedorowsky, A; Fournier, C; Gensous, D; Kindermans, M; Tournadre, P, 1989) |
| "The purpose of this prospective randomized trial was to compare the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias during the first 6 months following myocardial infarction (MI)." | 5.06 | Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction. ( Bah, M; Blondeau, M; Boujon, B; Brunet, M; Fournier, C; Giudicelli, JF; Kindermans, M; Tournadre, P, 1989) |
| "A multicentred, randomised, blind study was started in 1978 to compare propranolol or hyaluronidase with placebo in patients with acute myocardial infarction admitted within 18 hours of onset of symptoms." | 5.06 | Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS). ( Braunwald, E; Croft, C; Gold, HK; Hartwell, TD; Jaffe, AS; Muller, JE; Mullin, SM; Parker, C; Passamani, ER; Roberts, R, 1988) |
| "4 years) with uncomplicated acute myocardial infarction were randomly assigned to propranolol therapy (n = 25) or placebo (n = 25) in a double-blind manner within 24 hours of their presentation with acute symptoms." | 5.06 | Early intervention with propranolol after acute myocardial infarction: serial left ventricular function determined by M-mode and cross-sectional echocardiography. ( Garg, KC; Kaul, UA; Verma, R, 1988) |
| "The Beta-Blocker Heart Attack Trial was a randomized clinical trial of propranolol versus placebo in 3837 patients after myocardial infarction." | 5.06 | Are 24 hours of ambulatory ECG monitoring necessary for a patient after infarction? ( Davis, BR; Friedman, LM; Lichstein, E, 1988) |
| "The Beta-Blocker Heart Attack Trial was a placebo-controlled, randomized, double-blind clinical trial of the long-term administration of propranolol hydrochloride to patients who had had at least one myocardial infarction." | 5.06 | Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia. ( Byington, RP; Capone, RJ; Friedman, LM; Furberg, CD; Goldstein, S; Lichstein, E, 1986) |
| "The present study compared the relative efficacy of a behavioral stress-management procedure versus a pharmacologic method (the beta-blocker propranolol) in reducing psychophysiological reactivity in post-myocardial infarction (MI) patients." | 5.06 | Comparative efficacy of behavioral stress management versus propranolol in reducing psychophysiological reactivity in post-myocardial infarction patients. ( Gaffney, FA; Gatchel, RJ; Smith, JE, 1986) |
| "In the Beta Blocker Heart Attack Trial, a double blind, randomized, controlled study, patients taking propranolol (180 or 240 mg/day) initiated 5-21 days post myocardial infarction had 26% fewer deaths than those taking placebo over a 25 month (mean) followup." | 5.06 | Mortality in the beta blocker heart attack trial: circumstances surrounding death. ( Arensberg, D; Barker, A; Byington, R; Friedman, LM; Goldstein, S; Laubach, C; Peters, RW; Romhilt, DW; Wilner, GW, 1987) |
| "The effect of the beta-adrenergic blocking agent propranolol on morbidity and mortality risk after acute myocardial infarction was studied relative to coronary anatomy and left ventricular (LV) ejection fraction in a subset of 406 patients participating in a randomized study of 3,837 patients in the Beta Blocker Heart Attack Trial (BHAT)." | 5.06 | Efficacy of propranolol therapy after acute myocardial infarction related to coronary arterial anatomy and left ventricular function. ( Capone, R; Dahdah, S; Edmiston, WA; Goldstein, S; Haywood, J; Jafri, SM; Khaja, F; McFarland, T; Schultz, L; Tilley, B, 1987) |
| "The incidence of congestive heart failure was studied in the Beta Blocker Heart Attack Trial in which postmyocardial infarction patients between the ages of 30 and 69 years, with no contraindication to propranolol, were randomly assigned to receive placebo (n = 1921) or propranolol 180 or 240 mg daily (n = 1916) 5 to 21 days after admission to the hospital for the event." | 5.06 | Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. ( Byington, R; Chadda, K; Curb, JD; Goldstein, S, 1986) |
| "The value of beta-blockade and of disopyramide phosphate in the immediate treatment of patients with suspected acute myocardial infarction was assessed in two placebo controlled trials." | 5.05 | Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate. ( Wilcox, RG, 1981) |
| "The Beta Blocker Heart Attack Trial (BHAT) is a multicenter, randomized, double-blind, placebo control clinical trial sponsored by the National Heart, Lung, and Blood Institute designed to test the effectiveness of regular propranolol administration in reducing total mortality in patients who have survived a recent acute myocardial infarction." | 5.05 | Beta Blocker Heart Attack Trial: design features. ( , 1981) |
| "Recently completed Beta-Blocker Heart Attack Trial in which propranolol was administered to patients following an acute myocardial infarction resulted in a 26% decrease in total mortality and a 23% decrease in total coronary events in the propranolol-treated patients as compared to the placebo patients during the average follow-up of 25 months." | 5.05 | The Beta-Blocker Heart Attack Trial in perspective. ( Goldstein, S, 1983) |
| "A trial of intravenous followed by oral propranolol, started within 4 h of onset of suspected myocardial infarction and continued over 27 h, was carried out in 735 patients; 364 received propranolol, 371 were controls." | 5.05 | Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. ( Barnaby, PF; Brown, MA; Clarke, ED; Geary, GG; Logan, RL; Norris, RM; Sharpe, DN, 1984) |
| "The Beta-Blocker Heart Attack Trial was a randomized double blind controlled trial comparing propranolol with placebo in 3837 patients with a recent myocardial infarction." | 5.05 | Statistical aspects of early termination in the beta-blocker heart attack trial. ( DeMets, DL; Friedman, LM; Hardy, R; Lan, KK, 1984) |
| "The Beta-Blocker Heart Attack Trial (BHAT) was a multicentered, double-blind, randomized, placebo-controlled clinical trial designed to test the efficacy of long-term therapy with propranolol given to survivors of an acute myocardial infarction (MI)." | 5.05 | Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group. ( Byington, RP, 1984) |
| "The relevance of the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds to the clinical therapeutics of acute myocardial infarction was evaluated in 20 patients with an uncomplicated acute myocardial infarction by comparing the haemodynamic effects of equivalent beta-blocking doses of propranolol (non-cardioselective; no ISA) and pindolol (non-cardioselective; 50% ISA)." | 5.05 | Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction? ( Ahuja, RC; Hafizullah, M; Hussain, M; Nelson, GI; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "The Beta-Blocker Heart Attack Trial (BHAT) was a multicenter, randomized, double-blind, placebo-controlled trial that tested the effectiveness of propranolol in reducing the mortality rate in patients after myocardial infarction (MI)." | 5.05 | Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience. ( Harrist, R; Hubble, E; Lichstein, E; Morganroth, J, 1983) |
| "A randomized, double-blind, placebo-controlled trial of propranolol was carried out in 560 high-risk survivors of myocardial infarction enrolled at 12 Norwegian hospitals." | 5.05 | Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients. ( Hansteen, V, 1983) |
| "The Beta-Blocker Heart Attack Trial was a multicenter, randomized, double-blind, placebo-controlled trial of propranolol therapy in 3837 men and women with acute myocardial infarction." | 5.05 | Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial. ( Goldstein, S, 1983) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a placebo-controlled, randomized, double-blind clinical trial of the long-term administration of propranolol hydrochloride to persons who had had at least one confirmed myocardial infarction." | 5.05 | A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. ( , 1983) |
| "The relevance of the ancillary pharmacological properties of intrinsic sympathomimetic activity (ISA) and cardioselectivity to the haemodynamic profile following intravenous beta-blockade was examined in a randomised study of propranolol (16 mg), acebutolol (160 mg) or penbutolol (4 mg) in 30 patients with stable angina pectoris." | 5.05 | Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris. ( Ahuja, RC; Hussain, M; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "A multicenter randomized single-blind study was performed to evaluate the effects of propranolol administered during the evolution of myocardial infarction." | 5.05 | Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. ( Croft, C; Gold, HK; Hartwell, TD; Jaffe, AS; Muller, JE; Mullin, SM; Parker, C; Passamani, ER; Poole, WK; Roberts, R, 1984) |
| "A prospective, randomised, double-blind study was performed to compare the effects of propranolol and placebo on sudden cardiac death in a high-risk group of patients who survived acute myocardial infarction." | 5.05 | One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. ( Andersen, A; Bakken, J; Dyrbekk, D; Eika, C; Hansteen, V; Hoff, PI; Knudsen, K; Lorentsen, E; Møinichen, E; Refsum, AM; Smith, P; Strøm, O; Søiland, K; Tromsdal, A, 1982) |
| "The effects of propranolol on lipids and lipoproteins were investigated in survivors of a recent myocardial infarction who were enrolled in the double-blind Beta-Blocker Heart Attack Trial." | 5.05 | Effects of propranolol on blood lipids and lipoproteins in myocardial infarction. ( Campbell, J; Capone, RJ; Hawkins, CM; Henderson, LO; Herbert, PN; McClure, D; Saritelli, A; Shulman, RS, 1983) |
| "The value of beta-blockade for suspected acute myocardial infarction was assessed by determining the six-week and one-year mortality rates in patients started on propranolol, atenolol, or placebo immediately on entry to a coronary care unit." | 5.05 | Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Wilcox, RG, 1980) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a National Heart, Lung, and Blood Institute-sponsored, multicenter, randomized, double-blind, and placebo-controlled trial designed to test whether the regular administration of propranolol hydrochloride to men and women who had experienced at least one myocardial infarction would result in a significant reduction in total mortality during a two- to four-year period." | 5.05 | A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. ( , 1982) |
| "The London School of Hygiene Cardiovascular Questionnaire (Rose Questionnaire) was compared with physician opinion in assessment of angina pectoris in the Beta-Blocker Heart Attack Trial, a long-term (June 1978-October 1981), multicenter study of 3,837 post-myocardial infarction patients, half of whom were treated with propranolol and half with placebo." | 5.05 | Assessment of angina pectoris after myocardial infarction: comparison of "Rose Questionnaire" with physician judgment in the Beta-Blocker Heart Attack Trial. ( Byington, RP; Friedman, LM, 1985) |
| "The natural history of and the effect of propranolol on ventricular arrhythmias post-myocardial infarction were analyzed using data from the Beta-Blocker Heart Attack Trial (BHAT)." | 5.05 | Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias. ( Byington, R; Lichstein, E; Morganroth, J, 1985) |
| "Left ventricular function and exercise capacity were assessed in 79 patients randomised to receive intravenous and oral propranolol (n = 44) or conventional therapy (n = 35) within four hours of onset of their first myocardial infarction." | 5.05 | Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction. ( Barnaby, PF; Brandt, PW; Brown, MA; Geary, GG; Norris, RM, 1985) |
| "Twenty-four-hour electrocardiographic tape-recording was used to investigate the incidence of arrhythmias in patients with suspected myocardial infarction who were receiving either propranolol, atenolol, or placebo." | 5.04 | Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction. ( Banks, DC; Edwards, B; Fentem, PH; Hampton, JR; Roland, JM; Wilcox, RG, 1979) |
| " Although nifedipine is highly effective against vasospastic angina, its use in threatened myocardial infarction or severe unstable angina is not supported by recent studies, unless combined with a beta-blocker." | 4.77 | Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials. ( Opie, LH, 1988) |
| "Propranolol is known to decrease ischaemic damage in developing myocardial infarction." | 4.75 | Propranolol and experimental myocardial infarction: substrate effects. ( Opie, LH; Thomas, M, 1976) |
| "Considering the recognized role of thyroid hormones on the cardiovascular system during health and disease, we hypothesized that type 2 deiodinase (D2) activity, the main activation pathway of thyroxine (T4)-to-triiodothyronine (T3), could be an important site to modulate thyroid hormone status, which would then constitute a possible target for β-adrenergic blocking agents in a myocardial infarction (MI) model induced by left coronary occlusion in rats." | 3.91 | Propranolol inhibits myocardial infarction-induced brown adipose tissue D2 activation and maintains a low thyroid hormone state in rats. ( Araujo, IG; Império, GE; Marassi, MP; Mecawi, AS; Olivares, EL; Reis, LC; Seara, FAC; Silva, ACM, 2019) |
| " Three weeks after inducing myocardial infarction (MI), rats were treated daily with or without 20 and 75 mg/kg atenolol, a selective β(1) -AR antagonist, or propranolol, a non-selective β-AR antagonist, for 5 weeks." | 3.77 | β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure. ( Dhalla, NS; Elimban, V; Machackova, J; Sanganalmath, SK, 2011) |
| " At the end of treatment period, MI was induced by administering isoproterenol (ISO) or by subjecting heart to ischemia reperfusion injury (IRI)." | 3.75 | Role of Sida cordifolia L. leaves on biochemical and antioxidant profile during myocardial injury. ( Asdaq, SM; Kubavat, JB, 2009) |
| "We demonstrated that propranolol reduced the incidence of arrhythmias in a rat model of myocardial infarction by coronary artery occlusion." | 3.75 | MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. ( Dong, D; Li, B; Li, X; Lu, Y; Pan, Z; Qiao, G; Shan, H; Song, W; Xu, C; Yang, B; Zhang, B; Zhang, F; Zhang, Y, 2009) |
| "193 patients with their first non-Q-wave myocardial infarction (NQMI) were examined with the aim of studying the functional features of NQMI and estimate the influence of pre-hospital treatment with propranalol (PP), heparin and aspirin." | 3.73 | [Functional features of acute non-Q-wave myocardial infarction and the influence of pre-hospital treatment with propranalol, heparin and aspirin on the prognosis of the disease]. ( Baltabaev, TB; Beĭshenkulov, MT; Kudaĭbergenova, NT, 2005) |
| " The elevated ST segments of electrocardiogram (ECG), cardiac arrhythmias, and ratio of infarct size/risk zone were compared among the normal control (NC), ischemia and reperfusion (IR), electro-acupuncture (EA), electro-acupuncture plus propranolol (EAP), and EA at nonacupoint (EAN) groups." | 3.73 | A preliminary study on the cardioprotection of acupuncture pretreatment in rats with ischemia and reperfusion: involvement of cardiac beta-adrenoceptors. ( Fu, W; Gao, J; Jin, Z; Yu, X, 2006) |
| "Echocardiography, Doppler echocardiography and ECG mapping were used in 40 patients aged 30-70 years with first anterior Q-wave myocardial infarction (MI) for the study of effects of combination of fosinopril and propranolol (20 patients) in comparison with propranolol alone (20 patients) on hemodynamics and size of myocardial damage." | 3.72 | [Efficacy of combined use of fosinopril and propranolol in acute myocardial infarction]. ( Agaev, MM; Azizov, VA, 2003) |
| "The effects of pretreatment with cariporide on myocardial infarction and ventricular arrhythmias in a rat model of ischemia/reperfusion were compared with those of nicorandil, propranolol, and nifedipine." | 3.72 | Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs. ( Beguier, B; Wajima, T; Yaguchi, M, 2004) |
| "The effects of SMP-300, an orally active, potent, and selective Na+/H+ exchange inhibitor, were evaluated and compared with those of nifedipine, propranolol, and nicorandil on three experimental angina models and on myocardial infarction in rats." | 3.71 | Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats. ( Matsui, K; Ohashi, N; Sasabe, M; Yamamoto, S, 2002) |
| "Carvedilol, a selective alpha1 and non-selective beta-adrenoceptor antagonist and antioxidant, has been shown to provide significant cardiac protection in animal models of myocardial ischemia." | 3.70 | Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model. ( Arch, JR; Cheng, HY; Feuerstein, G; Hieble, JP; Liu, GL; Ma, XL; Ruffolo, RR; Yue, TL, 1998) |
| " Of 10,991 myocardial infarction survivors dispensed atenolol, metoprolol, propranolol, or timolol, 9458 (86." | 3.70 | Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. ( Anderson, GM; Clark, JP; Gurwitz, JH; Lau, P; Rochon, PA; Shear, NH; Tu, JV, 1999) |
| ") reduced or completely abolished the ventricular fibrillation (VF) induced by reperfusion after 5 min of regional ischemia, while lidocaine, a class I antiarrhythmic agent, showed less effect against VF as compared with FR168888." | 3.70 | Protective effect of FR168888, a new Na+/H+ exchange inhibitor, on ischemia and reperfusion-induced arrhythmia and myocardial infarction in rats: in comparison with other cardioprotective compounds. ( Goto, T; Maeda, K; Ohara, F; Ohkubo, K; Ozaki, T; Seki, J; Sugimoto, T; Yamamoto, N, 1999) |
| "Using microelectrode techniques, we investigated the electrophysiologic effects of cocaine on endocardial canine Purkinje fibers that survived 1 day of myocardial infarction." | 3.69 | Electrophysiologic effects of cocaine on subendocardial Purkinje fibers surviving 1 day of myocardial infarction. ( Assadi, M; Boutjdir, M; el-Sherif, N, 1995) |
| "We studied the effects of fluvoxamine and amitriptyline on epicardial activation delay of premature excitations, the effective refractory period, and the incidence of ventricular arrhythmias by programmed electrical ventricular stimulation in the canine heart after myocardial infarction." | 3.69 | Comparative electrophysiological effects of the antidepressants fluvoxamine and amitriptyline in the canine heart after myocardial infarction. ( Hashimoto, H; Ikeda, Y; Nakashima, M; Nishimoto, M; Shimazu, Y; Umemura, K, 1996) |
| "Myocardial infarction causes reversible depression of resting function and beta-adrenergic responsiveness in the remote and border zone areas, which is not prevented by metabolic therapy with orotic acid." | 3.69 | Depressed function in remote myocardium after myocardial infarction: influence of orotic acid. ( Cochrane, AD; Conyers, RA; Pathik, S; Rosenfeldt, FL; Smolich, JJ, 1996) |
| "By using receptor autoradiography to observe the distribution and density of receptors, the effects of propranolol, a beta-blocker, on beta-adrenergic receptor of experimental acute myocardial infarction (AMI) were studied." | 3.69 | Effects of propranolol on beta-adrenergic receptor of experimental acute myocardial infarction in rats. ( Guan, X; Liu, X; Liu, Z; Ouyang, X; Zhang, J, 1997) |
| " The comparative ability of carvedilol and propranolol to reduce infarct size in experimental models of acute myocardial infarction in the rat, pig and dog has been investigated utilizing a variety of experimental techniques." | 3.68 | Cardioprotective potential of carvedilol. ( Bril, A; Feuerstein, GZ; Ruffolo, RR, 1993) |
| "Myocardial infarction induced by coronary occlusion (O model) and reperfusion (R model) and the effects of nitroglycerin (Nit), propranolol (Pro), lidocaine (Lid), nifedipine (Nif), and saline were studied in rats by image analysis and weighing methods." | 3.68 | [Image analysis of effects of 4 drugs on coronary occlusion and myocardial reperfusion injury]. ( Han, L; Tang, ZM, 1993) |
| "In the test with saline solution, 100% of the dogs developed ventricular fibrillation; this occurred in only 10% of the tests with propranolol (95% confidence interval 0." | 3.68 | Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. ( De Ferrari, GM; Grossoni, M; Patrono, C; Salvati, P; Schwartz, PJ; Ukmar, G; Vaga, L, 1993) |
| "The effects of halothane on the effective refractory period (ERP) and the ventricular activation were examined in a canine myocardial infarction model, and compared with those of propranolol." | 3.68 | Comparison of the effects of halothane and propranolol on the effective refractory period and the ventricular activation in a canine myocardial infarction model. ( Hashimoto, H; Ikeda, K; Imamura, S; Nakashima, M, 1992) |
| " Propranolol treatment improved basal isometric muscle function and beta-adrenergic receptor density in rats after myocardial infarction but did not improve adenylate cyclase activity or isoproterenol-stimulated muscle function." | 3.68 | Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction. ( Bellah, KL; Goldman, S; Raya, TE; Roeske, WR; Warner, AL, 1992) |
| "The aim was to evaluate in a minipig model of acute myocardial infarction the cardioprotection provided by the beta adrenoceptor blocking and vasodilating activities present in carvedilol; comparison was made to the pure beta adrenoceptor antagonist, propranolol." | 3.68 | Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol. ( Bril, A; DiMartino, MJ; Feuerstein, GZ; Linee, P; Poyser, RH; Ruffolo, RR; Slivjak, M; Smith, EF, 1992) |
| "Survivors of myocardial infarction with less than 2 PVC/h on 24-h ambulatory electrocardiography were followed up for an average of 25 months (11 to 40 months) while receiving a placebo (1,222 patients) or propranolol, 180 or 240 mg/day (1,234 patients)." | 3.68 | The prognostic significance of very low frequency ventricular ectopic activity in survivors of acute myocardial infarction. BHAT Study Group. ( Kostis, JB; Wilson, AC, 1992) |
| "In rats with chronic myocardial infarction (MI), we have examined the effects of prolonged beta-adrenergic blockade with propranolol on left ventricular (LV) performance, weight, and volumes." | 3.68 | Chronic propranolol treatment promotes left ventricular dilation without altering systolic function after large myocardial infarction in rats. ( Gay, RG; Goldman, S; Raya, TE, 1990) |
| "Propranolol antihemolytic test parameters calculated with the Hill mathematical model from dose-dependent curves of saturation were studied in 27 patients with myocardial infarction." | 3.68 | [Beta-adrenergic reactivity in patients with myocardial infarct according to the antihemolytic test]. ( Anshelevich, IuV; Okun', KV; Sominskiĭ, VN, 1990) |
| "Paired bicycle ergometry [correction of veloergometric] testing was carried out in 94 patients with a history of myocardial infarction before and after single intakes of 40 mg of obsidan and 200 mg of labetalol." | 3.68 | [The use of labetalol and propranolol in patients who have had a myocardial infarct]. ( Babov, KD; Il'iash, MG; Kravtsova, LA; Shcherbak, IaIu, 1990) |
| "The effect of propranolol on precordial ST-segment elevation was studied in 24 patients with acute anterior myocardial infarction." | 3.67 | Usefulness of intravenous propranolol in predicting left anterior descending blood flow during anterior myocardial infarction. ( Gold, HK; Harper, RW; Leinbach, RC, 1984) |
| "Serum propranolol concentration, elimination t 1/2, and protein binding were studied after a combined intravenous/oral regimen in 20 subjects with myocardial infarction (MI) and 15 with chest pain (CP)." | 3.67 | Propranolol disposition after acute myocardial infarction. ( Norris, RM; Paxton, JW, 1984) |
| "In patients with mild hypertension, flurbiprofen in a dose of 100 mg daily for 7 days attenuated the hypotensive effect of a single dose of propranolol 80 mg but not of atenolol 100 mg." | 3.67 | Flurbiprofen interaction with single doses of atenolol and propranolol. ( Hawksworth, GM; McLean, I; Petrie, JC; Webster, J, 1984) |
| "Timolol and propranolol reduce the incidence of cardiac death after myocardial infarction (MI)." | 3.67 | Effects of timolol and propranolol on inducible sustained ventricular tachyarrhythmias in dogs with subacute myocardial infarction. ( Bigger, JT; Gang, ES; Uhl, EW, 1984) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 3.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| "The comparative haemodynamic dose-response effects of beta- (propranolol) or alpha- plus beta-blockade (labetalol) were evaluated in a randomised between-group study of 16 patients with an uncomplicated acute myocardial infarction." | 3.67 | Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction. ( Ahuja, RC; Nelson, GI; Silke, B; Taylor, SH; Walker, C, 1984) |
| "Blood gamma-endorphin concentrations were repeatedly measured, using an original radioimmunoassay, in patients with myocardial infarction." | 3.67 | [Blood endorphin levels in myocardial infarction]. ( Bykov, II; Dmitrieva, OF; Ivanikov, IO; Kolesov, SB; Maĭorov, NI, 1987) |
| "Effect of UM-272, a dimethyl propranolol has been studied in experimental myocardial necrosis induced by isoproterenol (ISP, 85 mg/kg, SC X 2 days) in rats." | 3.67 | Alterations in isoproterenol-induced cardiac metabolic changes by a quaternary analog of propranolol, UM-272. ( Gupta, M; Gupta, MP; Manchanda, SC; Seth, SD; Srivastava, LM, 1985) |
| "The effects of treatment with L-thyroxine (T4) for 10-12 days on left ventricular (LV) function and myosin isoenzyme content in rats with LV dysfunction after myocardial infarction were studied." | 3.67 | Effects of 10- to 12-day treatment with L-thyroxine in rats with myocardial infarction. ( Aguirre, M; Gay, RG; Goldman, S; Graham, S; Morkin, E, 1988) |
| "The use of propranolol since the first hours of myocardial infarction reduced the perinecrotic zone and restricted the zone of myocardial necrosis, decreased the frequency of arrhythmias and did not produce heart insufficiency." | 3.67 | [Inderal in the acute and post-myocardial infarct periods]. ( Alushkov, MV; Martynov, IV; Popov, VG; Voronin, VA, 1986) |
| "Latex-induced transmural myocardial infarction or epicardial application of phenol interrupts sympathetic fibers innervating myocardium apical to the infarction or to the phenol-painted area." | 3.67 | Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic. ( Inoue, H; Zipes, DP, 1987) |
| "Effects of nitroprusside, nitroglycerin, propranolol and mannitol on the size of infarcted and peri-infarction areas were examined in 276 patients with acute left-ventricular anterior myocardial infarction." | 3.67 | [Effect of nitroprusside, nitroglycerin, propranolol and mannitol on the size of a myocardial infarct]. ( Evdokimova, AG; Gaĭdukova, NI; Orlov, VN; Radzevich, AE; Shilova, NA, 1985) |
| "The experiments on rats with a 3-day myocardial infarction caused by the left coronary artery ligation have shown that multiple lidocaine and pyromecaine injections according to a given scheme decrease the size of the necrosis area." | 3.67 | [Effect of lidocaine and pyromecaine on the size of an experimental myocardial infarct]. ( Chichkanov, GG; Goldshteĭne, GKh; Tsorin, IB, 1986) |
| "The effect of the beta-blocker propranolol and of bensonal, a barbituric acid derivative stimulating microsomal oxidation of the liver monooxygenase, was evaluated using the model of experimental myocardial infarction (EMI) in the presence of 3-month cholesterol atherosclerosis." | 3.67 | [Experimental myocardial infarction in atherosclerosis--various methods of pharmacological correction]. ( Irgashev, ShB, 1985) |
| " Surveys were undertaken among participants in the Beta-Blocker Heart Attack Trial (BHAT) and the Aspirin Myocardial Infarction Study (AMIS) to obtain data on these perceptions." | 3.67 | Participation in a clinical trial: the patients' point of view. ( Curb, JD; Mattson, ME; McArdle, R, 1985) |
| "A combination of isosorbide dinitrate (40-120 mg daily) and propranolol (80-160 mg) was administered to 146 patients during the early hours of myocardial infarction." | 3.67 | [Combined use of nitrates and beta-adrenergic blockaders in patients with acute myocardial infarct]. ( Galitskaia, AK; Gvatua, NA; Kravtsov, VL; Malinovskaia, IE; Shumakov, VA, 1985) |
| " Seven days later, the animals were challenged with a dose of isoproterenol which would produce massive myocardial infarction and 50-60% mortality in non-treated animals." | 3.67 | Prolonged protective effects following propranolol withdrawal against isoproterenol-induced myocardial infarction in normotensive and hypertensive rats. ( Wexler, BC, 1985) |
| "The relative extent of myocardial infarction produced by occlusion of the left anterior descendens coronary artery in anesthetized dogs was determined under control conditions or following treatment (4 h after ligation) with propranolol (1 mg/kg), bevantolol (3 mg/kg) or N-dimethyl propranolol (10 mg/kg)." | 3.66 | Protection of ischemic myocardium: comparison of effects of propranolol, bevantolol and N-dimethyl propranolol on infarct size following coronary artery occlusion in anesthetized dogs. ( Brooks, HL; Gross, GJ; Hardman, HF; Jesmok, GJ; Warltier, DC, 1980) |
| "1 micrograms kg-1 min-1) or chronic (50-60 mg kg-1 daily for 12 days) propranolol treatment had little effect on arrhythmias, or other responses to ligation." | 3.66 | The effect of modification of sympathetic activity on responses to ligation of a coronary artery in the conscious rat. ( Botting, JH; Johnston, KM; Macleod, BA; Walker, MJ, 1983) |
| "Prophylactic effects of sulfinpyrazone (100 mg/Kg), aspirin (5 mg/Kg, 50 mg/Kg), and propranolol (2 mg/Kg, 10 mg/Kg) on myocardial necrosis and hypertrophy induced by isoproterenol were examined." | 3.66 | Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis. ( Hashimoto, H; Ogawa, K, 1981) |
| "The experiments on anaesthetized dogs have shown that with artificial ventilation and open chest adrenalin in arrhythmogenic and nonarrythmogenic doses enhances glycogenolysis in the heart proportionally to the dose used Block of beta-adrenergic receptors by propranolol decreased the activation of glycogenolysis in the ischaemic zone and the frequency of ventricular fibrillation after occlusion of the coronary artery." | 3.66 | [Role of catecholamine in activating glycogenolysis in experimental myocardial infarct complicated by ventricular fibrillation]. ( Dolgova, NP, 1982) |
| "This study was designed to investigate the relationships of myocardial concentrations of norepinephrine (NE) and cyclic AMP (c-AMP) to the development of ventricular fibrillation (VF) with reference to the effects of a premedication of dibutyryl cyclic AMP (DBC-AMP) and propranolol in dogs with experimental myocardial infarction." | 3.66 | Myocardial norepinephrine and cyclic amp concentration following myocardial ischemia--relation to ventricular fibrillation and sudden death. ( Ban, M; Kanayama, H; Ogawa, K; Ukai, M, 1983) |
| "The effect of propranolol on hypotonic erythrocyte hemolysis was investigated in normal subjects and coronary patients." | 3.66 | [Determination of the sensitivity of beta adrenergic receptors in patients with myocardial infarction]. ( Anshelevich, IuV; Okun', KV; Sominskiĭ, VN, 1983) |
| "Propranolol is an effective drug for patients with angina and has been shown to favorably alter exercise ejection fraction and myocardial perfusion images in patients with coronary disease." | 3.66 | Thallium-201 myocardial imaging during maximal and submaximal exercise: comparison of submaximal exercise with propranolol. ( Kirch, D; Rhodes, CA; Sklar, J; Steele, P; Vogel, R, 1983) |
| "Hemodynamic effects of combined nitroglycerin and propranolol administration were investigated in patients with acute myocardial infarction." | 3.66 | Combined administration of nitroglycerin and propranolol to patients with acute myocardial infarction. ( Becker, LC; Come, PC; Flaherty, JT; Greene, HL; Pitt, B; Weisfeldt, ML; Weiss, JL, 1981) |
| "In the present study, the effects of morphine and pethidine on coronary vessel resistance (CPP), blood pressure (BP), and experimental myocardial infarction-induced cardiac arrhythmia were investigated." | 3.66 | Effects of morphine and pethidine on coronary vascular resistance, blood pressure, and myocardial infarction-induced cardiac arrhythmias. ( Bhargava, KP; Mishra, N; Pant, KK; Singh, N; Sinha, JN; Verma, VK, 1983) |
| "Haemodynamic investigations were performed in 40 patients with acute myocardial infarction before and after intravenous application of 6 mg propranolol." | 3.66 | [Risks of treatment with beta-blocking agents in acute myocardial infarction (author's transl)]. ( Hochrein, H; Lehmann, HU; Oeff, M; Witt, E, 1981) |
| "Ventricular arrhythmias due to myocardial infarct were produced in 14 dogs, and the antiarrhytmic effects of quinidine (Qd), lidocaine (Lid), aprindine (Apr), and dl-propranolol (dl-Prop) were investigated." | 3.66 | [Effects of antiarrhythmic agents on ventricular arrhythmias following myocardial infarct induced with glass beads in dogs (author's transl)]. ( Haruna, M; Kimoto, S; Nakao, T; Ueda, M, 1981) |
| "The effects of propranolol on myocardial perfusion and metabolism during acute myocardial infarction were studied in 18 mongrel dogs." | 3.66 | Myocardial infarction in the dog: effects of intravenous propranolol. ( Fox, K; Selwyn, A; Welman, E, 1980) |
| "Three hundred fifty-eight of 429 (83%) consecutive patients with acute myocardial infarction (MI) and a normal PR interval received various antiarrhythmic drugs (AD), including lidocaine and/or procainamide, quinidine, digoxin, propranolol or disopyramide." | 3.66 | Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarction. ( Abbott, JA; Cheitlin, MD; Desai, J; Holford, N; Peters, RW; Remedios, P; Scheinman, MM, 1980) |
| "The hemodynamic effects of a single oral dose of 20 mg of nifedipine were studied in 21 stable patients after an acute myocardial infarction before withdrawal of Swan-Ganz and intra-arterial catheters." | 3.66 | Hemodynamic effects of a single oral dose of nifedipine following acute myocardial infarction. ( Debaisieux, JC; Mizgala, HF; Theroux, P; Waters, DD, 1980) |
| "In experiments in nembutal anesthetized dogs the authors studied the dependence between the antifibrillation activity of propranolol, which was appraised according to the value of the ventricular fibrillation thresholds and the rate of spontaneous fibrillation after occlusion of the coronary artery, and the cardiodepressive and hypotensive action of this agent." | 3.66 | [Antifibrillatory activity of propranolol in experimental myocardial infarct and its cardiodepressive and hypotensive action]. ( Kovacs, A; Raĭskina, ME; Shargorodskiĭ, BM; Urbanics, R, 1980) |
| "Propranolol was administered intravenously to 12 patients with presumed acute myocardial infarction in the attempt to limit infarct size." | 3.66 | Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and serial creatine kinase assessment. ( Cairns, JA; Klassen, GA, 1981) |
| "Experiments on anesthetized dogs have shown that intravenous infusion of 1 mg/kg of propranolol has no essential effect on the threshold of ventricular fibrillation, but considerably reduces the duration of the vulnerable period." | 3.66 | [Effect of propranolol on the fibrillation threshold and the period of vulnerability of cardiac ventricles under normal conditions and during acute coronary occlusion]. ( Gal'tseva, NA; Mishchenko, IK, 1978) |
| "The ability of practolol and propranolol of prevent ventricular fibrillation in experimental anterior myocardial infarction was compared in dogs subjected to ligation of the left anterior descending and first septal coronary arteries." | 3.66 | Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion. ( Gillis, RA; Pearle, DL; Williford, D, 1978) |
| "The cardiovascular effects of halothane-nitrous oxide anesthesia, and beta-receptor blockade with either propranolol or practolol, were studied in 15 dogs in which severe myocardial infarction had been induced ten days earlier." | 3.65 | Interaction of anesthesia, beta-receptor blockade, and blood loss in dogs with induced myocardial infarction. ( Bennett, MJ; Clarke, TN; Foëx, P; Prys-Roberts, C; Roberts, JG; Ryder, WA, 1976) |
| " Propranolol, 0-1 mg/kg intravenously, was administered to 20 patients with acute myocardial infarction without clinical evidence of left ventricular failure." | 3.65 | Propranolol in acute myocardial infarction in man: effects of haemodynamics and myocardial oxygenation. ( Ayres, SM; Mueller, H, 1976) |
| "The effect of intravenous administration of propranolol (3 to 10 mg) was studied in 12 patients with acute anterior transmural myocardial infarction within the first 8 hours from the onset of pain." | 3.65 | Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction. ( Gold, HK; Leinbach, RC; Maroko, PR, 1976) |
| "The records of 185 consecutive patients having myocardial revascularization were reviewed with regard to preoperative administration of propranolol and intraoperative or postoperative complications." | 3.65 | Propranolol therapy in patients undergoing myocardial revascularization. ( Dorney, ER; Douglas, JS; Hatcher, CR; Jones, EL; Kaplan, JA; King, SB, 1976) |
| "The haemodynamic effects of intravenous propranolol at low dosage (1 and 2 mg) have been evaluated on 14 patients in the acute stage of myocardial infarction." | 3.65 | Evaluation of haemodynamic effects of intravenous propranolol at low dosage (1 and 2 mg) in acute myocardial infarction. ( Letac, B; Letournel, J, 1975) |
| "Abrupt occlusion of the left anterior descending coronary artery was performed on 45 unanesthetized farm pigs in order to evaluate the relative effects on the latency to ventricular fibrillation (VFL) of 1) adaptation of the animals to the laboratory, and 2) beta-receptor blockade by propranolol." | 3.65 | Modification of ventricular fibrillation latency following coronary artery occlusion in the conscious pig. ( Entman, ML; Lie, JT; Skinner, JE, 1975) |
| "In animals without myocardial infarction the new beta-sympathicolytic agent atenolol (4-[2'-hydroxy-3'-iso-propylaminopropoxy]-phenyl acetamide, ICI 66 082) dose-dependently decreased heart rate, systolic aortic pressure and cardiac output." | 3.65 | [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)]. ( Bischoff, KO; Diesch, J; Geigenmüller, L; Hübner, H; Meesmann, W; Stephan, K, 1975) |
| "The data from this study document that dobutamine is a powerful inotropic agent in anesthetized dogs with acute myocardial ischemia and in awake, unsedated ones with chronic myocardial infarction." | 3.65 | Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs. ( Hutton, I; Platt, MR; Templeton, GH; Watson, JT; Willerson, JT, 1976) |
| "Isoproterenol (ISO), a drug which causes an increased strength of myocardial contraction when administered to animals in mug/kg doses, causes myocardial necrosis when given mg/kg doses." | 3.65 | Calcium as mediator of isoproterenol-induced myocardial necrosis. ( Bloom, S; Davis, DL, 1972) |
| "Diltiazem was ineffective in preventing SVT, the incidence being exactly the same as in the control group (35%)." | 2.68 | Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. ( Babin-Ebell, J; Elert, O; Keith, PR, 1996) |
| "Carvedilol is a multiple-action cardiovascular agent that is both a beta-adrenoceptor antagonist and a vasodilator and has recently been made available for the treatment of mild-to-moderate hypertension." | 2.67 | Myocardial protection with carvedilol. ( Bril, A; Feuerstein, GZ; Hamburger, SA; Ruffolo, RR; Smith, EF, 1992) |
| "The placebo arm of the Beta-Blocker Heart Attack Trial (BHAT) provides a unique opportunity to compare the long-term cardiac events in patients suffering from their first and uncomplicated Q wave or non-Q wave AMI." | 2.67 | Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial. ( Gheorghiade, M; Goldstein, S; Kao, W; Schultz, L; Tilley, B, 1991) |
| "with complicated infarctions or complex arrhythmias." | 2.66 | The Beta-blocker Heart Attack Trial. ( Furberg, CD, 1985) |
| "The Beta Blocker Heart Attack Trial (BHAT) recruited 3837 patients who within the previous 5-21-day period had experienced a myocardial infarction." | 2.66 | The Beta Blocker Heart Attack Trial: recruitment experience. ( Byington, R; Goldstein, S, 1987) |
| "Monitoring for adverse effects in an integral part of controlled clinical trials." | 2.66 | Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial. ( Davis, BR; Furberg, CD; Williams, CB, 1987) |
| "The Beta-Blocker Heart Attack Trial (BHAT), a double-blind study of 3837 post-myocardial infarction patients, was a multicenter clinical trial that ended early because therapeutic benefit had been demonstrated." | 2.66 | Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience. ( Bell, RL; Curb, JD; Friedman, LM; Payne, GH, 1985) |
| "The incidences of congestive heart failure, hypotension, AV blocks and ventricular arrhythmias were not significantly more common in the control group (8 vs." | 2.65 | Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits. ( Berglund, U; Dahlström, U; Karlsson, E, 1980) |
| "Post hoc analyses from the Beta-Blocker Heart Attack Trial suggest, and are supported by the Norwegian Timolol Study, that myocardial infarction patients older than age 60 years and those with arrhythmic and other complications not severe enough to preclude treatment benefit the most in absolute terms from beta blockers." | 2.65 | What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience. ( Byington, RP; Furberg, CD, 1983) |
| "The results from the Beta-Blocker Heart Attack Trial for patients ages 60-69 years indicate a significant beneficial effect of propranolol and an overall reduction in mortality of 33%." | 2.65 | Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience. ( Hawkins, CM; Richardson, DW; Vokonas, PS, 1983) |
| "Propranolol did not cause significant additional changes in plasma catecholamine contents during the subsequent 3 d." | 2.65 | Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. ( Ayres, SM; Mueller, HS, 1980) |
| "Hypertension is an important risk factor for adverse cardiovascular events including stroke, myocardial infarction, heart failure and renal failure." | 2.55 | Pharmacotherapy for hypertension in adults aged 18 to 59 years. ( Gueyffier, F; Musini, VM; Puil, L; Salzwedel, DM; Wright, JM, 2017) |
| " In addition, some patients are treated with agents whose long-term use has not been shown to be effective." | 2.43 | Beta-blockers for the post-myocardial infarction patient: current clinical evidence and practical considerations. ( Fonarow, GC, 2006) |
| "Type 2 diabetes is becoming very common and is closely linked to physical inactivity and obesity." | 2.41 | Beta-blockers and diabetes: the bad guys come good. ( Cruickshank, JM, 2002) |
| "Symptomatic arrhythmias, including sinus bradycardia, heart block, and ventricular tachyarrhythmias, have been documented to complicate coronary vasospasm." | 2.36 | Coronary arterial spasm. ( Come, PC, 1982) |
| "Propranolol can produce a significant reduction of myocardial oxygen consumption and may redirect coronary flow to ischemic areas." | 2.35 | Unstable angina pectoris. ( Cairns, JA; Fantus, IG; Klassen, GA, 1976) |
| " This dosing schedule caused daily drug-free periods of at least 6 h as evidenced by propranolol plasma concentrations and cardiac β-adrenergic responsiveness." | 1.56 | Intermittent β-adrenergic blockade downregulates the gene expression of β-myosin heavy chain in the mouse heart. ( Ambrosio, C; Barbagallo, F; Catalano, L; Grò, MC; Maccari, S; Marano, G; Matarrese, P; Molinari, P; Pace, V; Patrizio, M; Rizzi, R; Stati, T; Vezzi, V, 2020) |
| "Treatment with propranolol prevented the increased cAMP/PKA in 1 h MI, whereas propranolol had little effect on decreased cAMP/PKA in 3 months MI." | 1.36 | Propranolol regulates cardiac transient outward potassium channel in rat myocardium via cAMP/PKA after short-term but not after long-term ischemia. ( Cao, YX; Hong, Y; Liu, Y; Lu, YJ; Shan, HL; Xu, CQ; Yang, BF; Zhang, JL; Zhang, L; Zhao, M, 2010) |
| "Melatonin has potent cardioprotective properties." | 1.35 | Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. ( Genade, S; Genis, A; Huisamen, B; Lochner, A; Ytrehus, K, 2008) |
| "Ventricular premature beats frequently originated from the peri-infarct zone, and 37% showed elevation of Ca(i) prior to V(m) depolarization, suggesting reverse excitation-contraction coupling as their aetiology." | 1.34 | Remodelling of action potential and intracellular calcium cycling dynamics during subacute myocardial infarction promotes ventricular arrhythmias in Langendorff-perfused rabbit hearts. ( Chen, PS; Chou, CC; Fishbein, MC; Hayashi, H; Lin, SF; Liu, YB; Nihei, M; Weiss, JN; Wen, MS; Wu, D; Yeh, SJ; Zhou, S, 2007) |
| "The intramural coronary arteriosclerosis showed thickening of the wall due to medial hyperplasia by fibrosis, and arterial stenosis." | 1.33 | Chronic myocardial infarction due to arteriosclerosis of coronary arteries followed by acute thromboembolism of caudal abdominal aorta in a cat. ( Hikasa, Y; Minami, S; Morita, T; Okamoto, Y; Shimada, A; Tsujino, K, 2005) |
| "Treatment with propranolol had a negative chronotropic effect throughout the observation period of 72 h." | 1.32 | Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats. ( Briest, W; Deten, A; Holzl, A; Volz, HC; Zimmer, HG, 2003) |
| "Carvedilol is a beta-adrenoceptor blocker with a vasodilatory action that is more effective for the treatment of congestive heart failure than other beta-blockers." | 1.32 | Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts. ( Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Mori, H; Node, K; Ogai, A; Ogita, H; Sanada, S; Shinozaki, Y; Shintani, Y; Takashima, S; Tomoike, H, 2004) |
| "A suppression of arrhythmia by Pro and CPU86017 resulted from a regression of the dispersion and depression of RyR2 and SERCA2." | 1.32 | Dispersion of ventricular mRNA of RyR2 and SERCA2 associated with arrhythmogenesis in rats. ( Dai, DZ; Gao, E; Lu, F; Wang, HL; Zhang, YP, 2004) |
| "Pretreatment with propranolol or labetalol counteracted the appearance of the myocardial histological alterations and the associated ECG and biochemical lesions." | 1.32 | Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure. ( Accinni, R; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S, 2004) |
| "In propranolol-treated rats, hypertrophy of the LV septum, papillary muscle, and right ventricle were similar to those of the infarcted control." | 1.31 | Effects of prolonged propranolol treatment on left ventricular remodeling and oxidative stress after myocardial infarction in rats. ( Bonnefont-Rousselot, D; Komajda, M; Lechat, P; Mansuy, P; Mougenot, N; Raillecove, F; Ramirez-Gil, JF, 2000) |
| "The nipradilol-treated and captopril-treated rats had significantly smaller LVEDVI than did the vehicle-treated rats with both moderate and large infarction (large infarct: 2." | 1.30 | Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats. ( Nakamura, M; Sonoki, H; Takeshita, A, 1997) |
| "We use the Beta-Blocker Heart Attack Trial (BHAT) and AIDS Clinical Trials Group protocol 021 for illustration." | 1.30 | Construction of a continuous stopping boundary from an alpha spending function. ( Betensky, RA, 1998) |
| "The propranolol treated animals had higher LV end-diastolic pressures (27+/-2* vs 20+/(-3 mmHg) and a more restricted LV diastolic filling pattern (increased ratio of early to late filling velocities and more rapid E wave deceleration rate)." | 1.30 | Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. ( Douglas, PS; Katz, SE; Litwin, SE; Morgan, JP, 1999) |
| "Cardiac volume changes during septic shock could be responsible for the abnormal trends in phase angle spread and electrocardiographic data." | 1.28 | Changes in phase analysis patterns of radionuclide ventriculograms obtained from baboons during atrial pacing, septic shock, and induced myocardial infarction. ( Davies, J; Dormehl, IC; Hugo, N; Jacobs, L; Maree, M; van Gelder, AL, 1989) |
| "In the basal state, rats with congestive heart failure had significantly (p less than 0." | 1.27 | Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure. ( Brenner, BM; Duchin, KL; Ichikawa, I; Pfeffer, J; Pfeffer, M, 1984) |
| "In phentolamine-treated dogs, arterial pressure and heart rate were kept constant to prevent exacerbation of ischemia." | 1.27 | Effect of alpha-adrenergic blockade on arrhythmias induced by acute myocardial ischemia and reperfusion in the dog. ( Bolli, R; Fisher, DJ; Miller, RR; Taylor, AA; Young, JB, 1984) |
| "To evaluate the possible influence of sympathetic activation on the haemodynamic response to intravenous beta-blockade, the dose-response characteristics of three boluses of propranolol were evaluated in 8 patients with uncomplicated infarction and compared in a similar number of patients with stable angina." | 1.27 | Enhanced haemodynamic effects of propranolol in acute myocardial infarction. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP; Walker, C, 1984) |
| "Myocardial infarction was produced by ligation of the left anterior descending coronary artery at time of instrumentation (approximately 20% LV mass)." | 1.27 | Exercise tolerance and compensatory sympathetic tone during beta-blockade after myocardial infarction. ( Brice, G; Stone, HL, 1986) |
| "Propranolol treatment limited progressive death of myocardial cell population, reducing by 37% myocardial infarction size by day 7 of the experimental study, as compared to the situation in the untreated animals." | 1.27 | [Effect of the beta-blocker propranolol (obzidan) on the content of macroergic phosphates and the development of the size of necrotic areas in the myocardium in experimental acute coronary occlusion]. ( Irgashev, ShB; Iuldashev, NM; Mavridi, DI, 1988) |
| "Propranolol pretreatment decreased the infarct size but treatment after coronary ligation increased it." | 1.27 | Pharmacological interventions and myocardial infarct size in rat. ( Kumar, C; Singh, M, 1985) |
| "Oral treatment with propranolol, 3-30 mg/kg, reduced infarct size and reduced the elevated left ventricular end-diastolic pressure, which was shown to be most closely related with infarct size, in dogs with circumflex coronary artery ligation extending over 24 h." | 1.27 | Effects of propranolol on infarct size and the impaired hemodynamics in experimental myocardial infarcted dogs. ( Aihara, H; Kaneko, K; Kimura, M; Tsuchida, K; Yamazaki, R, 1985) |
| "Experience with treatment of myocardial infarction in man has shown that beta-blocking agents are well tolerated in patients presenting in hemodynamically stable condition (Killip groups I and II)." | 1.26 | [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)]. ( Himmler, FC; Klein, G; Schmidt, G; Wirtzfeld, A, 1981) |
| "The arrhythmias were prevented by higher doses of the calcium antagonist verapamil which, however, decreased the survival times." | 1.26 | Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction. ( Bernauer, W, 1982) |
| " What remains to be solved is the dosage level." | 1.26 | Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade. ( Kulling, P, 1982) |
| "Nitroglycerin has a reducing influence on these changes, but not down to the initial level." | 1.26 | [The treatment of acute myocardial infarctions with beta-receptor-blockers. II. Hemodynamic effects of propranolol with and without combination therapy with nitroglycerin (author's transl)]. ( Hochrein, H; Lehmann, HU; Oeff, M; Witt, E, 1981) |
| "6) were given propranolol- because of its alleged myocardium-protecting properties - intravenously at a dosage of 0." | 1.26 | [Treatment of acute myocardial infarction with betareceptor blocking agents. I. Hemodynamic effects of Propranolol in combination with digitalis (author's transl)]. ( Hochrein, H; Lehmann, HU; Oeff, M; Witt, E, 1981) |
| "81mKrypton was used to study regional myocardial perfusion, and myocardial metabolism was assessed using the epicardial ECG and release of creatine kinase activity (CK)." | 1.26 | The effects of propranolol on myocardial perfusion and metabolism during acute regional ischaemia. ( Fox, KM; Selwyn, AP; Welman, E, 1980) |
| "The effect is critically reviewed of chronic administration of beta-adrenoreceptor antagonists on morbidity and mortality in angina pectoris and myocardial infarction." | 1.26 | The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease. ( Fitzgerald, JD, 1976) |
| "Cardiomegaly was seen in 9/23 patients with nocturnal angina and 22/141 without (p less than 0." | 1.26 | Significance and treatment of nocturnal angina preceding myocardial infarction. ( Alosilla, C; Chadda, KD; Gupta, PK; Lichstein, E, 1977) |
| "Digoxin was given to 53 patients, lidocaine to 24, propranolol to 28, and quinidine to 11." | 1.26 | The elderly patient in the coronary care unit. II. Incidence and treatment of arrhythmias. ( Berman, ND, 1979) |
| "Propranolol was marketed for clinical use as 'Inderal' by the Pharmaceuticals Division of Imperial Chemical Industries, UK, where this original work had been done." | 1.26 | Protection from morbidity and mortality from first infarcts: the case for beta-blockade. ( Lambert, DM, 1978) |
| "Pretreatment with propranolol reduced necrosis from 85 +/- 3% (untreated) to 52 +/- 4% (P less than 0." | 1.26 | Infarct size reduction by propranolol before and after coronary ligation in dogs. ( Jennings, RB; Kloner, RA; Rasmussen, MM; Reimer, KA, 1977) |
| "1 The effects of propranolol and practolol, at equivalent myocardial beta-adrenoceptor blocking doses, (as assessed by the degree of shift of isoprenaline dose-response curves) were investigated in anaesthetized greyhounds before and after acute coronary artery ligation." | 1.26 | Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. ( Marshall, RJ; Parratt, JR, 1976) |
| "Myocardial infarction was produced by occlusion of the left circumflex coronary artery for 60 minutes followed by reperfusion and quantitation of infarct volume 24 hours later." | 1.26 | Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761). ( Abrams, GD; Burmeister, WE; Lomas, TE; Lucchesi, BR, 1976) |
| "Treatment with propranolol resulted in a significant reduction in the infarct size." | 1.26 | Prolonged epicardial mapping in myocardial infarction: the effects of propranolol and intra-aortic balloon pumping following coronary artery occlusion. ( Butt, KM; Dastgir, G; Ergin, MA; Stuckey, JH, 1976) |
| "Propranolol has been shown to reduce the extent of necrosis that develops after temporary coronary occlusion in dogs." | 1.26 | On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs. ( Jennings, RB; Rasmussen, MM; Reimer, KA, 1976) |
| "Propranolol has been shown to improve bioenergetics and reduce anaerobic glycolysis by a depression of the hemodynamic response of ischemic myocardium." | 1.26 | Metabolic evaluation of agents designed to protect the ischemic myocardium and to reduce infarct size. ( Brachfeld, N, 1976) |
| "When procainamide was reinfuse after propranolol (1 mg/kg), its hemodynamic effects were not significantly different from those observed before propranolol in both groups IA and IIA." | 1.25 | Hemodynamic effects of procainamide and quinidine and the influence of beta-blockade before and after experimental myocardial infarction. ( Côté, P; Harrison, DC; Schook, J; Schroeder, JS, 1975) |
| "Propranolol was observed to prevent the large decrease in contractile force seen with vagal stimulation." | 1.25 | Effect of autonomic neural influences on the cardiovascular changes induced by coronary occlusion. ( Corr, PB; Gillis, RA, 1975) |
| "Of particular importance are the arrhythmias observed immediately after experimentally induced acute myocardial infarction (AMI)." | 1.25 | Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system. ( Kniffen, FJ; Lucchesi, BR, 1975) |
| " The dose-response curve of TM was parallel to that of nitroglycerin and papaverine and steeper than that of dipyridamol or adenosine." | 1.25 | [Pharmacology of cornary dilator agent, trapymin. (2) Analysis of its mode of action]. ( Ogawa, N; Ohnishi, H; Tsukuda, S; Yamaguchi, K, 1975) |
| "About 7% died from cardiac arrhythmia four days or more after the onset of infarction." | 1.25 | Hospital mortality in acute myocardial infarction. ( Bensley, KE; Caughey, DE; Norris, RM; Scott, PJ, 1968) |
| "The toxic effects associated with rapid lipid mobilization and a high plasma free fatty acid (FFA) concentration produced by glucagon were evaluated." | 1.25 | Toxic effects of glucagon-induced acute lipid mobilization in geese. ( Connor, WE; Hoak, JC; Warner, ED, 1968) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 714 (83.41) | 18.7374 |
| 1990's | 89 (10.40) | 18.2507 |
| 2000's | 41 (4.79) | 29.6817 |
| 2010's | 11 (1.29) | 24.3611 |
| 2020's | 1 (0.12) | 2.80 |
| Authors | Studies |
|---|---|
| Lis, R | 1 |
| Morgan, TK | 1 |
| DeVita, RJ | 1 |
| Davey, DD | 1 |
| Lumma, WC | 1 |
| Wohl, RA | 1 |
| Diamond, J | 1 |
| Wong, SS | 1 |
| Sullivan, ME | 1 |
| Seara, FAC | 1 |
| Araujo, IG | 1 |
| Império, GE | 1 |
| Marassi, MP | 1 |
| Silva, ACM | 1 |
| Mecawi, AS | 1 |
| Reis, LC | 1 |
| Olivares, EL | 1 |
| Maccari, S | 1 |
| Pace, V | 1 |
| Barbagallo, F | 1 |
| Stati, T | 1 |
| Ambrosio, C | 1 |
| Grò, MC | 1 |
| Molinari, P | 1 |
| Vezzi, V | 1 |
| Catalano, L | 1 |
| Matarrese, P | 1 |
| Patrizio, M | 1 |
| Rizzi, R | 1 |
| Marano, G | 1 |
| Musini, VM | 1 |
| Gueyffier, F | 1 |
| Puil, L | 1 |
| Salzwedel, DM | 1 |
| Wright, JM | 1 |
| Pearson, JT | 1 |
| Collie, N | 1 |
| Lamberts, RR | 1 |
| Inagaki, T | 1 |
| Yoshimoto, M | 1 |
| Umetani, K | 1 |
| Davis, P | 1 |
| Wilkins, G | 1 |
| Jones, PP | 1 |
| Shirai, M | 1 |
| Schwenke, DO | 1 |
| Tofler, GH | 1 |
| Spinaze, M | 1 |
| Shaw, E | 1 |
| Buckley, T | 1 |
| Santos-Almeida, FM | 1 |
| Girão, H | 1 |
| da Silva, CA | 1 |
| Salgado, HC | 1 |
| Fazan, R | 1 |
| Holme, I | 1 |
| Kjeldsen, SE | 1 |
| Bai, Y | 1 |
| Siu, KL | 1 |
| Ashraf, S | 1 |
| Faes, L | 1 |
| Nollo, G | 1 |
| Chon, KH | 1 |
| Horowitz, JD | 1 |
| Arstall, MA | 1 |
| Zeitz, CJ | 1 |
| Beltrame, JF | 1 |
| Genade, S | 1 |
| Genis, A | 1 |
| Ytrehus, K | 1 |
| Huisamen, B | 1 |
| Lochner, A | 1 |
| Uretsky, BF | 2 |
| Birnbaum, Y | 1 |
| Osman, A | 2 |
| Gupta, R | 1 |
| Paniagua, O | 1 |
| Chamoun, A | 1 |
| Pohwani, A | 1 |
| Lui, C | 1 |
| Lev, E | 1 |
| McGehee, T | 1 |
| Kumar, D | 1 |
| Akhtar, A | 1 |
| Anzuini, A | 2 |
| Schwarz, ER | 1 |
| Wang, FW | 2 |
| Quinaglia e Silva, JC | 1 |
| Munhoz, DB | 1 |
| Morato, TN | 1 |
| Gurgel, A | 1 |
| Macedo, AC | 1 |
| Sever, P | 1 |
| Sposito, AC | 1 |
| Kubavat, JB | 1 |
| Asdaq, SM | 1 |
| Lu, Y | 1 |
| Zhang, Y | 2 |
| Shan, H | 2 |
| Pan, Z | 1 |
| Li, X | 1 |
| Li, B | 1 |
| Xu, C | 1 |
| Zhang, B | 1 |
| Zhang, F | 1 |
| Dong, D | 1 |
| Song, W | 1 |
| Qiao, G | 1 |
| Yang, B | 1 |
| Machackova, J | 1 |
| Sanganalmath, SK | 1 |
| Elimban, V | 1 |
| Dhalla, NS | 1 |
| Zhang, L | 1 |
| Xu, CQ | 1 |
| Hong, Y | 1 |
| Zhang, JL | 1 |
| Liu, Y | 1 |
| Zhao, M | 1 |
| Cao, YX | 1 |
| Lu, YJ | 1 |
| Yang, BF | 1 |
| Shan, HL | 1 |
| Zhu, W | 1 |
| Yang, L | 1 |
| Zhou, R | 1 |
| Su, Z | 1 |
| Du, Z | 1 |
| Park, YH | 1 |
| Kim, J | 2 |
| Cunnington, C | 1 |
| McDonald, JE | 1 |
| Singh, RK | 1 |
| Mircoli, L | 1 |
| Fedele, L | 1 |
| Benetti, M | 1 |
| Bolla, GB | 1 |
| Radaelli, A | 1 |
| Perlini, S | 1 |
| Ferrari, AU | 1 |
| Lampert, R | 1 |
| Ickovics, JR | 1 |
| Viscoli, CJ | 1 |
| Horwitz, RI | 7 |
| Lee, FA | 1 |
| Cruickshank, JM | 2 |
| Adamson, PB | 1 |
| Vanoli, E | 2 |
| Shibano, T | 1 |
| Foreman, RD | 2 |
| Schwartz, PJ | 4 |
| Otero, J | 1 |
| Stouffer, GA | 1 |
| Waxman, S | 1 |
| Afzal, A | 1 |
| Agaev, MM | 3 |
| Azizov, VA | 1 |
| SRIVASTAVA, SC | 1 |
| DEWAR, HA | 1 |
| NEWELL, DJ | 1 |
| SLOMAN, G | 5 |
| ROBINSON, JS | 1 |
| MCLEAN, K | 1 |
| Deten, A | 1 |
| Volz, HC | 1 |
| Holzl, A | 1 |
| Briest, W | 1 |
| Zimmer, HG | 2 |
| Wajima, T | 1 |
| Beguier, B | 1 |
| Yaguchi, M | 1 |
| Hardt, SE | 1 |
| Tomita, H | 1 |
| Katus, HA | 1 |
| Sadoshima, J | 1 |
| Asanuma, H | 1 |
| Minamino, T | 1 |
| Sanada, S | 1 |
| Takashima, S | 1 |
| Ogita, H | 1 |
| Ogai, A | 1 |
| Asakura, M | 1 |
| Liao, Y | 1 |
| Asano, Y | 1 |
| Shintani, Y | 1 |
| Shinozaki, Y | 1 |
| Mori, H | 1 |
| Node, K | 1 |
| Kitamura, S | 1 |
| Tomoike, H | 1 |
| Hori, M | 1 |
| Kitakaze, M | 1 |
| Wang, HL | 1 |
| Dai, DZ | 3 |
| Gao, E | 1 |
| Zhang, YP | 1 |
| Lu, F | 1 |
| Blandino, D | 1 |
| Pinelli, A | 1 |
| Trivulzio, S | 1 |
| Tomasoni, L | 1 |
| Brenna, S | 1 |
| Bonacina, E | 1 |
| Accinni, R | 1 |
| Duncker, DJ | 1 |
| Haitsma, DB | 1 |
| Liem, DA | 1 |
| Verdouw, PD | 2 |
| Merkus, D | 1 |
| Beĭshenkulov, MT | 1 |
| Kudaĭbergenova, NT | 1 |
| Baltabaev, TB | 1 |
| Tsujino, K | 1 |
| Hikasa, Y | 1 |
| Minami, S | 1 |
| Okamoto, Y | 1 |
| Morita, T | 1 |
| Shimada, A | 1 |
| Nogami, Y | 1 |
| Takase, B | 1 |
| Matsui, T | 1 |
| Hattori, H | 1 |
| Hamabe, A | 1 |
| Fujita, M | 1 |
| Ohsuzu, F | 1 |
| Ishihara, M | 1 |
| Maekara, T | 1 |
| Fonarow, GC | 1 |
| Takahashi, T | 1 |
| Tang, T | 1 |
| Lai, NC | 1 |
| Roth, DM | 1 |
| Rebolledo, B | 1 |
| Saito, M | 1 |
| Lew, WY | 1 |
| Clopton, P | 1 |
| Hammond, HK | 1 |
| Gao, J | 1 |
| Fu, W | 1 |
| Jin, Z | 1 |
| Yu, X | 1 |
| Goyagi, T | 1 |
| Kimura, T | 1 |
| Nishikawa, T | 1 |
| Tobe, Y | 1 |
| Masaki, Y | 1 |
| Chou, CC | 1 |
| Zhou, S | 1 |
| Hayashi, H | 1 |
| Nihei, M | 1 |
| Liu, YB | 1 |
| Wen, MS | 1 |
| Yeh, SJ | 1 |
| Fishbein, MC | 4 |
| Weiss, JN | 1 |
| Lin, SF | 1 |
| Wu, D | 1 |
| Chen, PS | 1 |
| Pentecost, BL | 1 |
| Austen, WG | 3 |
| Bay, G | 1 |
| Lund-Larsen, P | 1 |
| Lorentsen, E | 2 |
| Sivertssen, E | 2 |
| Furberg, C | 5 |
| Kernohan, RJ | 1 |
| Furman, S | 1 |
| Escher, DJ | 1 |
| Solomon, N | 1 |
| Lewes, D | 1 |
| Hill, DW | 1 |
| Linko, E | 2 |
| Koskinen, PJ | 1 |
| Siitonen, L | 2 |
| Ruosteenoja, R | 2 |
| Kahler, RL | 1 |
| Stannard, M | 2 |
| Preobrazhenskiĭ, DV | 1 |
| Oka, Y | 1 |
| Frishman, W | 1 |
| Becker, RM | 1 |
| Kadish, A | 1 |
| Strom, J | 1 |
| Matsumoto, M | 1 |
| Orkin, L | 1 |
| Frater, R | 1 |
| Dahlström, U | 1 |
| Berglund, U | 1 |
| Karlsson, E | 1 |
| Norris, RM | 17 |
| Warltier, DC | 1 |
| Gross, GJ | 2 |
| Jesmok, GJ | 2 |
| Brooks, HL | 1 |
| Hardman, HF | 2 |
| Opie, LH | 5 |
| Ivanova, LK | 3 |
| Maroko, PR | 13 |
| Davidson, DM | 1 |
| Golikov, AP | 6 |
| Maĭorov, NI | 3 |
| Vaniev, SB | 2 |
| Orlov, AI | 2 |
| Schröder, R | 3 |
| Wirtzfeld, A | 1 |
| Klein, G | 1 |
| Himmler, FC | 1 |
| Schmidt, G | 1 |
| Baber, NS | 3 |
| Evans, DW | 2 |
| Lewis, JA | 3 |
| Thomas, M | 5 |
| Pratt, CM | 2 |
| Welton, DE | 1 |
| Squires, WG | 1 |
| Kirby, TE | 1 |
| Hartung, GM | 1 |
| Miller, RR | 4 |
| Hampton, JR | 3 |
| Goldberg, HL | 1 |
| Borer, JS | 1 |
| Jacobstein, JG | 1 |
| Kluger, J | 1 |
| Scheidt, SS | 1 |
| Alonso, DR | 1 |
| Arensberg, D | 2 |
| Burmeister, WE | 3 |
| Reynolds, RD | 2 |
| Lee, RJ | 3 |
| Wilcox, RG | 3 |
| Berestov, AA | 3 |
| Frick, MH | 1 |
| Katila, M | 1 |
| Valentine, PA | 1 |
| Sutton, LD | 1 |
| Sloman, JG | 1 |
| Stewart, IM | 2 |
| Bernauer, W | 1 |
| Frommer, PL | 2 |
| Hjalmarson, A | 1 |
| Jentsch, G | 2 |
| Moser, M | 1 |
| Gorlin, R | 4 |
| Barnaby, PF | 3 |
| Geary, GG | 4 |
| Meerson, FZ | 3 |
| Vasil'ev, VK | 1 |
| Dosmagambetova, RS | 3 |
| Moss, AJ | 1 |
| Kulling, P | 1 |
| Staessen, J | 1 |
| Bulpitt, C | 1 |
| Cattaert, A | 1 |
| Fagard, R | 1 |
| Vanhees, L | 1 |
| Amery, A | 1 |
| Julian, DG | 1 |
| Shand, DG | 6 |
| Furberg, CD | 9 |
| Byington, RP | 8 |
| Griggs, TR | 1 |
| Wagner, GS | 3 |
| Gettes, LS | 2 |
| Bory, M | 1 |
| Bénichou, M | 1 |
| Botting, JH | 1 |
| Johnston, KM | 1 |
| Macleod, BA | 1 |
| Walker, MJ | 1 |
| Green, KG | 2 |
| Ribeiro, LG | 3 |
| Goldberg, S | 1 |
| Biamino, G | 1 |
| Roberts, R | 4 |
| Vacheron, A | 1 |
| Baubion, N | 1 |
| Delage, F | 1 |
| Elmfeldt, D | 1 |
| Berglund, G | 1 |
| Wedel, H | 1 |
| Wilhelmsen, L | 1 |
| Pedersen, OL | 1 |
| Gram, LF | 1 |
| Delius, W | 1 |
| Weisswange, A | 1 |
| Goldstein, S | 15 |
| Frishman, WH | 5 |
| Friedewald, WT | 2 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Johns, VJ | 1 |
| Rotmensch, HH | 1 |
| Vlasses, PH | 2 |
| Ferguson, RK | 2 |
| Ostapiuk, FE | 1 |
| Khvoĭnitskiĭ, VA | 1 |
| Tomov, I | 1 |
| Haywood, LJ | 2 |
| Brown, MA | 4 |
| Clarke, ED | 5 |
| Logan, RL | 1 |
| Sharpe, DN | 1 |
| Brenner, BM | 1 |
| Duchin, KL | 1 |
| Ichikawa, I | 1 |
| Pfeffer, J | 1 |
| Pfeffer, M | 1 |
| Willerson, JT | 3 |
| Buja, LM | 2 |
| Rose, G | 1 |
| DeMets, DL | 2 |
| Hardy, R | 1 |
| Friedman, LM | 10 |
| Lan, KK | 2 |
| Silke, B | 5 |
| Verma, SP | 4 |
| Ahuja, RC | 4 |
| Hussain, M | 3 |
| Hafizullah, M | 1 |
| Reynolds, G | 2 |
| Nelson, GI | 4 |
| Taylor, SH | 5 |
| Yasuda, M | 1 |
| Takeuchi, M | 1 |
| Kondo, M | 1 |
| Fujii, M | 1 |
| Konishi, T | 1 |
| Sugawa, M | 1 |
| Hamada, M | 1 |
| Nakano, T | 1 |
| Takezawa, H | 1 |
| Bolli, R | 1 |
| Fisher, DJ | 1 |
| Taylor, AA | 1 |
| Young, JB | 1 |
| Rudolph, W | 2 |
| Dirschinger, J | 2 |
| Sominskiĭ, VN | 3 |
| Okun', KV | 3 |
| Goldstein, DS | 1 |
| Spear, JF | 2 |
| Moore, EN | 2 |
| Mazur, NA | 3 |
| Ostrovskaia, TP | 1 |
| Dokuchaeva, EA | 2 |
| Smirnova, TM | 2 |
| Ivanova, LA | 2 |
| Gillis, AM | 1 |
| Clusin, WT | 1 |
| Kulginskaya, IV | 1 |
| Ostrovskaya, TP | 1 |
| Svet, EA | 1 |
| Vygodin, VA | 1 |
| Epps, DE | 1 |
| Mandel, F | 1 |
| Schwartz, A | 1 |
| Wu, GL | 2 |
| Chen, SG | 2 |
| Jia, DL | 2 |
| Cao, EH | 1 |
| Zhang, DM | 1 |
| Nakamura, T | 1 |
| Ogawa, K | 4 |
| Hashimoto, H | 3 |
| Dolgova, NP | 1 |
| Ban, M | 2 |
| Kanayama, H | 2 |
| Ukai, M | 1 |
| Anshelevich, IuV | 2 |
| Yasue, H | 1 |
| Omote, S | 1 |
| Takizawa, A | 1 |
| Nagao, M | 1 |
| Lichstein, E | 6 |
| Morganroth, J | 2 |
| Harrist, R | 1 |
| Hubble, E | 1 |
| Hansteen, V | 4 |
| Hawkins, CM | 4 |
| Richardson, DW | 1 |
| Vokonas, PS | 1 |
| Lewis, RP | 5 |
| Khan, AH | 1 |
| Okoli, RC | 1 |
| Croft, C | 2 |
| Gold, HK | 5 |
| Hartwell, TD | 2 |
| Jaffe, AS | 3 |
| Muller, JE | 4 |
| Mullin, SM | 3 |
| Parker, C | 2 |
| Passamani, ER | 2 |
| Poole, WK | 2 |
| Bourmayan, C | 1 |
| Artigou, JY | 1 |
| Fournier, C | 3 |
| Desnos, M | 1 |
| Gay, J | 1 |
| Gerbaux, A | 1 |
| Gvatua, NA | 3 |
| Kravtsov, VL | 3 |
| Shumakov, VA | 3 |
| Beziuk, NN | 1 |
| Galitskaia, AK | 2 |
| Ibel, H | 1 |
| Steinkopff, G | 1 |
| Jiang, WD | 1 |
| Yu, YZ | 1 |
| Liu, WW | 1 |
| Chen, YH | 1 |
| Wang, YP | 1 |
| Huang, TC | 1 |
| Leinbach, RC | 4 |
| Harper, RW | 1 |
| Zufarov, KA | 1 |
| Irgashev, ShB | 3 |
| Azizov, KN | 1 |
| Paxton, JW | 1 |
| Vik-Mo, H | 1 |
| Silverman, HS | 1 |
| Buxton, AE | 1 |
| Marchlinski, FE | 1 |
| Doherty, JU | 1 |
| Cassidy, DM | 1 |
| Vassallo, JA | 1 |
| Flores, BT | 1 |
| Josephson, ME | 1 |
| Toyooka, T | 1 |
| Kamishiro, T | 1 |
| Fumino, H | 1 |
| Masaki, T | 1 |
| Hosoda, S | 1 |
| Cohen, L | 1 |
| Laor, A | 1 |
| Kitzes, R | 1 |
| Grigor'eva, NN | 1 |
| Gichka, SG | 1 |
| Stepaniuk, GI | 1 |
| Degtiareva, LV | 1 |
| Webster, J | 1 |
| Petrie, JC | 1 |
| McLean, I | 1 |
| Hawksworth, GM | 1 |
| Urbaniuk, KG | 1 |
| Mazurets, AF | 1 |
| Volgina, AS | 1 |
| Schüffler, J | 1 |
| Pense, G | 1 |
| Fenton, L | 1 |
| Cheng, G | 1 |
| Smith, GT | 1 |
| Siu, B | 1 |
| McNamara, JJ | 1 |
| Schneck, DW | 2 |
| Gutschker, A | 1 |
| Geissler, W | 1 |
| Senst, E | 1 |
| Schirmer, G | 1 |
| Sysoliatina, NA | 1 |
| Sapozhkov, AV | 1 |
| Riabinin, VA | 3 |
| Polumiskov, VIu | 2 |
| Vakhliaev, VD | 2 |
| Pomerantsev, EV | 1 |
| Alliluev, IG | 1 |
| Zaĭtseva, NS | 1 |
| Nesterova, LA | 1 |
| Steele, P | 2 |
| Sklar, J | 1 |
| Kirch, D | 2 |
| Vogel, R | 2 |
| Rhodes, CA | 1 |
| Gang, ES | 1 |
| Bigger, JT | 2 |
| Uhl, EW | 1 |
| Orlov, VN | 4 |
| Evdokimova, AG | 2 |
| Koldaev, IaIa | 2 |
| Smirnova, AV | 1 |
| Murakami, E | 1 |
| Takekoshi, N | 1 |
| Matsui, S | 1 |
| Murakami, H | 1 |
| Walker, C | 2 |
| Kuznetsov, GP | 1 |
| Gligan, LI | 1 |
| Zil'berman, ES | 1 |
| Gubanova, TG | 1 |
| Fel'dman, MS | 1 |
| Warwick, S | 1 |
| Akers, M | 1 |
| Beecher, P | 1 |
| Helminger, K | 1 |
| Moses, B | 1 |
| Rigby, PA | 1 |
| Taplin, NE | 1 |
| Werner, W | 1 |
| Wettach, R | 1 |
| Cao, J | 1 |
| Adamian, KG | 1 |
| Tatinian, NG | 1 |
| Gabrielian, RS | 1 |
| Krishchian, EM | 1 |
| Asatrian, SV | 1 |
| Thrall, JH | 1 |
| Pitt, B | 2 |
| Brady, TJ | 1 |
| Kavtaradze, VG | 1 |
| Iosava, KV | 1 |
| Machavariani, PT | 1 |
| Kveselava, MV | 1 |
| Staffurth, JS | 1 |
| Emery, P | 1 |
| Shelova, NA | 1 |
| Kulikova, AG | 2 |
| Radzevich, AE | 2 |
| Come, PC | 2 |
| Flaherty, JT | 1 |
| Becker, LC | 2 |
| Weisfeldt, ML | 1 |
| Greene, HL | 1 |
| Weiss, JL | 1 |
| Buckley, MJ | 3 |
| Akins, CW | 1 |
| Levine, FH | 1 |
| Lehmann, HU | 3 |
| Oeff, M | 3 |
| Witt, E | 3 |
| Hochrein, H | 3 |
| Klein, NA | 1 |
| Strom, JA | 1 |
| Willens, H | 1 |
| LeJemtel, TH | 1 |
| Jentzer, J | 1 |
| Siegel, L | 1 |
| Klein, P | 1 |
| Kirschen, N | 1 |
| Silverman, R | 1 |
| Pollack, S | 1 |
| Doyle, R | 1 |
| Kirsten, E | 1 |
| Sonnenblick, EH | 1 |
| Møinichen, E | 1 |
| Andersen, A | 1 |
| Strøm, O | 1 |
| Søiland, K | 1 |
| Dyrbekk, D | 1 |
| Refsum, AM | 1 |
| Tromsdal, A | 1 |
| Knudsen, K | 1 |
| Eika, C | 1 |
| Bakken, J | 1 |
| Smith, P | 1 |
| Hoff, PI | 1 |
| Lessem, J | 1 |
| Morgan, T | 1 |
| Patterson, RE | 1 |
| Horowitz, SF | 1 |
| Eng, C | 1 |
| Meller, J | 1 |
| Goldsmith, SJ | 1 |
| Pichard, AD | 1 |
| Halgash, DA | 1 |
| Herman, MV | 2 |
| Osbakken, MD | 1 |
| Boucher, CA | 1 |
| Okada, RD | 1 |
| Bingham, JB | 1 |
| Strauss, HW | 2 |
| Pohost, GM | 1 |
| Sammel, NL | 4 |
| Hughes, CF | 1 |
| Johnson, RN | 1 |
| Ashton, NG | 1 |
| Elliott, RL | 1 |
| Shulman, RS | 1 |
| Herbert, PN | 1 |
| Capone, RJ | 2 |
| McClure, D | 1 |
| Henderson, LO | 1 |
| Saritelli, A | 1 |
| Campbell, J | 1 |
| Eller, BT | 1 |
| Patterson, E | 1 |
| Lucchesi, BR | 8 |
| Pant, KK | 1 |
| Verma, VK | 1 |
| Mishra, N | 1 |
| Singh, N | 1 |
| Sinha, JN | 1 |
| Bhargava, KP | 1 |
| du Cailar, C | 1 |
| Maillé, JG | 1 |
| Jones, W | 1 |
| Solymoss, BC | 1 |
| Chabot, M | 1 |
| Goulet, C | 1 |
| Delva, E | 1 |
| Grondin, CM | 1 |
| Segal, BL | 2 |
| Iskandrian, AS | 1 |
| Kotler, MN | 4 |
| Poirier, NL | 2 |
| Belliveau, PJ | 1 |
| Wynands, JE | 1 |
| Russell, RO | 1 |
| Rogers, WJ | 1 |
| Mantle, JA | 1 |
| Kouchoukos, NT | 1 |
| Karp, RB | 1 |
| Oberman, A | 1 |
| Charles, ED | 1 |
| Kronenfeld, JJ | 1 |
| Wayne, J | 1 |
| Rackley, CE | 1 |
| Resnekov, L | 1 |
| Wolk, M | 1 |
| Rosati, RA | 1 |
| Conti, CR | 3 |
| Hutter, AM | 3 |
| Biddle, TL | 1 |
| Schroeder, JC | 1 |
| Kaplan, EM | 1 |
| Gilbert, JP | 1 |
| Mock, MB | 1 |
| Koplin, JR | 1 |
| Shirinian, A | 1 |
| Burke, JF | 1 |
| Alexander, JC | 1 |
| Roland, JM | 2 |
| Banks, DC | 2 |
| Mitchell, JR | 1 |
| Florkiewicz, H | 1 |
| Rymar, B | 1 |
| Przegaliński, J | 1 |
| Markiewicz, M | 1 |
| Welman, E | 3 |
| Colbeck, JF | 1 |
| Selwyn, AP | 2 |
| Fox, KM | 3 |
| Orr, I | 1 |
| Howitt, G | 1 |
| Wilson, T | 1 |
| Dawes, PM | 1 |
| Handler, K | 1 |
| Tuson, R | 1 |
| Rolli, A | 1 |
| Favaro, L | 1 |
| Aurier, E | 1 |
| Tagliavini, S | 1 |
| Ciarlini, E | 1 |
| Brizzi, MP | 1 |
| Botti, G | 1 |
| May, GS | 1 |
| Passamani, E | 1 |
| Kolata, GB | 1 |
| Wells, PH | 1 |
| Kaplan, JA | 2 |
| Thaulow, E | 1 |
| Kjekshus, J | 2 |
| Erikssen, J | 1 |
| Jones, RJ | 1 |
| Stewart, JR | 1 |
| Gibson, JK | 2 |
| Pritchett, EL | 1 |
| Hammill, SC | 1 |
| Stargel, WW | 2 |
| McNabb, ME | 1 |
| Rainwater, J | 1 |
| LeFree, M | 1 |
| Jensen, D | 1 |
| Spodick, DH | 1 |
| Schaller, K | 1 |
| Lange, S | 1 |
| Abela, GS | 1 |
| Mehta, J | 2 |
| Millar, AB | 1 |
| Cameron, JS | 1 |
| Dersham, GH | 1 |
| Han, J | 1 |
| McNeil, GN | 1 |
| Shaw, PK | 1 |
| Dock, DS | 1 |
| Gendjev, Z | 1 |
| Gabauer, I | 2 |
| Trnovec, T | 1 |
| Okolicány, J | 1 |
| Styk, J | 2 |
| Holec, V | 1 |
| Caride, VJ | 1 |
| Popov, VG | 3 |
| Jdanova, NS | 1 |
| Jelnov, VV | 1 |
| Alushkov, MV | 2 |
| Barishnikova, GA | 1 |
| Ganguly, PK | 1 |
| Srivastava, LM | 4 |
| Bora, PS | 3 |
| Gupta, MP | 2 |
| Seth, SD | 2 |
| Gendenshteĭn, EI | 1 |
| Sernov, LN | 1 |
| Blümchen, G | 1 |
| Esche, HH | 1 |
| Gorczynski, RJ | 1 |
| Dickerson, DD | 1 |
| Mathews, MP | 1 |
| Kimoto, S | 1 |
| Haruna, M | 1 |
| Nakao, T | 1 |
| Ueda, M | 1 |
| Sager, G | 1 |
| Aakesson, I | 1 |
| Jacobsen, S | 1 |
| Mueller, HS | 6 |
| Ayres, SM | 4 |
| Fox, K | 1 |
| Selwyn, A | 1 |
| McLane, M | 1 |
| Krop, H | 1 |
| Nixon, JV | 1 |
| Hillert, MC | 1 |
| Shapiro, W | 1 |
| Smitherman, TC | 1 |
| Routledge, PA | 2 |
| Markis, JE | 1 |
| Joffee, CD | 1 |
| Roberts, BH | 1 |
| Ransil, BJ | 1 |
| Cohn, PF | 1 |
| Scheinman, MM | 1 |
| Remedios, P | 1 |
| Cheitlin, MD | 1 |
| Peters, RW | 6 |
| Holford, N | 1 |
| Desai, J | 1 |
| Abbott, JA | 1 |
| Koppes, GM | 1 |
| Beckmann, CH | 1 |
| Jones, FG | 1 |
| Belyĭ, IS | 1 |
| Sukhodol'skiĭ, AM | 1 |
| Debaisieux, JC | 1 |
| Theroux, P | 3 |
| Waters, DD | 2 |
| Mizgala, HF | 3 |
| Faber, J | 1 |
| Kirkegaard, C | 1 |
| Lumholtz, IB | 1 |
| Siersbaek-Nielsen, K | 1 |
| Friis, T | 1 |
| Brandt, PW | 2 |
| Shkliar, LV | 3 |
| Urbanics, R | 1 |
| Shargorodskiĭ, BM | 3 |
| Kovacs, A | 1 |
| Raĭskina, ME | 1 |
| Gratsianskiĭ, NA | 2 |
| Karpov, IuA | 2 |
| Evdokimov, VV | 1 |
| Bunaeva, VE | 1 |
| Goldman, L | 2 |
| Cairns, JA | 4 |
| Klassen, GA | 2 |
| Pavlova, TS | 1 |
| Vasil'eva, NN | 1 |
| Kul'ginskaia, IV | 1 |
| Aronow, WS | 5 |
| Ahn, C | 4 |
| Mercando, AD | 3 |
| Epstein, S | 3 |
| Rosenberg, CR | 2 |
| Shore, RE | 2 |
| Pasternack, BS | 2 |
| Osterziel, KJ | 1 |
| Leite, CM | 3 |
| Gomes, MG | 1 |
| Vassallo, DV | 4 |
| Mill, JG | 4 |
| Vaage-Nilsen, M | 1 |
| Hansen, JF | 1 |
| Mellemgaard, K | 1 |
| Hagerup, L | 1 |
| Sigurd, B | 1 |
| Steinmetz, E | 1 |
| Balkin, J | 2 |
| Rosenmann, D | 2 |
| Ilan, M | 2 |
| Klutstein, M | 2 |
| Zion, MM | 2 |
| Abraham, AS | 2 |
| Ruffolo, RR | 4 |
| Bril, A | 3 |
| Feuerstein, GZ | 3 |
| Han, L | 1 |
| Tang, ZM | 1 |
| Horwitz, SM | 2 |
| Bélichard, P | 1 |
| Savard, P | 1 |
| Cardinal, R | 1 |
| Nadeau, R | 1 |
| Gosselin, H | 1 |
| Paradis, P | 1 |
| Rouleau, JL | 2 |
| Gallagher, EJ | 1 |
| Viscoli, CM | 5 |
| Gheorghiade, M | 4 |
| Shivkumar, K | 2 |
| Schultz, L | 5 |
| Jafri, S | 1 |
| Tilley, B | 4 |
| Singer, BH | 3 |
| De Ferrari, GM | 2 |
| Salvati, P | 1 |
| Grossoni, M | 1 |
| Ukmar, G | 1 |
| Vaga, L | 1 |
| Patrono, C | 1 |
| Boutjdir, M | 2 |
| Assadi, M | 1 |
| el-Sherif, N | 2 |
| Makuch, RW | 2 |
| Sørensen, TI | 1 |
| Babin-Ebell, J | 1 |
| Keith, PR | 1 |
| Elert, O | 1 |
| Ikeda, Y | 1 |
| Nishimoto, M | 1 |
| Shimazu, Y | 1 |
| Umemura, K | 1 |
| Nakashima, M | 2 |
| Lemberg, L | 3 |
| Singh, RB | 1 |
| Niaz, MA | 1 |
| Rastogi, SS | 1 |
| Aslam, M | 1 |
| De Vecchis, R | 1 |
| Pucciarelli, G | 1 |
| Zarrelli, V | 1 |
| Setaro, A | 1 |
| Graziano, T | 1 |
| Rizzo, S | 1 |
| Cochrane, AD | 1 |
| Pathik, S | 1 |
| Smolich, JJ | 1 |
| Conyers, RA | 1 |
| Rosenfeldt, FL | 2 |
| Kronzon, I | 1 |
| Berdague, P | 1 |
| Mhenni, H | 1 |
| Smiri, Z | 1 |
| Haouala, H | 1 |
| Chebbi, N | 1 |
| Guediche, M | 1 |
| Delay, M | 1 |
| Puel, J | 1 |
| Senn, S | 1 |
| Harrell, F | 1 |
| Galenko-Iaroshevskiĭ, PA | 1 |
| Melkumova, ER | 1 |
| Bartashevich, VV | 1 |
| Uvarov, AV | 1 |
| Turovaia, AIu | 1 |
| Khankoeva, AI | 1 |
| Galygo, DS | 1 |
| Sonoki, H | 1 |
| Nakamura, M | 1 |
| Takeshita, A | 2 |
| Toleikis, PM | 1 |
| Tomlinson, CW | 1 |
| Tan, M | 1 |
| Xiong, X | 1 |
| Kutner, MH | 1 |
| Feuerstein, G | 1 |
| Liu, GL | 1 |
| Yue, TL | 1 |
| Cheng, HY | 1 |
| Hieble, JP | 1 |
| Arch, JR | 1 |
| Ma, XL | 1 |
| van Veldhuisen, DJ | 1 |
| van Gilst, WH | 1 |
| Francis, GS | 1 |
| Betensky, RA | 1 |
| Nozawa, T | 1 |
| Inoue, H | 2 |
| Liu, Z | 2 |
| Liu, X | 1 |
| Zhang, J | 1 |
| Ouyang, X | 2 |
| Guan, X | 2 |
| Tashchuk, VK | 1 |
| Polishchuk, OIu | 1 |
| Hrechko, SI | 1 |
| Makoviĭchuk, IO | 1 |
| Polians'ka, OS | 1 |
| Turubarova, NA | 1 |
| Chaplyns'kyĭ, RB | 1 |
| Sokur, IV | 1 |
| Nguyen, T | 1 |
| El Salibi, E | 1 |
| Houle, MS | 1 |
| Billman, GE | 2 |
| Rochon, PA | 1 |
| Anderson, GM | 1 |
| Tu, JV | 1 |
| Gurwitz, JH | 1 |
| Clark, JP | 1 |
| Shear, NH | 1 |
| Lau, P | 1 |
| Litwin, SE | 1 |
| Katz, SE | 1 |
| Morgan, JP | 1 |
| Douglas, PS | 1 |
| Ohara, F | 1 |
| Sugimoto, T | 1 |
| Yamamoto, N | 1 |
| Ohkubo, K | 1 |
| Ozaki, T | 1 |
| Maeda, K | 1 |
| Seki, J | 1 |
| Goto, T | 1 |
| Gu, M | 1 |
| Lai, TL | 1 |
| Faffe, DS | 1 |
| Chagas, PS | 1 |
| Medeiros, AS | 1 |
| Saad, EA | 1 |
| Saldiva, PH | 1 |
| Rocco, PR | 1 |
| Zin, WA | 1 |
| Chen, Y | 1 |
| Shi, B | 1 |
| Mansuy, P | 1 |
| Mougenot, N | 1 |
| Ramirez-Gil, JF | 1 |
| Bonnefont-Rousselot, D | 1 |
| Raillecove, F | 1 |
| Komajda, M | 1 |
| Lechat, P | 1 |
| Dahl, M | 1 |
| Gottlieb, SS | 1 |
| McCarter, RJ | 1 |
| Gorfine, M | 1 |
| Dickerson, LM | 1 |
| Carek, PJ | 1 |
| Morris, CD | 1 |
| Budde, JM | 1 |
| Velez, DA | 1 |
| Muraki, S | 1 |
| Zhao, ZQ | 1 |
| Puskas, JD | 1 |
| Guyton, RA | 1 |
| Vinten-Johansen, J | 1 |
| Vasil'ev, AP | 1 |
| Strel'tsova, NN | 1 |
| Gorbunova, TIu | 1 |
| Mal'tseva, IA | 1 |
| Zykova, EL | 1 |
| Yamamoto, S | 1 |
| Matsui, K | 1 |
| Sasabe, M | 1 |
| Ohashi, N | 1 |
| Lee, YC | 1 |
| Shatney, CH | 1 |
| MacCarter, DJ | 1 |
| Lillehei, RC | 1 |
| Ross, J | 7 |
| Prys-Roberts, C | 2 |
| Roberts, JG | 2 |
| Foëx, P | 2 |
| Clarke, TN | 2 |
| Bennett, MJ | 1 |
| Ryder, WA | 1 |
| Fitzgerald, JD | 2 |
| Bühler, FR | 1 |
| Berdeaux, A | 1 |
| Peres da Costa, C | 1 |
| Garnier, M | 1 |
| Boissier, JR | 1 |
| Giudicelli, JF | 2 |
| Polak, F | 1 |
| Lubbe, WF | 1 |
| Bolte, HD | 1 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Birkenhäger, WH | 2 |
| Kho, TL | 1 |
| Kolsters, G | 2 |
| Schalekamp, MA | 2 |
| Wester, A | 1 |
| Zaal, GA | 2 |
| Gupta, KK | 1 |
| Killip, T | 1 |
| D'Amato, PH | 1 |
| Taylor, JB | 1 |
| Rios, JC | 1 |
| Hultgren, HN | 2 |
| Pfeifer, JF | 1 |
| Angell, WW | 1 |
| Lipton, MJ | 1 |
| Bilisoly, J | 1 |
| Weidmann, P | 1 |
| Fuss, O | 1 |
| Smith, WM | 1 |
| Williams, B | 2 |
| Fox, KA | 1 |
| Oliver, MF | 1 |
| Langou, RA | 2 |
| Geha, AS | 1 |
| Hammond, GL | 2 |
| Cohen, LS | 2 |
| Shevchenko, OP | 1 |
| Gasilin, VS | 1 |
| Greenberg, MA | 1 |
| Arbeit, S | 1 |
| Rubin, IL | 1 |
| Col, J | 1 |
| Leonard, J | 1 |
| Plotnick, GD | 1 |
| Madias, JE | 2 |
| Pasternak, RC | 1 |
| DeSanctis, RW | 3 |
| JaRo, MF | 1 |
| Esenbaeva, ZM | 1 |
| Zimin, IuV | 1 |
| Kuznetsova, GV | 1 |
| Miseiuk, NK | 1 |
| Halawa, B | 2 |
| LeWinter, MM | 1 |
| Zipes, DP | 2 |
| Besch, HR | 1 |
| Watanabe, AM | 1 |
| Rabinowitz, B | 2 |
| Parmley, WW | 2 |
| Kligerman, M | 2 |
| Norman, J | 1 |
| Fujimura, S | 1 |
| Chiba, S | 1 |
| Matloff, JM | 2 |
| Alosilla, C | 1 |
| Chadda, KD | 1 |
| Gupta, PK | 1 |
| Chopra, MP | 1 |
| Portal, RW | 1 |
| Aber, CP | 1 |
| Côté, P | 1 |
| Schook, J | 1 |
| Harrison, DC | 5 |
| Schroeder, JS | 2 |
| Wit, AL | 1 |
| Hoffman, BF | 1 |
| Rosen, MR | 1 |
| Gronim, SS | 1 |
| Likoff, W | 2 |
| Segal, B | 1 |
| Flemma, RJ | 1 |
| Staller, B | 1 |
| DeMaria, AN | 1 |
| Vismara, LA | 1 |
| Salel, AF | 1 |
| Maxwell, KS | 1 |
| Armsterdam, EA | 1 |
| Mason, DT | 2 |
| Wiles, JC | 1 |
| Peduzzi, PN | 1 |
| Bonchek, LI | 1 |
| Olinger, GN | 1 |
| Keelan, MH | 1 |
| Tresch, DD | 1 |
| Siegel, R | 1 |
| Cohn, LH | 1 |
| Alpert, J | 1 |
| Koster, JK | 1 |
| Mee, RB | 1 |
| Collins, JJ | 1 |
| Halphen, C | 1 |
| Richmond, DR | 1 |
| Baird, DK | 1 |
| de Feyter, PJ | 1 |
| Majid, PA | 1 |
| Wardeh, R | 1 |
| Roos, JP | 1 |
| Boudoulas, H | 4 |
| Snyder, GL | 1 |
| Karayannacos, P | 1 |
| Vasko, JS | 2 |
| Riecker, G | 1 |
| Salerno, JA | 1 |
| Ray, M | 1 |
| Tavazzi, L | 2 |
| Medici, A | 1 |
| Piccinini, M | 1 |
| Chimienti, M | 1 |
| Bobba, P | 1 |
| Kaloianova, A | 1 |
| Beloev, I | 1 |
| Chaushev, A | 1 |
| Edwards, B | 1 |
| Fentem, PH | 1 |
| Symes, JF | 1 |
| Sniderman, AD | 1 |
| Mickelborough, L | 1 |
| Dobell, AR | 1 |
| Medd, WL | 1 |
| Hillis, LD | 2 |
| Braunwald, E | 11 |
| Berman, ND | 1 |
| Miura, M | 1 |
| Thomas, R | 1 |
| Ganz, W | 1 |
| Sokol, T | 1 |
| Shell, WE | 3 |
| Toshimitsu, T | 1 |
| Kwan, AC | 1 |
| Singh, BN | 5 |
| Inagaki, Y | 1 |
| Saito, T | 1 |
| Shukuya, M | 1 |
| Karayannacos, PE | 1 |
| Kakos, GS | 1 |
| Kilman, JW | 1 |
| Moulds, RF | 1 |
| Glasser, SP | 1 |
| Spoto, E | 1 |
| Solomon, DA | 1 |
| Smith, BF | 1 |
| Carr, ML | 1 |
| Maniscalco, BS | 1 |
| Wenkart, TR | 1 |
| Saxena, KK | 1 |
| Gupta, B | 1 |
| Srivastava, VK | 1 |
| Kulshrestha, VK | 1 |
| Prasad, DN | 1 |
| Ichikawa, M | 1 |
| Saito, S | 2 |
| Takahashi, N | 1 |
| Tomobe, K | 1 |
| Yamamoto, M | 1 |
| Watanabe, I | 1 |
| Komaki, K | 1 |
| Tanigawa, N | 1 |
| Ozawa, Y | 1 |
| Hatano, M | 1 |
| Rao, PS | 2 |
| Fletcher, J | 1 |
| Evans, R | 1 |
| Hertelendy, F | 1 |
| Stickley, L | 1 |
| Walter, K | 1 |
| Winkle, RA | 1 |
| Derrington, DC | 1 |
| Danilevicius, Z | 1 |
| De Ponti, C | 2 |
| Mauri, F | 1 |
| Fiorista, F | 1 |
| Ciliberto, GR | 1 |
| Carù, B | 1 |
| Rovelli, F | 1 |
| KU, DD | 1 |
| Peter, T | 1 |
| Heng, MK | 1 |
| Howell, DR | 1 |
| Ambler, PK | 1 |
| Wood, AJ | 1 |
| Shiroff, RA | 1 |
| Mathis, J | 1 |
| Zelis, R | 1 |
| Babb, JD | 1 |
| Leaman, DM | 1 |
| Hayes, AH | 1 |
| Kloner, RA | 2 |
| Pasotti, C | 1 |
| Vibelli, C | 1 |
| Capra, A | 1 |
| Mishchenko, IK | 1 |
| Gal'tseva, NA | 1 |
| Raina, S | 1 |
| Banka, VS | 2 |
| Ramanathan, K | 1 |
| Bodenheimer, MM | 2 |
| Helfant, RH | 2 |
| Quesada, LC | 1 |
| Eliot, RS | 2 |
| Todd, GL | 1 |
| Clayton, FC | 1 |
| Pieper, GM | 1 |
| Lambert, DM | 1 |
| Pearle, DL | 2 |
| Williford, D | 1 |
| Gillis, RA | 3 |
| Jugdutt, BI | 1 |
| Lee, SJ | 1 |
| Slutsky, A | 1 |
| Sobel, BE | 6 |
| Welch, TG | 1 |
| Forester, WF | 2 |
| Fantus, IG | 1 |
| Selden, R | 1 |
| Neill, WA | 1 |
| Ritzmann, LW | 1 |
| Okies, JE | 1 |
| Anderson, RP | 1 |
| Hood, WB | 1 |
| James, RG | 1 |
| Arnold, JM | 1 |
| Allen, JD | 1 |
| Pantridge, JF | 2 |
| Shanks, RG | 2 |
| Schulte, D | 1 |
| Klepzig, H | 1 |
| Taccardi, B | 1 |
| Macchi, E | 1 |
| de Ambroggi, L | 1 |
| Harner, RH | 1 |
| Boyd, RB | 1 |
| Muiesan, G | 1 |
| Valori, C | 1 |
| Kidner, PH | 1 |
| Baroldi, G | 1 |
| Silver, MD | 1 |
| Lixfeld, W | 1 |
| McGregor, DC | 1 |
| Rasmussen, MM | 3 |
| Reimer, KA | 3 |
| Jennings, RB | 4 |
| Singh, VS | 1 |
| Mehrotra, TN | 1 |
| Kirti, S | 1 |
| Aran, RK | 1 |
| Elhance, GP | 1 |
| Marshall, RJ | 1 |
| Parratt, JR | 2 |
| Counsell, J | 1 |
| Boyer, NH | 1 |
| Ziegelhöffer, A | 1 |
| Fedelesová, M | 1 |
| Pancza, D | 1 |
| Sventeková, A | 1 |
| Gulotta, SJ | 1 |
| Bloch, A | 1 |
| Beller, GA | 1 |
| Askenazi, J | 1 |
| Radvany, P | 1 |
| Reid, DS | 1 |
| Pelides, LJ | 1 |
| Shillingford, JP | 3 |
| Mueller, H | 2 |
| Hunt, D | 3 |
| Ross, D | 1 |
| Corr, PB | 2 |
| Pace, DG | 1 |
| Evans, DE | 1 |
| DiMicco, J | 1 |
| Lomas, TE | 1 |
| Abrams, GD | 1 |
| Fleming, JS | 1 |
| Buchanan, JO | 1 |
| Buyniski, JP | 1 |
| Ergin, MA | 1 |
| Dastgir, G | 1 |
| Butt, KM | 1 |
| Stuckey, JH | 1 |
| Jones, EL | 1 |
| Dorney, ER | 1 |
| King, SB | 2 |
| Douglas, JS | 2 |
| Hatcher, CR | 2 |
| Portzer, D | 1 |
| Sustaita, H | 1 |
| Chatterjee, K | 3 |
| Chaux, A | 1 |
| Marcus, HS | 1 |
| Swan, HJ | 1 |
| DeBusk, R | 1 |
| Logue, RB | 1 |
| Olson, HG | 1 |
| Amsterdam, EA | 1 |
| Letac, B | 1 |
| Letournel, J | 1 |
| Forrester, JS | 2 |
| Jobin, G | 1 |
| Mundth, ED | 1 |
| Daggett, WM | 1 |
| McEnamy, MT | 1 |
| Gold, HD | 1 |
| Ostheimer, GW | 1 |
| Alper, MH | 1 |
| Skinner, JE | 1 |
| Lie, JT | 1 |
| Entman, ML | 1 |
| Walter, P | 1 |
| Lesser, L | 1 |
| Schley, G | 1 |
| Meesmann, W | 2 |
| Wild, U | 1 |
| Kniffen, FJ | 2 |
| Aviado, DM | 1 |
| Steinbach, K | 1 |
| Sledzevskaia, IK | 1 |
| Bugaeva, VI | 1 |
| Sugakova, NK | 1 |
| Mangiameli, S | 1 |
| Circo, A | 1 |
| Galassi, A | 1 |
| Ohnishi, H | 1 |
| Tsukuda, S | 1 |
| Yamaguchi, K | 1 |
| Ogawa, N | 1 |
| Stephan, K | 1 |
| Bischoff, KO | 1 |
| Hübner, H | 1 |
| Geigenmüller, L | 1 |
| Diesch, J | 1 |
| Alderman, EL | 2 |
| Brachfeld, N | 1 |
| Hutton, I | 1 |
| Watson, JT | 1 |
| Platt, MR | 1 |
| Templeton, GH | 1 |
| Imamura, S | 1 |
| Ikeda, K | 1 |
| Warner, AL | 1 |
| Bellah, KL | 1 |
| Raya, TE | 2 |
| Roeske, WR | 1 |
| Goldman, S | 3 |
| Kogan, AK | 1 |
| Kudrin, AN | 1 |
| Losev, NI | 1 |
| Leite, DV | 1 |
| Novaes, MA | 1 |
| Lima-Pereira, FE | 1 |
| Slivjak, M | 1 |
| DiMartino, MJ | 1 |
| Linee, P | 1 |
| Poyser, RH | 1 |
| Smith, EF | 3 |
| Hamburger, SA | 1 |
| Wilson, AC | 2 |
| Kostis, JB | 4 |
| van Woerkens, LJ | 1 |
| Baas, NR | 1 |
| van der Giessen, WJ | 1 |
| Rao, MR | 2 |
| Jiang, H | 1 |
| Shui, B | 1 |
| Rong, P | 1 |
| Zhang, JE | 1 |
| Ruberman, W | 1 |
| Crow, R | 1 |
| Rautaharju, PM | 1 |
| Gay, RG | 2 |
| Garaev, GSh | 2 |
| Mamedov, IaD | 2 |
| Ismaĭlova, ZD | 2 |
| Mirzabekova, FI | 2 |
| Korochkin, IM | 1 |
| Chukaeva, II | 1 |
| Aleshkin, AV | 1 |
| Smolina, NV | 1 |
| Litvinova, SN | 1 |
| Aleksandrov, AA | 1 |
| Andreotti, F | 1 |
| Kluft, C | 1 |
| Davies, GJ | 1 |
| Huisman, LG | 1 |
| de Bart, AC | 1 |
| Maseri, A | 1 |
| Kao, W | 2 |
| Gilpin, E | 1 |
| Cali, G | 1 |
| Blackey, AR | 1 |
| Henning, H | 1 |
| Yusuf, S | 2 |
| Wittes, J | 2 |
| Probstfield, J | 1 |
| Berkman, L | 1 |
| Donaldson, RM | 1 |
| Murray, CJ | 1 |
| Ransohoff, DF | 1 |
| Sindelar, J | 1 |
| Stramba-Badiale, M | 1 |
| Cerati, D | 1 |
| Curtis, JL | 1 |
| Houghton, JL | 1 |
| Patterson, JH | 1 |
| Koch, G | 1 |
| Bradley, DA | 1 |
| Adams, KF | 1 |
| Rössner, S | 1 |
| Taylor, CL | 1 |
| Worthy, J | 1 |
| Craven, T | 1 |
| Shibleva, VV | 1 |
| Rubanovich, AI | 1 |
| Podinovskaia, IaA | 1 |
| Ruda, MIa | 1 |
| Bichan, NA | 1 |
| Gol'dberg, GA | 1 |
| Barradas, MA | 1 |
| Mikhailidis, DP | 1 |
| Il'iash, MG | 2 |
| Kravtsova, LA | 1 |
| Babov, KD | 1 |
| Shcherbak, IaIu | 1 |
| Jafri, SM | 2 |
| Tilley, BC | 1 |
| Peters, R | 1 |
| Schultz, LR | 1 |
| Barker, A | 2 |
| Sinitsyn, SP | 1 |
| Byington, R | 6 |
| Dmitrieva, OF | 1 |
| Ivanikov, IO | 1 |
| Kolesov, SB | 1 |
| Bykov, II | 1 |
| Brunet, M | 2 |
| Kindermans, M | 2 |
| Fedorowsky, A | 1 |
| Tournadre, P | 2 |
| Gensous, D | 1 |
| Blondeau, M | 2 |
| Egan, JW | 1 |
| Griswold, DE | 1 |
| Brunke, W | 1 |
| Anders, G | 1 |
| Müller, JH | 1 |
| Abet, U | 1 |
| Bodammer, M | 1 |
| Ogawa, T | 2 |
| Hieda, N | 2 |
| Sugiyama, S | 2 |
| Ito, T | 2 |
| Satake, T | 3 |
| Ozawa, T | 2 |
| Collins, MN | 1 |
| Mauser, M | 1 |
| Voelker, W | 1 |
| Ickrath, O | 1 |
| Hoffmeister, HM | 1 |
| Karsch, KR | 1 |
| Sidorenko, BA | 1 |
| Gruzdev, AK | 1 |
| Andriushchenko, OM | 1 |
| Mukherjee, D | 1 |
| Dormehl, IC | 1 |
| Hugo, N | 1 |
| van Gelder, AL | 1 |
| Maree, M | 1 |
| Jacobs, L | 1 |
| Davies, J | 1 |
| Parkhomenko, AN | 6 |
| Netiazhenko, VZ | 4 |
| Sirenko, IuN | 2 |
| Bhatt, SD | 2 |
| Chagas, AC | 1 |
| Da-Luz, PL | 1 |
| Pileggi, F | 1 |
| Simerzin, VV | 2 |
| Chiang, YK | 1 |
| Hardy, RJ | 1 |
| Kapadia, AS | 1 |
| Kiricuta, IC | 1 |
| Schmitt, WG | 1 |
| Beyer, HK | 1 |
| Bah, M | 1 |
| Boujon, B | 1 |
| Posel, D | 1 |
| Noakes, T | 1 |
| Kantor, P | 1 |
| Lambert, M | 1 |
| Luketich, J | 1 |
| Friehling, TD | 1 |
| O'Connor, KM | 1 |
| Kowey, PR | 1 |
| Alderman, MH | 1 |
| Ooi, WL | 1 |
| Madhavan, S | 1 |
| Cohen, H | 1 |
| Dobrotvorskaia, TE | 1 |
| Mustafaev, FM | 1 |
| Arifullin, ShS | 1 |
| Fletcher, GF | 1 |
| Ruggio, J | 1 |
| Babarskene, RS | 1 |
| Bloznialene, KP | 1 |
| Bluzhaĭte, II | 1 |
| Gaulene, AP | 1 |
| Griggs, T | 1 |
| Adams, K | 1 |
| Narvarte, H | 1 |
| Sheps, D | 1 |
| Rude, RE | 2 |
| Kjekshus, JK | 2 |
| Frais, MA | 1 |
| Mazurek, W | 1 |
| Brice, G | 1 |
| Stone, HL | 1 |
| Snisarenko, AA | 1 |
| Sandrikov, VA | 1 |
| Iakovlev, VF | 1 |
| Seleznev, MN | 1 |
| Maglakelidze, TA | 1 |
| Mazzuero, G | 1 |
| Galdangelo, F | 1 |
| Zotti, AM | 1 |
| Bertolotti, G | 1 |
| White, HD | 1 |
| Takayama, M | 1 |
| Maslowski, A | 1 |
| Bass, NM | 1 |
| Ormiston, JA | 1 |
| Whitlock, T | 1 |
| Algra, A | 1 |
| Roelandt, JR | 1 |
| Tijssen, JG | 1 |
| Simoons, ML | 1 |
| Pool, J | 1 |
| Kottwitz, B | 1 |
| Sia, ST | 1 |
| Cook, EF | 1 |
| Rutherford, JD | 1 |
| Weinstein, MC | 1 |
| Martinussen, HJ | 1 |
| Lolk, A | 1 |
| Szczepanski, C | 1 |
| Alstrup, P | 1 |
| Kuang, LX | 1 |
| Chen, L | 1 |
| Huang, ML | 1 |
| Zhang, DL | 1 |
| Zhang, XA | 1 |
| Ertl, G | 1 |
| Meesmann, M | 1 |
| Kochsiek, K | 2 |
| Croft, CH | 1 |
| Gustafson, N | 1 |
| Stone, PH | 1 |
| Raabe, DS | 1 |
| Thomas, LJ | 1 |
| Veronee, CD | 1 |
| Lewis, WR | 1 |
| Takla, MW | 1 |
| Hull-Ryde, EA | 1 |
| Lowe, JE | 1 |
| Mironova, OV | 1 |
| Ivanova, DK | 1 |
| Wood, M | 1 |
| Slepushkin, VD | 1 |
| Pavlenko, VS | 1 |
| Khlystov, VV | 1 |
| Lisachenko, GV | 1 |
| Usynin, AF | 1 |
| Slutsky, RA | 1 |
| Peck, WW | 1 |
| Gupta, M | 1 |
| Manchanda, SC | 1 |
| Graham, S | 1 |
| Aguirre, M | 1 |
| Morkin, E | 1 |
| Liu, GY | 1 |
| Gao, CZ | 1 |
| Liang, MD | 1 |
| Zhu, SH | 1 |
| Bogatyrev, IV | 1 |
| Makolkin, VI | 1 |
| Syrkin, AL | 2 |
| Mavridi, DI | 1 |
| Iuldashev, NM | 1 |
| Fushteĭ, IM | 1 |
| Torbin, ES | 1 |
| Tatarintseva, NP | 1 |
| Kaul, UA | 1 |
| Verma, R | 1 |
| Garg, KC | 1 |
| Karasawa, A | 1 |
| Kubo, K | 1 |
| Lu, XA | 1 |
| Ling, H | 1 |
| Dong, CR | 1 |
| Ouyang, JP | 1 |
| Davis, BR | 2 |
| Sanders, MR | 1 |
| Dollery, CT | 1 |
| Hara, Y | 1 |
| Ichihara, K | 1 |
| Abiko, Y | 1 |
| Tolstopiatov, SM | 2 |
| Lei, LQ | 1 |
| Rubin, SA | 1 |
| Hamilton, I | 1 |
| Connacher, AA | 1 |
| Bouchier, IA | 1 |
| Glogar, DH | 1 |
| Umezawa, S | 1 |
| Nogami, A | 1 |
| Taniguchi, K | 1 |
| Takeuchi, J | 1 |
| Fujiwara, H | 1 |
| Amemiya, H | 1 |
| Shiroyama, N | 1 |
| Hiroe, M | 1 |
| Gatchel, RJ | 1 |
| Gaffney, FA | 1 |
| Smith, JE | 1 |
| Romhilt, DW | 1 |
| Laubach, C | 1 |
| Wilner, GW | 1 |
| Williams, CB | 1 |
| Johnson, CT | 1 |
| Cowan, M | 1 |
| Khaja, F | 1 |
| McFarland, T | 1 |
| Capone, R | 1 |
| Dahdah, S | 1 |
| Haywood, J | 1 |
| Edmiston, WA | 1 |
| Iaremenko, OB | 2 |
| Kinnaird, AA | 1 |
| Man, RY | 1 |
| Morgan, TO | 1 |
| Martynov, IV | 1 |
| Voronin, VA | 1 |
| De Caprio, L | 1 |
| Vigorito, C | 1 |
| Acanfora, D | 1 |
| Artiaco, D | 1 |
| Ascione, L | 1 |
| Papa, M | 1 |
| Rengo, F | 1 |
| van der Bel-Kahn, J | 1 |
| Jolly, P | 1 |
| Zumwalt, R | 1 |
| Eve, B | 1 |
| Bell, RL | 2 |
| Curb, JD | 4 |
| McIntyre, KM | 1 |
| Payton-Ross, C | 1 |
| Malinovskaia, IE | 2 |
| Shilova, NA | 1 |
| Gaĭdukova, NI | 1 |
| Charchoglian, RA | 1 |
| Levshunov, SP | 1 |
| Fishchenko, AD | 1 |
| Goldshteĭne, GKh | 1 |
| Tsorin, IB | 1 |
| Chichkanov, GG | 1 |
| Chadda, K | 1 |
| Miyazawa, K | 1 |
| Fukuyama, H | 1 |
| Komatsu, E | 1 |
| Yamaguchi, I | 1 |
| Payne, GH | 1 |
| Mattson, ME | 1 |
| McArdle, R | 1 |
| Savov, VM | 1 |
| Didenko, VV | 1 |
| Kagan, VE | 1 |
| Wexler, BC | 1 |
| Kumar, C | 1 |
| Singh, M | 1 |
| Lagioia, R | 1 |
| Mangini, SG | 1 |
| Dibenedetto, A | 1 |
| Scrutinio, D | 1 |
| Rizzon, P | 1 |
| Angelutsa, PA | 1 |
| Gupta, RC | 1 |
| Sharma, SK | 1 |
| Arora, YK | 1 |
| Tripathi, K | 1 |
| Tsuchida, K | 1 |
| Yamazaki, R | 1 |
| Kaneko, K | 1 |
| Kimura, M | 1 |
| Aihara, H | 1 |
| Sterling, K | 1 |
| Hoffenberg, R | 1 |
| Doshchitsin, VL | 3 |
| Simonov, VI | 1 |
| Gamble, OW | 1 |
| Cohn, K | 1 |
| Myburgh, DP | 1 |
| Slome, R | 1 |
| Nellen, M | 1 |
| Diaz, RG | 2 |
| Somberg, JC | 1 |
| Freeman, E | 2 |
| Levitt, B | 2 |
| Pierce, WS | 1 |
| Carter, DR | 1 |
| McGavran, MH | 1 |
| Waldhausen, JA | 1 |
| Basta, LL | 1 |
| Theilen, EO | 2 |
| Ehrenhaft, JL | 1 |
| Tributs, TV | 1 |
| Pidrman, V | 1 |
| Hamet, A | 1 |
| Black, JW | 1 |
| Prichard, BN | 1 |
| Smith, ER | 1 |
| Figini, A | 1 |
| Campolo, L | 1 |
| Jewitt, DE | 6 |
| Davies, RO | 1 |
| Snow, PJ | 2 |
| Balcon, R | 4 |
| Davies, JP | 2 |
| Oram, S | 3 |
| Clausen, J | 2 |
| Felsby, M | 2 |
| Jorgensen, FS | 2 |
| Nielsen, BL | 2 |
| Roin, J | 2 |
| Strange, B | 2 |
| Grayson, J | 2 |
| Ledwich, JR | 1 |
| Covino, BG | 1 |
| D'Amato, HE | 1 |
| Chazov, EI | 1 |
| Zharov, EI | 1 |
| Arshakuni, RO | 1 |
| Hansen, HW | 1 |
| Wagener, HH | 1 |
| Lukomskiĭ, PE | 1 |
| Selzer, A | 1 |
| Cohn, KE | 1 |
| McGuire, J | 1 |
| Russek, HI | 5 |
| Touche, M | 1 |
| Touche, S | 1 |
| Jouvet, M | 1 |
| Trouve, P | 1 |
| Kattus, AA | 1 |
| Coltart, DJ | 1 |
| Wettach, GE | 1 |
| Franklin, D | 1 |
| Kemper, WS | 1 |
| Weser, C | 1 |
| Scheidler, K | 1 |
| Guy, CR | 1 |
| Surawicz, B | 1 |
| Méhes, G | 1 |
| Rajkovits, K | 1 |
| Papp, G | 1 |
| Shadaksharappa, KS | 1 |
| Nantel, A | 1 |
| Wilson, WR | 1 |
| Bennet, D | 1 |
| Hoy, J | 1 |
| Sowton, E | 1 |
| van Buchem, FS | 2 |
| Bosschieter, E | 2 |
| Staszewska-Barczak, J | 1 |
| Krosch, H | 1 |
| Rikirsch, P | 1 |
| Teichmann, W | 1 |
| Mansour, KA | 1 |
| Zakaryia, MS | 1 |
| Schuster, DP | 1 |
| Nobel, NL | 1 |
| Mimnaugh, MN | 1 |
| Counsell, RE | 1 |
| Jebavý, P | 1 |
| Ressl, J | 1 |
| Jandová, R | 1 |
| Zammit Maempel, JV | 1 |
| Sivkov, II | 1 |
| Kukes, VG | 1 |
| Mamedova, AD | 1 |
| Rozinov, IuI | 1 |
| Maziĭ, SA | 1 |
| Branzi, A | 1 |
| Binetti, G | 1 |
| Zannoli, R | 1 |
| Magnani, B | 1 |
| Morita, Y | 1 |
| Ishiyama, T | 1 |
| Tsukamoto, N | 1 |
| Yamamura, Y | 1 |
| Master, AM | 1 |
| Jaffe, HL | 1 |
| Sewell, WH | 1 |
| Moran, JM | 1 |
| Mulet, J | 1 |
| Caralps, JM | 1 |
| Pifarre, R | 1 |
| Miyahara, M | 1 |
| Ashinaga, T | 1 |
| Morikawa, R | 1 |
| Minemawari, Y | 1 |
| Zoneraich, S | 1 |
| Zoneraich, O | 1 |
| Peart, WS | 1 |
| Religa, A | 1 |
| Evans, RG | 1 |
| Tulloch, BR | 1 |
| Libby, P | 3 |
| Giardina, EG | 1 |
| Altieri, S | 1 |
| Desai, DC | 1 |
| Alexander, S | 1 |
| Vohra, J | 1 |
| Ludbrook, P | 2 |
| Karliner, JS | 2 |
| Kostuk, W | 1 |
| O'Rourke, RA | 2 |
| Kats, IA | 2 |
| Le Pailleur, C | 1 |
| Meilhac, B | 1 |
| Neveux, JY | 1 |
| Mathey, J | 1 |
| Di Matteo, J | 1 |
| Lavelle, JF | 1 |
| Covell, JW | 4 |
| Chung, EK | 2 |
| Osnes, JB | 1 |
| Madan, BR | 1 |
| Jain, BK | 1 |
| Bennett, M | 1 |
| Krauss, XH | 1 |
| Leon-Sotomayor, LA | 1 |
| Gill, CC | 1 |
| Wechsler, AS | 1 |
| Sabiston, DC | 1 |
| Ginks, W | 1 |
| Sybers, HD | 2 |
| Marshall, CE | 1 |
| Shappell, SD | 1 |
| Somberg, J | 1 |
| Castan, R | 1 |
| Moser, K | 1 |
| Lujf, A | 1 |
| Caughey, DE | 2 |
| Scott, PJ | 2 |
| Cranston, WI | 1 |
| Jacobsen, K | 1 |
| Carstens, PH | 1 |
| Battock, DJ | 1 |
| Alvarez, H | 1 |
| Chidsey, CA | 1 |
| Kobayashi, T | 1 |
| Matsumoto, S | 1 |
| Dotremont, G | 1 |
| De Geest, H | 1 |
| Neilson, GH | 1 |
| Seldon, WA | 1 |
| Banerjea, JC | 1 |
| Mukherjee, SK | 1 |
| Mukherjee, TP | 1 |
| Castellanos, A | 2 |
| Arcebal, AG | 2 |
| Iyengar, RN | 1 |
| Papp, C | 1 |
| Patton, RD | 1 |
| Verstraete, M | 1 |
| Harumi, K | 1 |
| Matsuo, H | 1 |
| Chen, CM | 1 |
| Sacrez, A | 1 |
| Tempe, JD | 1 |
| Storck, D | 1 |
| Hammann, B | 1 |
| Wertenschlag, J | 1 |
| Martin, G | 1 |
| Marriott, HJ | 2 |
| Diederich, KW | 1 |
| Nager, F | 1 |
| Masters, AM | 1 |
| Monroe, RG | 1 |
| LaFarge, CG | 1 |
| Gamble, WJ | 1 |
| Kumar, AE | 1 |
| Manasek, FJ | 1 |
| Kobayashi, K | 1 |
| Krauss, KR | 1 |
| Sommers, HM | 1 |
| Wray, R | 1 |
| Sutcliffe, SB | 1 |
| Bloor, CM | 1 |
| Lull, RJ | 1 |
| Dunn, BE | 1 |
| Gregoratos, G | 1 |
| Cox, WA | 1 |
| Fisher, GW | 1 |
| Nola, GT | 1 |
| Kerber, RE | 1 |
| Stacks, PE | 1 |
| Gore, I | 1 |
| Kobayakawa, T | 1 |
| Bellet, S | 1 |
| Horstmann, E | 1 |
| Roman, LR | 1 |
| DeGuzman, NT | 1 |
| Weissler, AM | 1 |
| Bloom, S | 1 |
| Davis, DL | 1 |
| Novitskiĭ, NS | 1 |
| Serrano, PA | 1 |
| Chăvez-Lara, B | 1 |
| Bisteni, A | 1 |
| Sodi Pallares, D | 1 |
| Danzig, R | 1 |
| Lee, GB | 1 |
| Campion, BC | 1 |
| Feola, M | 1 |
| Haiderer, O | 1 |
| Kennedy, JH | 1 |
| Toshima, H | 1 |
| Matoba, T | 1 |
| Shimada, H | 1 |
| Tanaka, R | 1 |
| Kimura, N | 1 |
| Dalle, XS | 1 |
| Meltzer, E | 1 |
| Kravitz, B | 1 |
| Chung, D | 1 |
| Stasiewicz, J | 1 |
| Manaczyński, A | 1 |
| Szalaj, W | 1 |
| Hofman, J | 1 |
| Mercer, CJ | 1 |
| Hubner, PJ | 1 |
| Drion, EF | 1 |
| Wigbout, M | 1 |
| Lund-Larsen, G | 1 |
| Cornil, A | 1 |
| Thys, JP | 1 |
| Vanroux, A | 1 |
| Neve, P | 1 |
| Nicaise, J | 1 |
| Bernard, R | 1 |
| Burgess, PA | 1 |
| Lewartowski, B | 1 |
| Sedek, G | 1 |
| Gawin, E | 1 |
| Rothfeld, EL | 3 |
| Zucker, IR | 3 |
| Tiu, R | 1 |
| Parsonnet, V | 3 |
| Beller, BM | 1 |
| Collens, R | 1 |
| Pyzik, Z | 1 |
| Sedziwy, L | 1 |
| Kimmel, Z | 1 |
| Kozlowska, A | 1 |
| Bachman, K | 1 |
| Kachel, S | 1 |
| Watanabe, T | 1 |
| Levitsky, S | 1 |
| Mullin, EM | 1 |
| Sloane, RE | 1 |
| Morrow, AG | 1 |
| Horgan, JH | 1 |
| Dhurandhar, RW | 1 |
| Teasdale, SJ | 1 |
| Mahon, WA | 1 |
| Papazoglov, NM | 1 |
| Robelli, F | 1 |
| De Vita, C | 1 |
| Cadel, A | 1 |
| Luger, GW | 1 |
| el-Gamal, M | 1 |
| Kozená, J | 1 |
| Kolár, J | 1 |
| Harland, WA | 1 |
| Orr, JS | 1 |
| Dunnigan, MG | 1 |
| Fyfe, T | 1 |
| Kühns, K | 1 |
| Wettich, JE | 1 |
| Samwer, KF | 1 |
| Roberts, CI | 1 |
| Wharton, CF | 1 |
| Irvine, M | 1 |
| Cunningham, J | 1 |
| Sangster, L | 1 |
| Ikram, H | 1 |
| Bensley, KE | 1 |
| Gedeon, A | 1 |
| Wallnöfer, H | 1 |
| Bereitter, E | 1 |
| Lipowitz, M | 1 |
| Bernstein, A | 2 |
| Kel'man, IM | 1 |
| Gurevich, MA | 1 |
| Shtabnitskiĭ, MS | 1 |
| Hoak, JC | 1 |
| Connor, WE | 1 |
| Warner, ED | 1 |
| Dotti, F | 1 |
| Piva, M | 1 |
| Ongari, R | 1 |
| Raftery, EB | 1 |
| Stutz, DR | 1 |
| Winfield, RA | 1 |
| Corday, E | 1 |
| Vyden, JK | 1 |
| Lang, TW | 1 |
| Boszormenyi, E | 1 |
| Carvalho, M | 1 |
| Gold, H | 1 |
| Goldman, A | 1 |
| Rosselot, E | 1 |
| Dissmann, W | 1 |
| Buschmann, HJ | 1 |
| Schneider, J | 1 |
| Sykes, MK | 1 |
| Orr, DS | 1 |
| Lehr, D | 1 |
| Krukowski, M | 1 |
| Colón, R | 1 |
| Lal, HB | 1 |
| Caroli, RK | 1 |
| Sen Gupta, D | 1 |
| Basumalick, SN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Brasilia Heart Study of Outcome Markers in ST-elevation Myocardial Infarction[NCT02062554] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2006-05-31 | Recruiting | |||
| [NCT00000492] | Phase 3 | 0 participants | Interventional | 1977-09-30 | Completed | ||
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)[NCT00430612] | 7,057 participants (Actual) | Observational [Patient Registry] | 2009-05-31 | Completed | |||
| [NCT00000493] | Phase 3 | 0 participants | Interventional | 1977-09-30 | Completed | ||
| [NCT00005217] | 0 participants | Observational | 1988-04-30 | Completed | |||
| Development and Evaluation of a Therapeutic Education Intervention Focused on the Accession of Patients Treated With Hormonal Therapy in the Management of Breast Cancer: PEPs Hormonotherapy[NCT02300675] | 352 participants (Actual) | Interventional | 2014-05-31 | Completed | |||
| PRospectIve Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in PatiEnts With Heart Failure and Preserved Ejection Fraction[NCT04128891] | Phase 3 | 0 participants (Actual) | Interventional | 2020-02-01 | Withdrawn (stopped due to Funding not approved) | ||
| "Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by the Funny Channel Current (If) Inhibitor Ivabradine"[NCT01186783] | Phase 2 | 70 participants (Anticipated) | Interventional | 2010-05-31 | Recruiting | ||
| A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)[NCT01131260] | 11,108 participants (Actual) | Interventional | 2010-11-30 | Completed | |||
| A Phase 3 Randomized Double-blind Study Comparing TR-701 FA and Linezolid in Ventilated Gram-positive Nosocomial Pneumonia[NCT02019420] | Phase 3 | 726 participants (Actual) | Interventional | 2014-01-06 | Completed | ||
| A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix[NCT02901626] | Phase 3 | 544 participants (Actual) | Interventional | 2017-02-14 | Terminated (stopped due to The study was stopped per the recommendation of the DSMB and NICHD.) | ||
| [NCT00000485] | Phase 3 | 0 participants | Interventional | 1971-05-31 | Completed | ||
| [NCT00000491] | Phase 3 | 0 participants | Interventional | 1974-10-31 | Completed | ||
| Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II[NCT02592824] | Phase 3 | 321 participants (Actual) | Interventional | 2015-11-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score. (NCT01131260)
Timeframe: 5 minutes after Delivery
| Intervention | score on a scale (Median) |
|---|---|
| Open Group | 9 |
| Masked Group | 9 |
Duration of labor in hours after randomization through delivery (NCT01131260)
Timeframe: Onset of Labor through delivery
| Intervention | Hours (Median) |
|---|---|
| Open Group | 3.8 |
| Masked Group | 3.9 |
Days of stay in the hospital (NCT01131260)
Timeframe: From admission to labor and delivery through hospital discharge
| Intervention | Days (Median) |
|---|---|
| Open Group | 2 |
| Masked Group | 2 |
Intermediate care nursery or neonatal intensive care (anything more than well-baby nursery) (NCT01131260)
Timeframe: Delivery and 1 month of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 498 |
| Masked Group | 470 |
Neonatal encephalopathy experienced between delivery and discharge (NCT01131260)
Timeframe: Delivery through hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 4 |
| Masked Group | 5 |
Number of infants who experienced Neonatal Seizure (NCT01131260)
Timeframe: Birth through hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 3 |
| Masked Group | 4 |
Major congenital malformation (NCT01131260)
Timeframe: Delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 38 |
| Masked Group | 23 |
The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score. The lowest score is 0, the highest score is 10. (NCT01131260)
Timeframe: 5 minutes after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 17 |
| Masked Group | 6 |
Meconium aspiration syndrome (NCT01131260)
Timeframe: Delivery through discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 20 |
| Masked Group | 20 |
Umbilical-artery blood pH < = 7.05 and base deficit in extracellular fluid > = 12 mmol/liter (NCT01131260)
Timeframe: Delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 3 |
| Masked Group | 8 |
Death of the fetus during the intrapartum period. (NCT01131260)
Timeframe: During labor and through delivery of the baby
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 0 |
| Masked Group | 0 |
Death of the newborn between delivery and1 month of age (NCT01131260)
Timeframe: Delivery through1 month of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 3 |
| Masked Group | 1 |
Neonatal intubation for ventilation in the delivery room (NCT01131260)
Timeframe: Delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 42 |
| Masked Group | 27 |
Presence of shoulder dystocia during delivery (NCT01131260)
Timeframe: Delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 141 |
| Masked Group | 158 |
Postpartum endometritis (NCT01131260)
Timeframe: Delivery through hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 71 |
| Masked Group | 88 |
Blood transfusion from delivery and through hospital stay until discharge (NCT01131260)
Timeframe: Delivery through hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 80 |
| Masked Group | 74 |
Chorioamnionitis (NCT01131260)
Timeframe: Any time from Randomization through Delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 286 |
| Masked Group | 269 |
Composite primary outcome of intrapartum fetal death, neonatal death, Apgar score <=3 at 5 minutes, neonatal seizure, umbilical artery blood pH <= 7.05 with base deficit >=12 mmol/L in extra-cellular fluid, intubation for ventilation at delivery, neonatal encelphalopathy (NCT01131260)
Timeframe: From Delivery through 1 month of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Group | 52 |
| Masked Group | 40 |
Indication for delivery by forceps or vacuum (NCT01131260)
Timeframe: During labor through delivery
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Fetal indication | Dystocia | Other | |
| Masked Group | 218 | 101 | 8 |
| Open Group | 225 | 95 | 9 |
The number of MRSA-infected participants with all-cause mortality within 28 days after randomization was determined in the mITT population. Participants who had confirmed MRSA culture results from respiratory tract or pleural fluid specimens obtained within 72 hours of study Day 1 were included. Any participants who were lost to follow-up and not known to be alive or deceased by Day 28 were imputed as deceased. (NCT02019420)
Timeframe: Up to 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 14 |
| Linezolid | 20 |
The number of MSSA-infected participants with all-cause mortality within 28 days after randomization was determined in the mITT population. Participants who had confirmed MSSA culture results from respiratory tract or pleural fluid specimens obtained within 36 hours of study Day 1 were included. Any participants who were lost to follow-up and not known to be alive or deceased by Day 28 were imputed as deceased. (NCT02019420)
Timeframe: Up to 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 31 |
| Linezolid | 32 |
An AE is any untoward medical occurrence associated with the use of a drug in humans, whether or not considered drug related. Safety analysis was based on actual treatment received and not randomization. (NCT02019420)
Timeframe: Up to 14 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 4 |
| Linezolid | 3 |
An AE is any untoward medical occurrence associated with the use of a drug in humans, whether or not considered drug related. Safety analysis is based on actual treatment received instead of randomization. (NCT02019420)
Timeframe: Up to 32 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 327 |
| Linezolid | 325 |
The number of patients in the mITT population with a favorable response at EOT was determined. Favorable response included eradication (absence of the baseline pathogen) and presumed eradication (no source specimen to culture in a participant assessed as a clinical cure by the investigator). (NCT02019420)
Timeframe: 1-3 days after completing study therapy (Days 8-10 or Days 15-17)
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 123 |
| Linezolid | 166 |
The number of patients in the ME-1 population with a favorable response at EOT was determined. Favorable response included eradication (absence of the baseline pathogen) and presumed eradication (no source specimen to culture in a participant assessed as a clinical cure by the investigator). (NCT02019420)
Timeframe: 1-3 days after completing study therapy (Days 8-10 or Days 15-17)
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 123 |
| Linezolid | 166 |
The number of patients in the mITT population with a favorable response at TOC was determined. Favorable response included eradication (absence of the baseline pathogen) and presumed eradication (no source specimen to culture in a participant assessed as a clinical cure by the investigator). (NCT02019420)
Timeframe: 7-14 days after end of therapy - TOC
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 117 |
| Linezolid | 158 |
The number of patients in the ME-2 population with a favorable response at TOC was determined. Favorable response included eradication (absence of the baseline pathogen) and presumed eradication (no source specimen to culture in a participant assessed as a clinical cure by the investigator). (NCT02019420)
Timeframe: 7-14 days after end of therapy - TOC
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 65 |
| Linezolid | 74 |
The numbers of participants with all-cause mortality within 28 days after randomization was determined in the ITT population. Any participants who were lost to follow-up and not known to be alive or deceased by Day 28 were imputed as deceased. (NCT02019420)
Timeframe: Up to 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 103 |
| Linezolid | 95 |
The numbers of participants with all-cause mortality within 28 days after randomization was determined in the mITT population. Any participants who were lost to follow-up and not known to be alive or deceased by Day 28 were imputed as deceased. (NCT02019420)
Timeframe: Up to 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Tedizolid | 46 |
| Linezolid | 49 |
The clinical response in the CE population at the TOC visit (derived from the Investigator's assessment at the EOT and TOC visits) was determined by the investigator to be either: clinical success, clinical failure, or indeterminate. Clinical success was declared when most or all clinical signs were completely resolved, with no new signs of infection, no additional antibiotic therapy was required, and the participant was alive. Indeterminate was declared when the investigator could not determine success or failure. Clinical failure was declared with progression, relapse, or recurrence of new symptoms of infection, or a persistence or insufficient improvement in signs and symptoms of VNP. (NCT02019420)
Timeframe: 7-14 days after end of therapy - TOC
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Clinical Success | Clinical Failure | Indeterminate | |
| Linezolid | 146 | 97 | 0 |
| Tedizolid | 143 | 124 | 0 |
The clinical response in the ITT population at the TOC visit (derived from the Investigator's assessment at the EOT and TOC visits) was determined by the investigator to be either: clinical success, clinical failure, or indeterminate. Clinical success was declared when most or all clinical signs were completely resolved, with no new signs of infection, no additional antibiotic therapy was required, and the participant was alive. Indeterminate was declared when the investigator could not determine success or failure. Clinical failure was declared with progression, relapse, or recurrence of new symptoms of infection, or a persistence or insufficient improvement in signs and symptoms of VNP. (NCT02019420)
Timeframe: 7-14 days after end of therapy - TOC
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Clinical Success | Clinical Failure | Indeterminate | |
| Linezolid | 230 | 110 | 20 |
| Tedizolid | 206 | 144 | 16 |
Median gestational age (in weeks) at the time of delivery (NCT02901626)
Timeframe: From randomization to delivery (up to a length of 189 days)
| Intervention | weeks (Median) |
|---|---|
| Arabin Cervical Pessary | 37.3 |
| No Pessary | 37.4 |
The median interval between randomization to delivery or death of the fetus. (NCT02901626)
Timeframe: from randomization to delivery or fetal death (up to a length of 189 days)
| Intervention | days (Median) |
|---|---|
| Cervical Arabin Pessary | 105 |
| No Pessary | 103 |
Median number of days a neonate received supplemental oxygen after admission to the NICU or intermediate nursery. Supplemental oxygen is defined as FiO2 > 0.21. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | days (Median) |
|---|---|
| Cervical Arabin Pessary | 7 |
| No Pessary | 6 |
Median number of days a neonate or infant was on a ventilator or received continuous positive airway pressure. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | days (Median) |
|---|---|
| Cervical Arabin Pessary | 6 |
| No Pessary | 5 |
Median number of days from maternal hospital admission for delivery and the date of delivery. (NCT02901626)
Timeframe: from date of admission for delivery up to delivery date (up to 5 days)
| Intervention | days (Median) |
|---|---|
| Pessary | 1 |
| No Pessary | 1 |
Median number of days the neonate/infant remained in hospital. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | days (Median) |
|---|---|
| Cervical Arabin Pessary | 3 |
| No Pessary | 3 |
Median number of days the neonate/infant remained in the neonatal intensive care unit or special care nursery. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | days (Median) |
|---|---|
| Cervical Arabin Pessary | 50 |
| No Pessary | 37 |
"The number of neonates diagnosed with any one of the following:~Sepsis (within 72 hours and > 72 hours after birth) defined as a clinically ill infant in whom systemic infection is suspected with a positive blood, CSF, or catheterized/suprapubic urine culture; or, in the absence of positive cultures, clinical evidence of cardiovascular collapse or an unequivocal radiograph confirming infection.~Suspected sepsis. The diagnosis of suspected sepsis will include infants with suspicious clinical findings of infection, but no positive cultures or radiographs.~Pneumonia. The diagnosis of pneumonia will be confirmed by radiograph or positive blood culture." (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 53 |
| No Pessary | 65 |
The number of neonates with a diagnosis of respiratory distress syndrome defined as the presence of clinical signs of respiratory distress (tachypnea, retractions, flaring, grunting, or cyanosis), with oxygen requirement and a chest x-ray that show hypoaeration and reticulogranular infiltrates. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 67 |
| No Pessary | 69 |
The number of neonates or infants who required ventilator support or received continuous positive airway pressure. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 75 |
| No Pessary | 82 |
The number of neonates whose birthweight compared with gestational age at delivery was less than the 5th percentile, as assessed by sex and race, using United States birth certificate data. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 5 |
| No Pessary | 6 |
The number of neonates with a clinical diagnosis of bronchopulmonary dysplasia defined as oxygen requirement at 28 days of life if delivered at or after 32 weeks gestation, or at 36 weeks project gestational age if delivered before 32 weeks gestation. (NCT02901626)
Timeframe: Delivery through 28 days of life if delivered at or after 32 weeks. Delivery through 36 weeks gestation if delivered before 32 weeks.
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 14 |
| No Pessary | 19 |
The number of neonates diagnosed with any one of fetal or neonatal death or Respiratory Distress Syndrome, Grade 3 or 4 Intraventricular Hemorrhage, Periventricular Leukomalacia, Stage 2 or 3 Nectrotizing Enterocolitis, Bronchopulmonary Dysplasia, Stage III or higher Retinopathy of Prematurity, or early onset sepsis. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 81 |
| No Pessary | 74 |
The number of neonates with a clinical diagnosis of sepsis within 72 hours of life, defined as a clinically ill infant in whom systemic infection is suspected with a positive blood, cerebrospinal fluid, or catheterized/suprapubic urine culture; or, in the absence of positive cultures, clinical evidence of cardiovascular collapse or an unequivocal radiograph confirming infection. (NCT02901626)
Timeframe: within 72 hours of birth
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 5 |
| No Pessary | 2 |
The number of neonates diagnosed with hyperbilirubinemia, defined as peak total bilirubin of at least 15 mg% or the use of phototherapy (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 84 |
| No Pessary | 82 |
IVH grades III or IV are as determined by cranial ultrasounds performed as part of routine clinical care and classified based on the Papile classification system (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 4 |
| No Pessary | 7 |
The number of neonates with a clinical diagnosis of sepsis at or after 72 hours of life, defined as the presence of a clinically ill infant in whom systemic infection is suspected with a positive blood, cerebrospinal fluid, or catheterized/suprapubic urine culture; or, in the absence of positive cultures, clinical evidence of cardiovascular collapse or an unequivocal radiograph confirming infection. (NCT02901626)
Timeframe: 72 hours of birth or later (up to hospital discharge - a maximum of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 8 |
| No Pessary | 12 |
The number of neonates diagnosed with NEC, defined as modified Bell Stage 2 or 3 where stage 2 represents clinical signs and symptoms with pneumatosis intestinalis on radiographs and stage 3 is defined as advanced clinical signs and symptoms, pneumatosis, impending or proven intestinal perforation. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 7 |
| No Pessary | 6 |
The number of neonates with a clinical diagnosis of pneumonia within 72 hours of birth and confirmed by either an x-ray demonstrating consolidation with air bronchograms, or a positive blood culture performed at the time of clinical diagnosis. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 2 |
| No Pessary | 4 |
The number of neonates with a clinical diagnosis of retinopathy of prematurity where an ophthalmologic examination of the retina was performed. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 27 |
| No Pessary | 23 |
The number of neonates with a clinical diagnosis of seizures who received anti-seizure medication. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 1 |
| No Pessary | 1 |
The number of neonates with suspicious clinical findings of infection, but no positive cultures or radiographs. (NCT02901626)
Timeframe: delivery through hospital discharge (up to a length of 435 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 38 |
| No Pessary | 51 |
The number of participants who received any one of the following treatments for preterm labor: tocolysis, cerclage, bedrest, antenatal corticosteroids for fetal lung maturity, or magnesium sulfate for neuroprotection. (NCT02901626)
Timeframe: From randomization to delivery (up to a length of 189 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 150 |
| No Pessary | 143 |
The number of participants who underwent a surgical procedure for delivery (cesarean) at any gestational age. (NCT02901626)
Timeframe: From randomization to delivery (up to a length of 189 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 86 |
| No Pessary | 80 |
The number of participants who had a clinical diagnosis of chorioamnionitis and a body temperature of at least 100.0° F (38° C) and no other defined infection. (NCT02901626)
Timeframe: From randomization to delivery (up to a length of 189 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 18 |
| No Pessary | 16 |
The number of participants who underwent labor induction or had an assisted vaginal delivery with forceps or vacuum or cesarean delivery prior to 37 weeks gestation. (NCT02901626)
Timeframe: from randomization to delivery (up to a length of 189 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 18 |
| No Pessary | 14 |
The number of participants who either delivered or experienced a fetal death prior to 28 weeks gestation. (NCT02901626)
Timeframe: from randomization to less than 28 weeks gestation (a period of less than 91 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 72 |
| No Pessary | 54 |
The number of participants who either delivered or experienced a fetal death prior to 32 weeks gestation. (NCT02901626)
Timeframe: from randomization to less than 32 weeks gestation (a period of less than 119 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 93 |
| No Pessary | 73 |
The number of participants who either delivered or experienced a fetal death prior to 35 weeks gestation. (NCT02901626)
Timeframe: from randomization to less than 35 weeks gestation (a period of less than 140 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 111 |
| No Pessary | 90 |
Participants who either delivered or experienced a fetal death prior to 37 weeks gestation. (NCT02901626)
Timeframe: Before 37 weeks 0 days gestation, a period of up to 21 weeks from enrollment.
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 127 |
| No Pessary | 120 |
Participants were categorized as yes if the amniotic membranes ruptured prior to labor onset and before 37 weeks gestation. (NCT02901626)
Timeframe: Before 37 weeks 0 days gestation, a period of up to 21 weeks from enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 64 |
| No Pessary | 46 |
The number of participants who experienced spontaneous onset of labor and had an unassisted vaginal delivery prior to 37 weeks gestation. Induction for delivery was not performed and operative techniques such as forceps or vacuum were not used. (NCT02901626)
Timeframe: From randomization to delivery (up to a length of 189 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 109 |
| No Pessary | 106 |
The number of participants with a clinical diagnosis of a vaginal infection. Includes participants with at least one study visit. (NCT02901626)
Timeframe: From randomization to delivery (up to a length of 189 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 57 |
| No Pessary | 41 |
The number of participants who received antibiotics or antifungal medication for a vaginal infection (out of the total sample for which data is available) (NCT02901626)
Timeframe: From randomization to delivery (up to a length of 189 days)
| Intervention | Participants (Count of Participants) |
|---|---|
| Cervical Arabin Pessary | 55 |
| No Pessary | 37 |
Postoperative mortality was defined as mortality within 30 days of surgery. (NCT02592824)
Timeframe: up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate Infusion | 1 |
| Intravenous Saline Infusion | 6 |
suspected unexpected serious adverse reaction (NCT02592824)
Timeframe: within 24 hours from infusion
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate Infusion | 0 |
| Intravenous Saline Infusion | 0 |
"Postoperative stroke was defined as neurological or cognitive deficit with a cerebral injury verified on (Computed Tomography) CT-scan. All suspected cases of stroke underwent CT-scan.~Stroke within 24 h of surgery was defined as a stroke that occurred within 24 h of surgery or signs of a stroke, when first assessable in deeply sedated patients on a ventilator." (NCT02592824)
Timeframe: within 24 hours from surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate Infusion | 0 |
| Intravenous Saline Infusion | 4 |
"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.~In the first GLUTAMICS trial a good agreement between hemodynamic criteria for postoperative heart failure and postoperative NT-proBNP was found." (NCT02592824)
Timeframe: from the day before surgery to the third postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 5390 |
| Intravenous Saline Infusion | 6452 |
"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.~Previous observations suggest a blunted effect of glutamate in diabetic hearts." (NCT02592824)
Timeframe: from preoperative level to the third postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 4503 |
| Intravenous Saline Infusion | 6825 |
Postoperative NT-proBNP reflects postoperative myocardial dysfunction. (NCT02592824)
Timeframe: first postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 4438 |
| Intravenous Saline Infusion | 4420 |
Postoperative NT-proBNP reflects postoperative myocardial dysfunction. (NCT02592824)
Timeframe: third postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 8055 |
| Intravenous Saline Infusion | 8804 |
87 reviews available for propranolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Cause of Death; Coronary Diseas | 2017 |
Is there still a role for treatment with beta-adrenoceptor antagonists in post-myocardial infarction patients with well-preserved left ventricular systolic function?
Topics: Adrenergic Antagonists; Angioplasty, Balloon, Coronary; Endothelium, Vascular; Humans; Metoprolol; M | 2008 |
Beta-blockers and diabetes: the bad guys come good.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bisoprolol; Coronary Disease; Diabet | 2002 |
Beta-blockers for the post-myocardial infarction patient: current clinical evidence and practical considerations.
Topics: Adrenergic beta-Antagonists; Algorithms; Atenolol; Carbazoles; Carvedilol; Humans; Myocardial Infarc | 2006 |
[New therapeutic possibilities of propranolol].
Topics: Antithyroid Agents; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; | 1984 |
Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Glucose; Heart Rate; Heparin; Humans; Hyaluron | 1980 |
Rest and the acutely ischaemic heart.
Topics: Adrenergic beta-Antagonists; Bed Rest; Coronary Disease; Humans; Myocardial Infarction; Propranolol | 1980 |
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibr | 1981 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Fe | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Acute myocardial infarction--coronary thrombosis and salvage of the ischemic myocardium.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Collateral Circulation; Coronary Circulation; | 1983 |
What is the real pharmacological rationale for beta-receptor blocking agents?
Topics: Adrenergic beta-Antagonists; Betaxolol; Coronary Disease; Heart Rate; Humans; Myocardial Contraction | 1983 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Atenolol; Blood Pressur | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial In | 1984 |
Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Catecholamines; Clinical Trials as Topic; Coronary Disease; Do | 1984 |
The contribution of cellular electrophysiology in the development of antiarrhythmic agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Dogs; Drug Evaluatio | 1982 |
The role of beta-adrenergic receptor antagonists in the prevention of sudden cardiac death.
Topics: Action Potentials; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium; Calcium Channel Block | 1984 |
Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review.
Topics: Angina Pectoris, Variant; Animals; Arteriosclerosis; Autonomic Nervous System; Calcium; Calcium Chan | 1983 |
The use of systolic time intervals for evaluation of left ventricular function.
Topics: Anesthetics; Anti-Arrhythmia Agents; Electrocardiography; Heart Diseases; Heart Ventricles; Humans; | 1983 |
Radionuclide wall motion study and ejection fraction in clinical practice.
Topics: Aminophylline; Coronary Artery Bypass; Coronary Disease; Doxorubicin; Erythrocytes; Heart; Heart Dis | 1980 |
Coronary arterial spasm.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blockers; Co | 1982 |
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Huma | 1981 |
Optimal management of patients with ischemic heart disease for noncardiac surgery by complementary anesthesiologist and cardiologist interaction.
Topics: Aged; Anesthesia; Anesthesiology; Arrhythmias, Cardiac; Cardiology; Cerebrovascular Disorders; Coron | 1981 |
Effect of infarct size limitation by propranolol on ventricular arrhythmias after myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden; Dogs; Humans; Myocardial Infarction; | 1982 |
Pharmacokinetic studies: their role in determining therapeutic efficacy of agents designed to prevent sudden death.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden; Dose-Response Relatio | 1982 |
Antiplatelet therapy in coronary heart disease.
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disor | 1982 |
Adherence to treatment and health outcomes.
Topics: Clofibrate; Double-Blind Method; Evaluation Studies as Topic; Humans; Hypercholesterolemia; Male; My | 1993 |
[Treatment with beta-blockers in patients with acute coronary syndrome].
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Atenolol; Clinical Trials as Topic; Co | 1998 |
Determination of power and sample size in the design of clinical trials with failure-time endpoints and interim analyses.
Topics: Adrenergic beta-Antagonists; Humans; Monte Carlo Method; Myocardial Infarction; Propranolol; Randomi | 1999 |
Beta-blockers, angiotensin-converting enzyme inhibitors, and calcium antagonists in treatment of elderly patients with acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Hum | 2000 |
Clinical usefulness of the beta-adrenergic antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Anx | 1978 |
beta-Adrenergic blockade in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Electrocardiography; Hemodynamics; Humans; Myocardial | 1978 |
Beta-blockade withdrawal.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Humans; Myocardial Infarctio | 1975 |
Myocardial infarction size: measurement and modification.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Coronary Disease; Creatine Kinase; Digitalis Glycoside | 1977 |
[Drug therapy in hypertension 1977. Empirical and rational viewpoints].
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Age Factors; Aged; Blood Volume; Diuretics; Drug The | 1978 |
Current management of unstable angina.
Topics: Angina Pectoris; Bed Rest; Coronary Artery Bypass; Hospitalization; Humans; Myocardial Infarction; N | 1978 |
The role of physical training in patients with coronary artery disease.
Topics: Aged; Angina Pectoris; Coronary Circulation; Coronary Disease; Female; Hemodynamics; Humans; Male; M | 1979 |
Approach to the management of unstable angina.
Topics: Angina Pectoris; Anticoagulants; Coronary Artery Bypass; Coronary Circulation; Critical Care; Digita | 1979 |
Tissue salvage in acute myocardial infarction.
Topics: Animals; Assisted Circulation; Collateral Circulation; Coronary Circulation; Coronary Disease; Creat | 1979 |
[Protective effect of drugs on myocardial cells in acute myocardial infarct].
Topics: Acute Disease; Drug Combinations; Glucose; Heart; Humans; Infusions, Parenteral; Insulin; Mannitol; | 1979 |
Role of the slow current in cardiac electrophysiology.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Calcium; Cyclic AMP; Digita | 1975 |
[Hemodynamic and therapeutic aspects of acute myocardial infarct. II. Pharmacological evaluations and guidelines for therapy].
Topics: Acute Disease; Digoxin; Diuretics; Heart; Hemodynamics; Humans; Hyaluronoglucosaminidase; Methylpred | 1978 |
Myocardial ischemia (third of three parts).
Topics: Acute Disease; Animals; Assisted Circulation; Coronary Disease; Disease Models, Animal; Dogs; Glucoc | 1977 |
Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
Topics: Anaerobiosis; Animals; Dogs; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Insulin; Isoprotereno | 1976 |
Usefulness of systolic time intervals in coronary artery disease.
Topics: Acute Disease; Cardiac Output; Chronic Disease; Coronary Artery Bypass; Coronary Disease; Female; Fo | 1976 |
Unstable angina pectoris.
Topics: Angina Pectoris; Angiocardiography; Anticoagulants; Hemodynamics; Humans; Myocardial Infarction; Myo | 1976 |
Propranolol and experimental myocardial infarction: substrate effects.
Topics: Animals; Dogs; Energy Metabolism; Fatty Acids, Nonesterified; Glucose; Heart; Heart Rate; Humans; La | 1976 |
Modification of infarct size.
Topics: Animals; Assisted Circulation; Coronary Circulation; Creatine Kinase; Electrocardiography; Heart; He | 1975 |
Diabetic patients and beta-blockers after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Cohort Studies; Diabetes Mellitus; Electrocardiography, Ambulator | 1990 |
[Possibilities of phosphorus 31 spectroscopy in assessing the therapeutic effects on cellular energy metabolism of the myocardium].
Topics: Acebutolol; Cardioplegic Solutions; Chlorpromazine; Energy Metabolism; Humans; Magnetic Resonance Sp | 1989 |
Use of beta-adrenergic blocking agents after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; M | 1985 |
[Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aftercare; Aged; Clinical Trials as Topic; Follow-Up Studies; Hu | 1986 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Ca | 1986 |
Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
Topics: Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Thera | 1988 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias.
Topics: Adrenergic beta-Antagonists; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Fl | 1973 |
Activation and blockade of beta adrenoceptors in common cardiac disorders.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Coronary Circulation; H | 1973 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillatio | 1970 |
Acute myocardial infarction and muscle salvage: a potential role for pharmacological agents.
Topics: Adenosine; Adrenergic alpha-Agonists; Animals; Assisted Circulation; Collateral Circulation; Coronar | 1974 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; | 1974 |
Beta-Blockers in the management of myocardial ischemia.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Volume; Coronary Disease; Depre | 1974 |
Current status of antiarrhythmic drug therapy.
Topics: Anesthetics, Local; Anti-Arrhythmia Agents; Anticonvulsants; Antimalarials; Arrhythmias, Cardiac; At | 1968 |
[Treatment of arrhythmia in myocardial infarct].
Topics: Amides; Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Cardiac Complexes, Premature; Cardiac G | 1968 |
Treatment of ventricular extrasystoles and tachyarrhythmias in acute myocardial infarction.
Topics: Acidosis; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electric Count | 1970 |
The pathophysiologic vulnerability of the subendocardium of the left ventricle.
Topics: Arrhythmias, Cardiac; Capillaries; Cardiomegaly; Coronary Disease; Coronary Vessels; Endocardium; He | 1973 |
[The beta-adrenolytics].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiovascular Diseases; Ethanolamines; Heart Diseases; Human | 1968 |
Beta-adrenergic receptor blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Digitalis | 1968 |
Control of myocardial oxygen consumption: physiologic and clinical considerations.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Blood Pressure; Calci | 1971 |
Anti-arrhythmic actions of -adrenergic receptor antagonists: review of fundamental aspects.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Card | 1972 |
[Catecholamines and arteriosclerosis].
Topics: Adrenal Glands; Angina Pectoris; Arteriosclerosis; Catecholamines; Depression, Chemical; Epinephrine | 1972 |
Life-threatening arrhythmias.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Bradycardia; Electrocardiography; Female; Heart | 1973 |
Lipid changes in thyroid disease: the effect of thyroxine and analogues.
Topics: Animals; Cholesterol; Humans; Hypercholesterolemia; Hyperthyroidism; In Vitro Techniques; Lipid Meta | 1974 |
Reduction of infarct size following coronary occlusion.
Topics: Anaerobiosis; Animals; Assisted Circulation; Coronary Vessels; Creatine Kinase; Electrocardiography; | 1974 |
Rational use of antiarrhythmic drugs alone and in combination.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Digitalis Glycosides; Drug Therapy, | 1974 |
[Variant form of angina pectoris. (Review of literature; case reports; nosologic classification; physiopathogenetic aspects)].
Topics: Angina Pectoris; Arteriosclerosis; Asthma; Blood Pressure; Coronary Disease; Electrocardiography; He | 1972 |
Treatment of severe angina pectoris.
Topics: Angina Pectoris; Carotid Sinus; Coronary Artery Bypass; Coronary Care Units; Coronary Circulation; C | 1972 |
Advances in medicine.
Topics: Acute Kidney Injury; Asthma; Blindness; Catecholamines; Contraceptives, Oral; Coronary Disease; Guan | 1968 |
[The circulatory system].
Topics: Angiocardiography; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Cardiac Surgic | 1969 |
Changing concepts in the care of patients with acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Blood Gas Analysis; Bundle-Branch Block; Cardiac Output; | 1969 |
[Clinical management of arrhythmia].
Topics: Arrhythmias, Cardiac; Digitalis Glycosides; Electric Countershock; Humans; Myocardial Infarction; Pa | 1969 |
The treatment of arrhythmias following acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Bradycardia; Coronary Care Units; Digitalis Gly | 1971 |
New look at arrhythmias.
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Diagnosis, Differential; Electric Countershock; Electro | 1969 |
Management of arrhythmias in acute myocardial infarction.
Topics: Acid-Base Equilibrium; Adams-Stokes Syndrome; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac O | 1971 |
[Electrocardiography of the bundle of His].
Topics: Electrocardiography; Heart Atria; Heart Block; Heart Conduction System; Heart Ventricles; Humans; Li | 1971 |
Management of cardiac dysrhythmias complicating acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atropine; Bradycardia; Bretylium Compound | 1968 |
178 trials available for propranolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Artery Disea | 2008 |
Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; C-Reactive Protein; Cohort Studies; Drug Therapy, Combination; Fe | 2009 |
Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Autonomic Nervous System; Death, Sudden, Cardiac; Female; | 2003 |
Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker.
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Coronary Artery Di | 2003 |
[Clinical efficiency of the use of monopril, propanolol and heparinum in stationary rehabilitation of patients with myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Fibrinol | 2008 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 10. Beta-adrenoceptor blockade and coronary artery surgery.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials | 1980 |
Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Femal | 1980 |
Beta adrenoceptor blockade in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Creatine Kinase; Dose-Respon | 1980 |
Beta-blockers in immediate treatment of myocardial infarction.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Humans; Myoca | 1980 |
Beta-blockers after myocardial infarction.
Topics: Clinical Trials as Topic; Humans; Myocardial Infarction; Propranolol | 1981 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Fe | 1981 |
Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Disopyramide; Double-B | 1981 |
Beta Blocker Heart Attack Trial: design features.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Meth | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Forum: beta-adrenoreceptor blockade after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial | 1982 |
beta-Blockers and myocardial infarction.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Diuretic | 1982 |
Postinfarction therapy with beta blockers: who should be treated?
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Heart; Human | 1982 |
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myoc | 1982 |
What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience.
Topics: Adrenergic beta-Antagonists; Aged; Clinical Trials as Topic; Humans; Middle Aged; Myocardial Infarct | 1983 |
Beta-adrenergic blocking agents after myocardial infarction: an undocumented need in patients at lowest risk.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Metoprolol; Myocardial Infarction; Pr | 1983 |
Beta-blockers and myocardial infarction: infarction and ischaemia in the practolol and propranolol trials.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Humans | 1983 |
Chronic beta blockade therapy in patients after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Humans | 1983 |
[Use of adrenergic beta blockaders after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Metoprolol; Myocardial Infarction; Pr | 1983 |
Incidence and importance of metabolic side-effects during antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Bendroflumethiazide; Blood Glucose; Cholesterol; Clinical Trials as Top | 1983 |
[Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blocke | 1983 |
[Improved prognosis using beta blockers after myocardial infarct?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Metoprolol | 1984 |
The Beta-Blocker Heart Attack Trial in perspective.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sud | 1983 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Coronar | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial In | 1984 |
Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Black or African American; Cholesterol; Clinical Tr | 1984 |
Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Black or African American; Cholesterol; Clinical Tr | 1984 |
Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Black or African American; Cholesterol; Clinical Tr | 1984 |
Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Black or African American; Cholesterol; Clinical Tr | 1984 |
Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Female; Hu | 1984 |
Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Catecholamines; Clinical Trials as Topic; Coronary Disease; Do | 1984 |
Statistical aspects of early termination in the beta-blocker heart attack trial.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Myocardial Infarction; Probability; P | 1984 |
Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Human | 1984 |
Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?
Topics: Adrenergic beta-Antagonists; Aged; Dose-Response Relationship, Drug; Hemodynamics; Humans; Injection | 1984 |
Results of long-term propranolol treatment in myocardial infarction survivors with advanced grades of ventricular extrasystoles.
Topics: Cardiac Complexes, Premature; Death, Sudden; Electroencephalography; Heart Ventricles; Hemodynamics; | 1984 |
Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Diabetes Complications; Diuretics; Doub | 1983 |
Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ma | 1983 |
Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Myoca | 1983 |
Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Midd | 1983 |
Beta-adrenoreceptor blocking agents. Their role in reducing chances of recurrent infarction and death.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Inf | 1983 |
A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Fo | 1983 |
Effect of propranolol in postinfarction patients with mechanical or electrical complications.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Heart Failur | 1984 |
Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
Topics: Acebutolol; Adult; Angina Pectoris; Clinical Trials as Topic; Dose-Response Relationship, Drug; Exer | 1984 |
Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial.
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Creatine Kinase; Electrocardiography; Humans; | 1984 |
Issues in the natural history and treatment of coronary heart disease in black populations: medical management.
Topics: Adult; Aged; Black or African American; California; Cardiovascular Diseases; Clinical Trials as Topi | 1984 |
An acute intervention trial: the research nurse coordinator's role.
Topics: Administrative Personnel; Clinical Trials as Topic; Electrocardiography; Follow-Up Studies; Humans; | 1984 |
Propranolol after myocardial infarction.
Topics: Clinical Trials as Topic; Humans; Myocardial Infarction; Propranolol | 1982 |
[Anti-angina effectiveness of sustak and obzidan in the acute period of myocardial infarct].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Middle Ag | 1980 |
Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Fe | 1982 |
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
Topics: Adult; Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Female; Heart Arrest; Hum | 1982 |
Radionuclide evaluation of CHF.
Topics: Adolescent; Adult; Coronary Disease; Digoxin; Female; Heart Aneurysm; Heart Failure; Hemodynamics; H | 1981 |
Effects of propranolol on blood lipids and lipoproteins in myocardial infarction.
Topics: Adult; Aged; Cholesterol; Coronary Disease; Female; Humans; Lipoproteins; Male; Middle Aged; Myocard | 1983 |
Unstable angina pectoris: National Cooperative Study Group to Compare Medical and Surgical Therapy. IV. Results in patients with left descending coronary artery disease.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Artery Bypass; Electrocardiography; Female; Hosp | 1981 |
Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction.
Topics: Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Double-Blind | 1980 |
[Use of adrenergic beta receptor blockaders in myocardial infarct].
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myoc | 1980 |
Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarct | 1980 |
[Changes on release of MB isoenzyme of creatine kinase by propranolol in acute myocardial infarction (author's transl)].
Topics: Clinical Trials as Topic; Creatine Kinase; Female; Humans; Isoenzymes; Kinetics; Male; Middle Aged; | 1980 |
Beta-blocker prophylaxis after myocardial infarction.
Topics: Aging; Clinical Trials as Topic; Double-Blind Method; Humans; Myocardial Infarction; Placebos; Propa | 1981 |
The randomized clinical trial: bias in analysis.
Topics: Acute Disease; Alprenolol; Atenolol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Huma | 1981 |
The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Control Groups; Double-Blind Method; Federal G | 1981 |
Drug found to help heart attack survivors.
Topics: Adult; Aged; Clinical Trials as Topic; Humans; Middle Aged; Myocardial Infarction; Propranolol | 1981 |
Effect of timolol on platelet aggregation in coronary heart disease.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female | 1981 |
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Double-Blind | 1982 |
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Double-Blind | 1982 |
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Double-Blind | 1982 |
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Double-Blind | 1982 |
beta-Blockade and recurrent myocardial infarction.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Myocardial Infarction; Propranolol; Random Al | 1982 |
Smoking, propranolol, and myocardial infarction.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Myocardial Infarction; Propranolol; Smoking | 1982 |
The Norwegian propranolol trial in selected patients.
Topics: Adult; Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Humans; Middle Aged; Myoc | 1982 |
Effect of propranolol on myocardial perfusion images and exercise ejection fraction in men with coronary artery disease.
Topics: Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease; Double-Blin | 1982 |
Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.
Topics: Adult; Aged; Catecholamines; Epinephrine; Fatty Acids, Nonesterified; Female; Hemodynamics; Humans; | 1980 |
[The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome].
Topics: Adult; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Exercise Tolerance; Humans; Ma | 1994 |
Effect of propranolol on circadian variation of ventricular arrhythmias in elderly patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Cardiac Complexes, Premature; Circadian Rhythm; Humans; Hypertension; Middl | 1995 |
Height and mortality after myocardial infarction.
Topics: Adult; Aged; Body Height; Case-Control Studies; Cause of Death; Confidence Intervals; Double-Blind M | 1995 |
Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Circadian Rhythm; Death, Sudden, Cardiac; Electrocard | 1995 |
Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II).
Topics: Aged; Arrhythmias, Cardiac; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; M | 1995 |
A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction.
Topics: Aged; Female; Heart Block; Humans; Incidence; Infusions, Intravenous; Injections, Intravenous; Magne | 1994 |
Long-term follow-up after acute myocardial infarction in patients randomized to treatment with intravenous magnesium or intravenous propranolol in the acute phase.
Topics: Aged; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Magnesium Sulfate; M | 1994 |
Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Circadian Rhythm; Death, Sudden, Cardiac; Female; Hea | 1994 |
The relationship of treatment adherence to the risk of death after myocardial infarction in women.
Topics: Adult; Aged; Cohort Studies; Female; Humans; Middle Aged; Myocardial Infarction; Patient Compliance; | 1993 |
Prognostic significance of electrocardiographic persistent ST depression in patients with their first myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
Topics: Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Pl | 1993 |
Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness.
Topics: Adult; Aged; Arrhythmias, Cardiac; Bias; Comorbidity; Double-Blind Method; Female; Follow-Up Studies | 1993 |
Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Approval; Female; Humans; Male; Middle Aged; Multicen | 1996 |
Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Artery Bypass; Diltiazem; Dose-Res | 1996 |
[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)].
Topics: Acute Disease; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Drug Therapy, Combination; Femal | 1996 |
Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Diur | 1997 |
Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
Topics: Adrenergic beta-Antagonists; Death, Sudden, Cardiac; Double-Blind Method; Electrocardiography; Femal | 1998 |
[Antioxidant and antiarrhythmic activity of carvedilol in patients with ischemic heart disease. Comparison with anaprilin].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Car | 2001 |
beta-Adrenergic blocking agents in the post-myocardial infarction patient.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Myocardial Infarction; | 1979 |
Beta-blockers after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Humans; Myoc | 1979 |
Beta-blockade withdrawal.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Humans; Myocardial Infarctio | 1975 |
Protective effect of propranolol in threatened myocardial infarction.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Creatine | 1978 |
Anti-dysrhythmic treatment in acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind | 1979 |
Propranolol in threatened myocardial infarction.
Topics: Clinical Trials as Topic; Humans; Myocardial Infarction; Propranolol; Prospective Studies; Random Al | 1979 |
[Effect of nitroglycerin, digoxin and inderal of myocardial asynergy in ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Digoxin; Drug Evaluation; | 1978 |
Unstable angina pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy.
Topics: Angina Pectoris; Coronary Artery Bypass; Coronary Circulation; Electrocardiography; Employment; Fema | 1978 |
[Changes in myocardial contractile function and in the hemodynamic indices in patients with myocardial infarct before and after beta-blockader treatment].
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Heart Rate; Hemodynam | 1978 |
Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction.
Topics: Arrhythmias, Cardiac; Atenolol; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; | 1979 |
[Effectiveness of nifedipine on exercise tolerance in patients with angina pectoris. Comparison with a nitroderivative and a beta-blocking agent].
Topics: Adolescent; Adult; Angina Pectoris; Exercise Test; Heart; Humans; Isosorbide Dinitrate; Middle Aged; | 1977 |
Reduction of enzyme levels by propranolol after acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Creatine Kinase; Electrocardiography; Female; Heart Rate | 1978 |
Medical versus surgical therapy for acute coronary insufficiency. A randomized study.
Topics: Acute Disease; Adult; Angina Pectoris; Coronary Artery Bypass; Exercise Test; Follow-Up Studies; Hos | 1975 |
Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Hum | 1975 |
Editorial: Propranolol withdrawal.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Humans; Myocard | 1975 |
Myocardial protection with carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coronary Disease; Dogs; Heart; Injecti | 1992 |
Intermittent ST depression and mortality after myocardial infarction.
Topics: Adult; Aged; Case-Control Studies; Double-Blind Method; Electrocardiography, Ambulatory; Humans; Mid | 1992 |
[Effects of beta blockers on the parameters of acute phase response and level of circulating immune complexes in myocardial infarct].
Topics: Acute-Phase Proteins; Adrenergic beta-Antagonists; alpha 1-Antitrypsin; Antigen-Antibody Complex; Hu | 1991 |
British MRC trial of treatment for mild hypertension--a more favorable interpretation.
Topics: Bendroflumethiazide; Cerebrovascular Disorders; Dose-Response Relationship, Drug; England; Humans; H | 1991 |
Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
Topics: Double-Blind Method; Electrocardiography; Follow-Up Studies; Humans; Myocardial Infarction; Placebos | 1991 |
Diabetic patients and beta-blockers after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Cohort Studies; Diabetes Mellitus; Electrocardiography, Ambulator | 1990 |
Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers.
Topics: Adrenergic beta-Antagonists; Bias; Electrocardiography; Humans; Myocardial Infarction; Propranolol; | 1990 |
Treatment adherence and risk of death after a myocardial infarction.
Topics: Adult; Aged; Double-Blind Method; Health Behavior; Humans; Male; Middle Aged; Multicenter Studies as | 1990 |
Propranolol therapy alters estimation of potential cardiovascular risk derived from submaximal postinfarction exercise testing.
Topics: Cardiovascular Diseases; Exercise Test; Hemodynamics; Humans; Myocardial Infarction; Prognosis; Prop | 1991 |
Long term propranolol treatment and changes in body weight after myocardial infarction.
Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Randomiz | 1990 |
Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experience.
Topics: Adult; Aged; Cholesterol; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studie | 1990 |
Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
Topics: Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Multicenter Studies as | 1990 |
[The effect of various types of stress-limiting therapy on the outcome of myocardial infarction].
Topics: Aged; Antioxidants; Clinical Trials as Topic; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Fe | 1990 |
Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience).
Topics: Adult; Aged; Circadian Rhythm; Death, Sudden; Double-Blind Method; Humans; Middle Aged; Myocardial I | 1990 |
Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction.
Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Inf | 1990 |
Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
Topics: Death, Sudden; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardi | 1990 |
Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Electrocardiography; H | 1987 |
[Comparative efficacy of amiodarone and propranolol on ventricular arrhythmia in the post-infarction period].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Female; Follow-Up Studies; Humans; Male | 1989 |
[The acute hemodynamic effects of the new vasodilating beta blocker carvedilol in comparison with combined administration of nifedipine and propranolol in patients with coronary heart disease].
Topics: Carbazoles; Carvedilol; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Female; H | 1989 |
[Obsidan treatment of neuroendocrine disorders and hyperkinetic syndrome in patients with macrofocal myocardial infarction].
Topics: Adult; Aged; Clinical Trials as Topic; Epinephrine; Female; Hemodynamics; Humans; Male; Middle Aged; | 1989 |
An illness-death process with time-dependent covariates.
Topics: Biometry; Clinical Trials as Topic; Humans; Models, Statistical; Morbidity; Mortality; Myocardial In | 1989 |
Comparison of the efficacy of propranolol and amiodarone in suppressing ventricular arrhythmias following myocardial infarction.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; M | 1989 |
Use of beta-adrenergic blocking agents after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; M | 1985 |
The Beta-blocker Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary D | 1985 |
Propranolol in acute myocardial infarction: the MILIS experience.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Creatine Kinase; Double-Blind Method; Electro | 1986 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rat | 1986 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rat | 1986 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rat | 1986 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rat | 1986 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rat | 1986 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rat | 1986 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rat | 1986 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rat | 1986 |
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
Topics: Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dogs; Double-Blind Method; Heart Rat | 1986 |
Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Coronary Disease; Heart Rate; Hemodyna | 1986 |
[Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aftercare; Aged; Clinical Trials as Topic; Follow-Up Studies; Hu | 1986 |
Intravenous beta-blockade during acute myocardial infarction.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Humans; Injec | 1986 |
Effects of propranolol, atenolol, and chlordesmethyldiazepam on response to mental stress in patients with recent myocardial infarction.
Topics: Adult; Aged; Anti-Anxiety Agents; Atenolol; Benzodiazepines; Diazepam; Electrocardiography; Hemodyna | 1987 |
Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Cineangiography; Clinical Trials as Topic; Double-Blind Method; Female; | 1987 |
The Beta Blocker Heart Attack Trial: recruitment experience.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Protocols; Clinical Trials as Topic; Female; Huma | 1987 |
Supraventricular tachyarrhythmias after coronary bypass surgery--a double blind randomized trial of prophylactic low dose propranolol.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Coronary Artery Bypass; Double-Blind Method; | 1988 |
Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course.
Topics: Aged; Ambulatory Care; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Creatine Kinase; D | 1986 |
[Effect of obsidan and labetalol on the course of myocardial infarction].
Topics: Adult; Aged; Clinical Trials as Topic; Humans; Labetalol; Male; Middle Aged; Myocardial Infarction; | 1988 |
Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS).
Topics: Clinical Trials as Topic; Coronary Disease; Creatine Kinase; Double-Blind Method; Humans; Hyaluronog | 1988 |
Early intervention with propranolol after acute myocardial infarction: serial left ventricular function determined by M-mode and cross-sectional echocardiography.
Topics: Acute Disease; Adult; Aged; Echocardiography; Electrocardiography; Female; Heart; Humans; Male; Midd | 1988 |
Are 24 hours of ambulatory ECG monitoring necessary for a patient after infarction?
Topics: Adult; Aged; Ambulatory Care; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; E | 1988 |
Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction who receive propranolol.
Topics: Analysis of Variance; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Drug Administra | 1988 |
An update on the Medical Research Council Hypertension Trial.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Cerebrovascular Disorders; Clinical Trials as Topic; Fem | 1987 |
Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia.
Topics: Adult; Aged; Ambulatory Care; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; E | 1986 |
Comparative efficacy of behavioral stress management versus propranolol in reducing psychophysiological reactivity in post-myocardial infarction patients.
Topics: Adult; Aged; Behavior Therapy; Biofeedback, Psychology; Blood Pressure; Galvanic Skin Response; Hear | 1986 |
Beta-blockers and mortality after myocardial infarction.
Topics: Clinical Trials as Topic; Humans; Myocardial Infarction; Propranolol | 1987 |
Mortality in the beta blocker heart attack trial: circumstances surrounding death.
Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Female; | 1987 |
Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial.
Topics: Adult; Aged; Bronchial Spasm; Clinical Trials as Topic; Cross-Sectional Studies; Depression; Double- | 1987 |
Efficacy of propranolol therapy after acute myocardial infarction related to coronary arterial anatomy and left ventricular function.
Topics: Coronary Vessels; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Risk Factor | 1987 |
Enhancement of visit adherence in the national beta-blocker heart attack trial.
Topics: Adult; Aged; Appointments and Schedules; Clinical Trials as Topic; Double-Blind Method; Humans; Midd | 1985 |
Assessment of angina pectoris after myocardial infarction: comparison of "Rose Questionnaire" with physician judgment in the Beta-Blocker Heart Attack Trial.
Topics: Angina Pectoris; Clinical Trials as Topic; Diagnostic Errors; Electrocardiography; Female; Humans; M | 1985 |
Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Ele | 1985 |
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
Topics: Heart Failure; Humans; Myocardial Infarction; Propranolol; Retrospective Studies; Time Factors | 1986 |
Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience.
Topics: Adult; Aged; Clinical Trials as Topic; Data Collection; Double-Blind Method; Follow-Up Studies; Huma | 1985 |
Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience.
Topics: Adult; Aged; Clinical Trials as Topic; Data Collection; Double-Blind Method; Follow-Up Studies; Huma | 1985 |
Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience.
Topics: Adult; Aged; Clinical Trials as Topic; Data Collection; Double-Blind Method; Follow-Up Studies; Huma | 1985 |
Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience.
Topics: Adult; Aged; Clinical Trials as Topic; Data Collection; Double-Blind Method; Follow-Up Studies; Huma | 1985 |
Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction.
Topics: Adult; Blood Pressure; Cineangiography; Electrocardiography; Exercise Test; Heart Rate; Heart Ventri | 1985 |
[Use of beta-blockaders in the treatment of arrhythmias associated with acute myocardial infarct].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Fe | 1973 |
Effect of propranolol in myocardial infarction.
Topics: Adult; Aged; Humans; Middle Aged; Mortality; Myocardial Infarction; Parasympatholytics; Prognosis; P | 1965 |
A controlled trial of propranolol in acute myocardial infarction.
Topics: Adult; Aged; Aspartate Aminotransferases; Electrocardiography; Female; Humans; L-Lactate Dehydrogena | 1966 |
Absence of prophylactic effect of propranolol in myocardial infarction.
Topics: Arrhythmias, Cardiac; Aspartate Aminotransferases; Coronary Disease; Electrocardiography; Female; He | 1966 |
Propranolol in acute myocardial infarction. A multicentre trial.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Heart Arrest; Heart Failure; Humans; Hypotension; Mal | 1966 |
A trial of propranolol in myocardial infarction.
Topics: Adult; Aged; Aspartate Aminotransferases; Atrial Fibrillation; Blood Pressure; Cardiac Complexes, Pr | 1968 |
[Ventricular fibrillation at the acute phase of myocardial infarction: prognosis after resuscitation].
Topics: Adult; Ajmaline; Angina Pectoris; Clinical Trials as Topic; Diagnosis, Differential; Electric Counte | 1973 |
The influence of sympathicolytics of the electrocardiogram.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cardiovascular Diseases; Clinical Trials as Topic; Dia | 1970 |
The organization of a multi-centre randomized control therapeutic trial for mild to moderate hypertension.
Topics: Adult; Blood Pressure Determination; Clinical Trials as Topic; Female; Guanethidine; Humans; Hyperte | 1973 |
Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Clinical Trials | 1974 |
A controlled trial of propranolol in acute myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Hypotension; Male; Middle Aged; Myocardial In | 1967 |
[Double-blind studies with Inderal in angina pectoris].
Topics: Angina Pectoris; Blood Pressure; Catecholamines; Clinical Trials as Topic; Humans; Myocardial Infarc | 1967 |
Trial of propranolol in acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Myocardial Infarction; Placebos; Propranolol | 1968 |
[Propranolol (Inderal) in acute myocardial infarct].
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Humans; Male; Middle Ag | 1967 |
[Prophylactic use of propranolol in acute coronary occlusion. A double-blind study].
Topics: Aged; Clinical Trials as Topic; Electrocardiography; Female; Humans; Male; Methods; Middle Aged; Myo | 1968 |
Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris.
Topics: Adrenal Glands; Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Synergi | 1969 |
New dimension in angina pectoris therapy.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Drug Synergism; Electrocar | 1969 |
The use of propranolol (inderal) in acute myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography; Female; Heart Bloc | 1968 |
Propranolol in angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Drug Synergism; Hemorrhage; Humans; Myocardial Infarction | 1969 |
Propranolol in the therapy of ischaemic heart disease with angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Heart Rate; Humans; | 1969 |
The difficulty of appraisal of streptokinase treatment of myocardial infarction.
Topics: Anti-Arrhythmia Agents; Clinical Trials as Topic; Coronary Care Units; Glucocorticoids; Glucose; Hep | 1971 |
[Experience in the treatment of acute myocardial infarct with beta-receptor-blocking agents].
Topics: Electrocardiography; Glucose; Heart Rate; Humans; Insulin; Male; Middle Aged; Myocardial Infarction; | 1968 |
602 other studies available for propranolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cattle; Chemical Phenomena; Chemistry; | 1987 |
Propranolol inhibits myocardial infarction-induced brown adipose tissue D2 activation and maintains a low thyroid hormone state in rats.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Iodide Peroxida | 2019 |
Intermittent β-adrenergic blockade downregulates the gene expression of β-myosin heavy chain in the mouse heart.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Down-Regulation; Female; Isoproteren | 2020 |
Ghrelin Preserves Ischemia-Induced Vasodilation of Male Rat Coronary Vessels Following β-Adrenergic Receptor Blockade.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Ghrelin; Heart Rate; Male; Myocardial Infarc | 2018 |
Therapy for triggered acute risk prevention in subjects at increased cardiovascular risk.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aspirin; Death, Sudden, Cardiac; Drug Therapy, | 2013 |
Cholinergic stimulation with pyridostigmine protects myocardial infarcted rats against ischemic-induced arrhythmias and preserves connexin43 protein.
Topics: Animals; Arrhythmias, Cardiac; Atropine Derivatives; Blood Pressure; Cholinesterase Inhibitors; Conn | 2015 |
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3.
Topics: Adult; Aged; Antihypertensive Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Hyperten | 2015 |
Nonlinear coupling is absent in acute myocardial patients but not healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Algorithms; Atropine; Case-Control Studies; E | 2008 |
Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions.
Topics: Adrenergic Antagonists; Animals; Colforsin; Cyclic AMP; Guanylate Cyclase; Heart; Indoles; Isoproter | 2008 |
Role of Sida cordifolia L. leaves on biochemical and antioxidant profile during myocardial injury.
Topics: Animals; Antioxidants; Catalase; Creatine Kinase, MB Form; Heart; Isoproterenol; L-Lactate Dehydroge | 2009 |
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cyclic AMP-Dep | 2009 |
β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blotting, Northern; Ca(2+) Mg(2+)-ATPase; Dose-Respo | 2011 |
Propranolol regulates cardiac transient outward potassium channel in rat myocardium via cAMP/PKA after short-term but not after long-term ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Cyclic AMP; Cyclic AMP-Dependent Protein Ki | 2010 |
MicroRNA expression analysis: clinical advantage of propranolol reveals key microRNAs in myocardial infarction.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expressi | 2011 |
Bidirectional ventricular tachycardia in a patient with acute myocardial infarction and aortic stenosis.
Topics: Aged; Aortic Valve Stenosis; Echocardiography; Electrocardiography; Follow-Up Studies; Humans; Hyper | 2013 |
Epinephrine-induced myocardial infarction in severe anaphylaxis: is nonselective β-blockade a contributory factor?
Topics: Adrenergic beta-Antagonists; Adult; Anaphylaxis; Anti-Allergic Agents; Anti-Bacterial Agents; Corona | 2013 |
Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Baroreflex; Blood Pressure; Body Weight; Bradycardia; Catechol | 2002 |
Combined sodium and calcium channel blockade in prevention of lethal arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Death, Sudde | 2003 |
[Efficacy of combined use of fosinopril and propranolol in acute myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2003 |
DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA OF EFFORT.
Topics: Angina Pectoris; Biomedical Research; Double-Blind Method; Electrocardiography; Humans; Myocardial I | 1964 |
PROPRANOLOL (INDERAL) IN PERSISTENT VENTRICULAR FIBRILLATION.
Topics: Digitalis Glycosides; Drug Therapy; Electric Countershock; Heart Arrest; Heart Failure; Heart Massag | 1965 |
Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Collagen; Cytokines; Female; Gene Expression; | 2003 |
Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiograp | 2004 |
Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Topics: Adenoviridae; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atri | 2004 |
Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Topics: 5'-Nucleotidase; Adenosine; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Cells, Cul | 2004 |
Dispersion of ventricular mRNA of RyR2 and SERCA2 associated with arrhythmogenesis in rats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Berberine; Calcium Channels, L-Type; Calcium- | 2004 |
The power of power.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Humans; Myocardial Infarction; Probability; Propr | 2004 |
Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure.
Topics: Adrenergic beta-Antagonists; Animals; Electrocardiography; Isoproterenol; Labetalol; Lipid Peroxides | 2004 |
Exercise unmasks autonomic dysfunction in swine with a recent myocardial infarction.
Topics: Animals; Atropine; Autonomic Nervous System; Coronary Circulation; Disease Models, Animal; Exercise | 2005 |
[Functional features of acute non-Q-wave myocardial infarction and the influence of pre-hospital treatment with propranalol, heparin and aspirin on the prognosis of the disease].
Topics: Adrenergic beta-Antagonists; Adult; Anticoagulants; Aspirin; Data Interpretation, Statistical; Elect | 2005 |
Chronic myocardial infarction due to arteriosclerosis of coronary arteries followed by acute thromboembolism of caudal abdominal aorta in a cat.
Topics: Animals; Aorta, Abdominal; Benzazepines; Cat Diseases; Cats; Coronary Artery Disease; Diltiazem; Dip | 2005 |
Effect of antiarrhythmic agents on heart rate variability indices after myocardial infarction: comparative experimental study of aprindine and procainamide.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Atrop | 2005 |
Beta blockers for the treatment of primary hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Humans; Hypertension; Middle Aged; Myocardial Infar | 2006 |
Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Apoptosis; Calcium; Cyclic AMP; Female; Gen | 2006 |
A preliminary study on the cardioprotection of acupuncture pretreatment in rats with ischemia and reperfusion: involvement of cardiac beta-adrenoceptors.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Disease Models, Animal; Electroac | 2006 |
Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics, Inhalation; Animals; Brain; Carbazoles; Carved | 2006 |
Remodelling of action potential and intracellular calcium cycling dynamics during subacute myocardial infarction promotes ventricular arrhythmias in Langendorff-perfused rabbit hearts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cardiac Complexes | 2007 |
Beta-adrenergic blockade in experimental myocardial infarction.
Topics: Animals; Coronary Vessels; Dogs; Endotoxins; Myocardial Infarction; Propranolol; Ventricular Fibrill | 1966 |
Haemodynamic effects of propranolol (Inderal) in acute myocardial infarction.
Topics: Aged; Blood Circulation Time; Blood Pressure; Cardiac Output; Female; Heart Rate; Humans; Male; Midd | 1967 |
Adrenergic beta-blockade and electrocardiographical ST-T changes.
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Electrocardiography; Exercise Test; Humans; Middl | 1967 |
"Man errs so long as he strives".
Topics: Digitalis Glycosides; Humans; Myocardial Infarction; Propranolol | 1967 |
Haemodynamic effects of propranolol.
Topics: Adult; Aged; Atropine; Heart Rate; Humans; Hypertension; Isoproterenol; Middle Aged; Myocardial Infa | 1967 |
Standby pacing for multiple cardiac arrhythmias.
Topics: Adams-Stokes Syndrome; Bradycardia; Digitalis; Digoxin; Electrocardiography; Heart Arrest; Heart Rat | 1967 |
Application of multipoint electrodes to telemetry in patient-monitoring and during physical exercise.
Topics: Adult; Atrial Fibrillation; Digoxin; Electrocardiography; Humans; Male; Middle Aged; Monitoring, Phy | 1967 |
Resuscitation in cardiac arrest. An analysis of 100 successive medical cases.
Topics: Adult; Age Factors; Aged; Electric Countershock; Female; Follow-Up Studies; Heart Arrest; Heart Mass | 1967 |
The adrenergic nervous system in the normal and diseased heart.
Topics: Angina Pectoris; Animals; Heart Conduction System; Humans; Myocardial Infarction; Propranolol; Sympa | 1967 |
Beta-adrenergic blockade and cardiac arrhythmias.
Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Electrocardiography; | 1967 |
Protection of ischemic myocardium: comparison of effects of propranolol, bevantolol and N-dimethyl propranolol on infarct size following coronary artery occlusion in anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Dogs; Female; Hemodynamics; Ligation; Male; | 1980 |
[Effect of obsidan on the dynamics of the myocardial infarct zone in the 1st days of the disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Evaluation; Electrocardiography; Humans; Male; Middle | 1980 |
Beta-blockade: metabolic effects in experimental myocardial infarction.
Topics: Adrenergic beta-Antagonists; Catecholamines; Humans; Myocardial Infarction; Propranolol | 1980 |
Clinical aspects of beta-blockade in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Humans; Myocardial Infarction; Oxygen Consumption; Propr | 1980 |
[Hemodynamic reactions to the use of beta-adrenoblockaders in acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; | 1980 |
[Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Coronary Circulation; Creatine Kinase; Electroc | 1981 |
Demonstration of training effect during chronic beta-adrenergic blockade in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Coronary Disease; Heart Rate; Humans; | 1981 |
Anterior S-T segment depression in acute inferior myocardial infarction: indicator of posterolateral infarction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Coronary Artery Bypass; Creatine Kinase; Electrocardiograp | 1981 |
The role of beta adrenergic blocking agents in the management of the patient with acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Drug Administration Schedule; Heart Rate; Humans; Hyp | 1981 |
Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Dogs; Female; Heart; Heart Rate; Mal | 1981 |
[Use of beta-adrenoblockaders in the therapy of the syndromes accompanying acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiac Output; Hemodynamics; Humans | 1981 |
[Beta blockage after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Humans; Myocardial Infarction; Practolol; Propranolol; Time | 1982 |
Recent concepts in the management of ischaemic cardiac syndromes.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Co | 1982 |
beta-Adrenoceptor blockade and the incidence of myocardial infarction during treatment of severe hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Diastole; Humans; Hypertension | 1982 |
Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers | 1982 |
Beta-blockers after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Humans; Metoprolol; Myocardial Infarction; Propranolol; Timolol | 1982 |
Publicity on the beta-blocker heart attack trial (continued)
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Myocardial Infarction; National Insti | 1982 |
[Therapeutic potential of beta-receptor blockers in acute anterior wall infarct].
Topics: Adrenergic beta-Antagonists; Aged; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Propan | 1982 |
Intravenous beta-blockers during unstable angina and threatened infarction.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Disease; Electrocardiography; Humans; Injecti | 1982 |
The beta-blocker heart attack trial.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Myocardial Infarction; Propranolol; R | 1982 |
[DNA changes in a nonischemic area of the rat myocardium in experimental myocardial infarct and its prevention].
Topics: Adrenergic beta-Antagonists; Animals; Butylated Hydroxytoluene; Coronary Disease; DNA; DNA Repair; M | 1982 |
Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Anesthesia; Cardiac Catheterizat | 1982 |
Secondary prevention after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Humans; Metoprolol; Myocardial Infarction; Prognosis; | 1982 |
Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Bronchial Spasm; Fatigue; Heart Failure; Humans | 1983 |
[Comparison of the action of beta-blockers and calcium inhibitors in the treatment of primary angina pectoris].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Angina Pectoris; Calcium Channel Blockers; Coronary | 1983 |
The effect of modification of sympathetic activity on responses to ligation of a coronary artery in the conscious rat.
Topics: Adrenalectomy; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary | 1983 |
[Secondary prevention of myocardial infarct with beta blockers].
Topics: Adrenergic beta-Antagonists; Coronary Circulation; Coronary Disease; Humans; Metoprolol; Myocardial | 1983 |
[Beta blockade after myocardial infarction?].
Topics: Adrenergic beta-Antagonists; Humans; Myocardial Infarction; Propranolol; Timolol | 1983 |
Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Heart Failure; Heart Rate; Male; Myocardial In | 1984 |
Intravenous propranolol in acute myocardial infarction.
Topics: Humans; Injections, Intravenous; Myocardial Infarction; Propranolol | 1984 |
Beta-blockers after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Humans; Myocardial Infarction; Oxprenolol; Propranolol; Timolol | 1984 |
[Two cases of subendocardial infarction associated with subacute thyroiditis].
Topics: Acute Disease; Adrenergic beta-Antagonists; Endocardium; Female; Humans; Male; Middle Aged; Myocardi | 1984 |
Effect of alpha-adrenergic blockade on arrhythmias induced by acute myocardial ischemia and reperfusion in the dog.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Carbon Dioxide; Coronar | 1984 |
[Standard therapy of acute myocardial infarction.--II: Management of arrhythmias].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac Complexes, Premature; D | 1981 |
[Increase in the osmotic resistance of erythrocytes due to propranolol].
Topics: Adult; Erythrocytes; Female; Humans; Male; Middle Aged; Myocardial Infarction; Osmotic Fragility; Pr | 1981 |
Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Diazepam; Drug Interactions; He | 1981 |
[Long-term obsidan therapy of ischemic heart disease patients at high risk for sudden death].
Topics: Adult; Angina Pectoris; Cardiac Complexes, Premature; Coronary Disease; Death, Sudden; Humans; Male; | 1982 |
The alteration of rabbit skeletal sarcoplasmic reticulum function by N-acylethanolamine, a lipid associated with myocardial infarction.
Topics: Animals; Biological Transport; Calcium; Calcium-Transporting ATPases; Dibucaine; Ethanolamines; Myoc | 1982 |
[Effect of a combined use of propranolol and nifedipine on experimental myocardial infarct size].
Topics: Animals; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Hemodynamics; Male; | 1984 |
[Cyclic AMP and cyclic GMP in ischemic myocardium and effect of propranolol on those nucleotides (author's transl)].
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Coronary Disease; Cyclic AMP; Cyclic GMP; Dogs; Myocar | 1980 |
Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis.
Topics: Animals; Aspirin; Body Weight; Creatine Kinase; Cyclic AMP; Heart; Isoproterenol; Male; Myocardial I | 1981 |
[Role of catecholamine in activating glycogenolysis in experimental myocardial infarct complicated by ventricular fibrillation].
Topics: Animals; Arrhythmias, Cardiac; Dogs; Epinephrine; Glycogen; Male; Myocardial Infarction; Myocardium; | 1982 |
Myocardial norepinephrine and cyclic amp concentration following myocardial ischemia--relation to ventricular fibrillation and sudden death.
Topics: Animals; Bucladesine; Coronary Disease; Cyclic AMP; Death, Sudden; Dogs; Female; Male; Myocardial In | 1983 |
[Determination of the sensitivity of beta adrenergic receptors in patients with myocardial infarction].
Topics: Adult; Erythrocytes; Female; Hemolysis; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial I | 1983 |
[Effect of preliminary blocking of alpha- and beta-adrenergic receptors on impairment of relaxation and contraction of nonischemic heart regions during experimental myocardial infarct].
Topics: Animals; Male; Myocardial Contraction; Myocardial Infarction; Phentolamine; Propranolol; Rats; Rats, | 1983 |
[A myocardial bridge: prognosis and treatment. Apropos of 13 cases].
Topics: Adult; Aged; Angina Pectoris; Cardiomyopathy, Hypertrophic; Coronary Angiography; Coronary Disease; | 1983 |
[Effect of the combined use of nitrates and beta-adrenergic blockaders on hemodynamics in patients with acute myocardial infarction].
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Hemodynamics; Humans; Infusions, Paren | 1983 |
Ribose prevents the propranolol-induced reduction of myocardial adenine nucleotide biosynthesis.
Topics: Adenine Nucleotides; Animals; Female; Heart; Isoproterenol; Myocardial Infarction; Myocardium; Propr | 1984 |
[Effects of sodium tanshinone II-A sulfonate and propranolol on coronary collaterals in acutely infarcted dogs (author's transl)].
Topics: Animals; Cardiovascular Agents; Collateral Circulation; Coronary Circulation; Dogs; Furans; Hemodyna | 1981 |
Usefulness of intravenous propranolol in predicting left anterior descending blood flow during anterior myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Coronary Circulation; Electrocardiography; Heart Rate; Humans; Infus | 1984 |
[Evaluation of the effectiveness of the long-term use of obzidan in experimental myocardial infarct].
Topics: Animals; Methionine; Myocardial Infarction; Myocardium; Oxidative Phosphorylation; Propranolol; Rats | 1984 |
Propranolol disposition after acute myocardial infarction.
Topics: Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Hemodynamics; Humans; Injec | 1984 |
Comparative effects of propranolol, timolol and metoprolol on myocardial infarct size after experimental coronary artery occlusion.
Topics: Animals; Blood Pressure; Coronary Circulation; Dogs; Fatty Acids, Nonesterified; Female; Heart Rate; | 1984 |
Propranolol and infarct size.
Topics: Humans; Myocardial Infarction; Propranolol | 1984 |
Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Electrocardiography; Exercise Test; Female; Hum | 1984 |
Rabbit hearts for the critical evaluation of drugs to reduce the size of experimentally produced acute myocardial infarction.
Topics: Animals; Calcium Channel Blockers; Dilazep; Male; Myocardial Infarction; Myocardium; Propranolol; Ra | 1984 |
Serum magnesium in propranolol-treated patients with acute myocardial infarction.
Topics: Analysis of Variance; Fatty Acids, Nonesterified; Humans; Magnesium; Myocardial Infarction; Proprano | 1984 |
[Morphological criteria of the effectiveness of using kordaron and obzidan in experimental myocardial ischemia].
Topics: Amiodarone; Animals; Benzofurans; Coronary Disease; Dogs; Drug Evaluation, Preclinical; Histocytoche | 1984 |
[Comparative effects of obsidan and isoptin on the size of myocardial infarction].
Topics: Adult; Aged; Female; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Propranolo | 1984 |
Flurbiprofen interaction with single doses of atenolol and propranolol.
Topics: Adult; Aldosterone; Atenolol; Blood Pressure; Body Weight; Female; Flurbiprofen; Heart Rate; Humans; | 1984 |
[Use of beta-blockers and a calcium antagonist in angina pectoris during the period of postinfarct rehabilitation].
Topics: Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Myocardial Infarction; | 1984 |
[Simulation of intramural heart infarct in ECG by beta-receptor blockader].
Topics: Adult; Arrhythmias, Cardiac; Diagnosis, Differential; Electrocardiography; Female; Humans; Male; Myo | 1984 |
Failure of pretreatment with propranolol to reduce the zone of myocardial infarction after 2 hours of coronary occlusion in the primate heart.
Topics: Animals; Blood Pressure; Collateral Circulation; Constriction; Coronary Vessels; Heart Rate; Myocard | 1983 |
Therapeutic rounds at the Milton S. Hershey Medical Center: central nervous system toxicity caused by lidocaine.
Topics: Cognition Disorders; Confusion; Drug Interactions; Heart Failure; Humans; Lidocaine; Male; Middle Ag | 1983 |
[Prognostic value of the exercise test in the 3d week after myocardial infarct, and its role during treatment with small doses of beta-blockaders as part of the rehabilitation program].
Topics: Exercise Test; Humans; Male; Myocardial Infarction; Prognosis; Propranolol; Time Factors | 1983 |
[Comparative characteristics of the effect of long-term beta-adrenostimulation and beta-adrenoblockade on myocardial metabolism in experimental myocardial infarction].
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Dogs; Female; Male; Myocardial Infarction; M | 1983 |
[Treatment of patients with myocardial infarct and hyperdynamic syndrome with propranolol].
Topics: Adult; Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Inf | 1983 |
[Use of peripheral vasodilators and beta-adrenergic blockaders in the acute period of myocardial infarction (hemodynamic and metabolic aspects)].
Topics: Adult; Aged; Drug Therapy, Combination; Ferricyanides; Hemodynamics; Humans; Male; Middle Aged; Myoc | 1983 |
Thallium-201 myocardial imaging during maximal and submaximal exercise: comparison of submaximal exercise with propranolol.
Topics: Angina Pectoris; Coronary Circulation; Coronary Disease; Heart; Heart Rate; Humans; Male; Myocardial | 1983 |
Stress damage to nonischemic divisions of the heart in experimental infarction and its prevention.
Topics: Animals; Atrial Function; Coronary Vessels; Humans; Ligation; Male; Myocardial Contraction; Myocardi | 1983 |
Effects of timolol and propranolol on inducible sustained ventricular tachyarrhythmias in dogs with subacute myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Dogs; Electrocardiography; Heart Ventricles; Myocardi | 1984 |
[1st attempt at using the antioxidant dibunol in the acute stage of a myocardial infarct].
Topics: Acute Disease; Adult; Aged; Antioxidants; Butylated Hydroxytoluene; Drug Therapy, Combination; Femal | 1984 |
[Use of propranolol (inderal) in the acute stage of myocardial infarction].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Fatty Acids, Nonesterified; Heart; Humans; Middle Aged; | 1984 |
Nifedipine in hypertension and heart failure.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heart F | 1984 |
Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction.
Topics: Aged; Cardiac Output; Dose-Response Relationship, Drug; Ethanolamines; Heart Rate; Hemodynamics; Hum | 1984 |
[Experience with using obzidan in myocardial infarct].
Topics: Adult; Aged; Drug Evaluation; Electrocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; | 1984 |
Enhanced haemodynamic effects of propranolol in acute myocardial infarction.
Topics: Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Hemodynamic | 1984 |
[Effect of amiodarone treatment on the myocardial infart size in experimental dogs].
Topics: Amiodarone; Animals; Benzofurans; Dogs; Electrocardiography; Female; Male; Myocardial Infarction; Pr | 1984 |
[Quantitative evaluation of electrocardiographic changes in acute myocardial infarction].
Topics: Cardiotonic Agents; Drug Therapy, Combination; Electrocardiography; Humans; Monitoring, Physiologic; | 1984 |
Adverse interaction between nifedipine and beta-blockade.
Topics: Drug Interactions; Humans; Hypotension; Male; Middle Aged; Myocardial Infarction; Nifedipine; Propra | 1981 |
Determination of the area of the periinfarction zone using the data of 35 ECG precordial leads.
Topics: Acute Disease; Electrocardiography; Humans; Mannitol; Myocardial Infarction; Nitroglycerin; Nitropru | 1981 |
Combined administration of nitroglycerin and propranolol to patients with acute myocardial infarction.
Topics: Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Heart Ventricles; Humans; Male; Middl | 1981 |
Intracoronary streptokinase in evolving infarction.
Topics: Animals; Coronary Angiography; Dogs; Humans; Infusions, Intra-Arterial; Myocardial Infarction; Nitro | 1981 |
[The treatment of acute myocardial infarctions with beta-receptor-blockers. II. Hemodynamic effects of propranolol with and without combination therapy with nitroglycerin (author's transl)].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; | 1981 |
[Limitation of the size of a myocardial infarct by using nitroprusside, nitroglycerin, propranolol and mannitol].
Topics: Electrocardiography; Ferricyanides; Humans; Infusions, Parenteral; Mannitol; Myocardial Infarction; | 1982 |
Monotherapy in the treatment of hypertension.
Topics: Benzothiadiazines; Blood Pressure; Diet, Sodium-Restricted; Diuretics; Humans; Hypertension; Myocard | 1983 |
Can noninvasive exercise test criteria identify patients with left main or 3-vessel coronary disease after a first myocardial infarction?
Topics: Adult; Cardiac Catheterization; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart | 1983 |
Spectrum of global left ventricular responses to supine exercise. Limitation in the use of ejection fraction in identifying patients with coronary artery disease.
Topics: Adult; Blood Pressure; Cardiac Output; Coronary Disease; Electrocardiography; Exercise Test; Female; | 1983 |
Severity of canine myocardial infarcts in relation to indices of oxygen demand: preservation of myocardial creatine kinase activity by vagal stimulation and propranolol.
Topics: Animals; Coronary Circulation; Creatine Kinase; Dogs; Electric Stimulation; Hemodynamics; Myocardial | 1983 |
Ventricular fibrillation in a conscious canine model--its prevention by UM-272.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Electrocardiography; Male; Myocardial | 1983 |
Effects of morphine and pethidine on coronary vascular resistance, blood pressure, and myocardial infarction-induced cardiac arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Atropine; Blood Pressure; Coronary Vessels; Dogs; Female; Male; Meper | 1983 |
MB creatine kinase and the evaluation of myocardial injury following aortocoronary bypass operation.
Topics: Angina Pectoris; Coronary Artery Bypass; Coronary Vessels; Creatine Kinase; Extracorporeal Circulati | 1980 |
Unstable angina pectoris: therapeutic choices.
Topics: Angina Pectoris; Coronary Artery Bypass; Coronary Vessels; Electrocardiography; Humans; Intra-Aortic | 1980 |
Effect of cardioplegic solution and of propranolol on perioperative infarction after cardiac surgery for unstable angina.
Topics: Adult; Aged; Angina Pectoris; Coronary Artery Bypass; Heart Arrest, Induced; Humans; Intraoperative | 1980 |
Management of unstable angina pectoris.
Topics: Angina Pectoris; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Coronary Artery Bypass; C | 1981 |
Captopril in severe treatment-resistant hypertension.
Topics: Adolescent; Adult; Aged; Blood Pressure; Captopril; Female; Furosemide; Heart Rate; Humans; Hydralaz | 1980 |
Plasma lysosomal enzyme activity in acute myocardial infarction and the effects of drugs.
Topics: Acetylglucosaminidase; Adult; Creatine Kinase; Female; Hexosaminidases; Humans; Isoenzymes; Lysosome | 1980 |
Controlled trials and escape clauses.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Myocardial Infarction; Propranolol; Random Al | 1982 |
[Effect of propranolol on the free fatty acid content in the acute period of myocardial infarct].
Topics: Adult; Aged; Depression, Chemical; Fatty Acids, Nonesterified; Female; Humans; Male; Middle Aged; My | 1982 |
[The effect of beta-receptor blockers and cardiac glycosides on the heart rate, systolic blood pressure and ST interval in submaximal ergometer exertion].
Topics: Adult; Blood Pressure; Cardiac Glycosides; Electrocardiography; Exercise Test; Heart Rate; Humans; M | 1982 |
Effect of propranolol on mortality and morbidity after acute myocardial infarction.
Topics: Adult; Aged; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol | 1982 |
Myocardial infarction during asthmatic attack induced by ingestion of propranolol.
Topics: Asthma; Female; Humans; Middle Aged; Myocardial Infarction; Propranolol | 1982 |
Effects of epinephrine on the electrophysiologic properties of Purkinje fibers surviving myocardial infarction.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Epinephrin | 1982 |
Substitution of atenolol for propranolol in a case of propranolol-related depression.
Topics: Angina Pectoris; Atenolol; Depressive Disorder; Female; Humans; Hypertension; Imipramine; Middle Age | 1982 |
[Experimental intramural myocardial infarction in the rat. A morphometrical method for a quantitative evaluation of the drug's influence].
Topics: Animals; Coronary Vessels; Dipyridamole; Female; Ligation; Myocardial Infarction; Propranolol; Rats; | 1982 |
[Possibilities of increasing the effectiveness of intra-aortic balloon counterpulsation with the administration of adrenergic blockers].
Topics: Animals; Assisted Circulation; Dogs; Hemodynamics; Intra-Aortic Balloon Pumping; Myocardial Infarcti | 1982 |
Drug carriers in cardiovascular pharmacology.
Topics: Animals; Cardiovascular Diseases; Carrier Proteins; Dogs; Gangliosides; Humans; Lidocaine; Liposomes | 1980 |
[Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
Topics: Analgesics; Atropine; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart | 1981 |
Precardiac mapping of R waves and ST intervals. Results in patients in acute period of extensive anterior myocardial infarction and effect of some drugs on the periinfarction zone.
Topics: Acute Disease; Body Surface Area; Digoxin; Electrocardiography; Humans; Myocardial Infarction; Necro | 1981 |
[Treatment of acute myocardial infarction with betareceptor blocking agents. I. Hemodynamic effects of Propranolol in combination with digitalis (author's transl)].
Topics: Acute Disease; Adult; Aged; Digoxin; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; | 1981 |
Nifedipine--a new calcium antagonist in experimental myocardial necrosis.
Topics: Animals; Calcium; Male; Myocardial Infarction; Myocardium; Necrosis; Nifedipine; Propranolol; Pyridi | 1981 |
[Correction of hypersensitivity to strophanthin in experimental myocardial infarction by pharmacologic effects on extracardiac innervation].
Topics: Animals; Atropine; Bretylium Tosylate; Cats; Drug Therapy, Combination; Drug Tolerance; Ephedrine; F | 1981 |
[Risks of treatment with beta-blocking agents in acute myocardial infarction (author's transl)].
Topics: Adult; Aged; Blood Pressure; Capillaries; Cardiac Output; Female; Heart Rate; Humans; Lung; Male; Mi | 1981 |
[Chronic administration of beta blocking agents: left ventricular hemodynamics in myocardial infarctions during exercise (author's transl)].
Topics: Adult; Angina Pectoris; Cardiac Catheterization; Electrocardiography; Heart Ventricles; Hemodynamics | 1981 |
Effects of propranolol on myocardial infarct size with and without coronary artery reperfusion in the dog.
Topics: Animals; Blood Pressure; Coronary Circulation; Dogs; Female; Heart Rate; Heart Septum; Heart Ventric | 1981 |
[Effects of antiarrhythmic agents on ventricular arrhythmias following myocardial infarct induced with glass beads in dogs (author's transl)].
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Vessels; Disease Models, | 1981 |
Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.
Topics: Adult; Aged; Blood Proteins; Fatty Acids, Nonesterified; Female; Glycoproteins; Heparin; Humans; Lip | 1981 |
Myocardial infarction in the dog: effects of intravenous propranolol.
Topics: Animals; Blood Pressure; Creatine Kinase; Dogs; Electrocardiography; Heart Rate; Injections, Intrave | 1980 |
Psychosexual adjustment and counseling after myocardial infarction.
Topics: Adult; Anxiety; Counseling; Depression; Humans; Male; Myocardial Infarction; Propranolol; Sexual Beh | 1980 |
Submaximal exercise testing after unstable angina.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Exercise Test; Heart Rate; Humans; M | 1980 |
Increased plasma propranolol binding in myocardial infarction.
Topics: Blood Proteins; Glycoproteins; Humans; Myocardial Infarction; Propranolol; Protein Binding | 1980 |
Evolution of left ventricular dysfunction in coronary artery disease. Serial cineangiographic studies without surgery.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cineangiography; Collateral Circulation; Coronary Disea | 1980 |
Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarction.
Topics: Aged; Anti-Arrhythmia Agents; Bundle-Branch Block; Digoxin; Disopyramide; Heart Block; Heart Conduct | 1980 |
The effects of propranolol on myocardial perfusion and metabolism during acute regional ischaemia.
Topics: Animals; Coronary Disease; Creatine Kinase; Dogs; Heart; Krypton; Myocardial Infarction; Propranolol | 1980 |
Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Electrocardiograp | 1980 |
Propranolol therapy for ventricular arrhythmias 2 months after acute myocardial infarction.
Topics: Adult; Aged; Ambulatory Care; Arrhythmias, Cardiac; Blood Pressure; Dose-Response Relationship, Drug | 1980 |
[Myocardial lesions in acute surgical pathology of the abdominal organs].
Topics: Abdomen, Acute; Adult; Aged; Cardiomyopathies; Electrocardiography; Female; Humans; Male; Middle Age | 1980 |
Hemodynamic effects of a single oral dose of nifedipine following acute myocardial infarction.
Topics: Administration, Oral; Adult; Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contr | 1980 |
Variations in serum T3, rT3, 3,3'-diiodothyronine and 3',5'-diiodothyronine induced by acute myocardial infarction and propranolol.
Topics: Aged; Diiodothyronines; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Thyro | 1980 |
Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts.
Topics: Adult; Angiocardiography; Creatine Kinase; Female; Heart Ventricles; Humans; Male; Middle Aged; Myoc | 1980 |
[Use of obzidan in the acute period of myocardial infarct].
Topics: Adult; Aged; Creatine Kinase; Drug Evaluation; Electrocardiography; Hemodynamics; Humans; Male; Midd | 1980 |
[Antifibrillatory activity of propranolol in experimental myocardial infarct and its cardiodepressive and hypotensive action].
Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiac Glycosides; Depression, Chemical; | 1980 |
[Intravenous administration of propranolol in the acute period of myocardial infarct].
Topics: Acute Disease; Adult; Aged; Female; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; | 1980 |
Clinical observations on propranolol in acute myocardial infarction: hemodynamics and metabolism.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol | 1980 |
Noncardiac surgery in patients receiving propranolol. Case reports and recommended approach.
Topics: Anesthesia, General; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm; Cardiovascular Diseases; Hu | 1981 |
Experimental infarction studies.
Topics: Animals; Chlorpromazine; Dogs; Heart Rate; Ibuprofen; Morphine; Myocardial Infarction; Myocardium; P | 1980 |
Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and serial creatine kinase assessment.
Topics: Adult; Aged; Creatine Kinase; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Ag | 1981 |
[Beta-receptor blockers after revascularization in coronary sclerosis].
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Diseas | 1995 |
Changes in collagen content in the residual myocardium surviving after infarction in rats. Influence of propranolol or hydralazine therapy.
Topics: Animals; Collagen; Hydralazine; Male; Myocardial Infarction; Myocardium; Propranolol; Rats; Rats, Wi | 1995 |
Cardioprotective potential of carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Diltiazem; Dogs; Free Radical Scavenge | 1993 |
[Image analysis of effects of 4 drugs on coronary occlusion and myocardial reperfusion injury].
Topics: Animals; Female; Image Processing, Computer-Assisted; Male; Myocardial Infarction; Myocardial Reperf | 1993 |
Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias.
Topics: Animals; Captopril; Cardiac Pacing, Artificial; Hypertrophy, Left Ventricular; Male; Myocardial Infa | 1994 |
Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction.
Topics: Animals; Autonomic Nervous System; Coronary Circulation; Death, Sudden, Cardiac; Depression, Chemica | 1993 |
Electrophysiologic effects of cocaine on subendocardial Purkinje fibers surviving 1 day of myocardial infarction.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Caffeine; Calcium; Central Nervous System S | 1995 |
Which patients may be harmed by good treatments?
Topics: Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Humans; Myocardial Infarc | 1996 |
Comparative electrophysiological effects of the antidepressants fluvoxamine and amitriptyline in the canine heart after myocardial infarction.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; | 1996 |
Atrial fibrillation in acute myocardial infarction: a prospective study based on data from a consecutive series of patients admitted to the coronary unit.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Humans; Myocardial Infarction; Propranolol | 1996 |
Responses to acute myocardial stress and prior drug therapy on plasma levels of antioxidants and oxidants and the proposed role of interventions on molecular adaptations.
Topics: Anti-Arrhythmia Agents; Antioxidants; Captopril; Humans; Myocardial Infarction; Oxidants; Propranolo | 1996 |
[Abnormal vasomotor response of the forearm due to propranolol-induced loss of cardiopulmonary baroreflex sensitivity: experience with seven cases of recent myocardial infarct].
Topics: Adrenergic beta-Antagonists; Aged; Baroreflex; Blood Flow Velocity; Female; Forearm; Humans; Lower B | 1996 |
Depressed function in remote myocardium after myocardial infarction: influence of orotic acid.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Echocardiography; Heart; Myocardial Contraction; Myocard | 1996 |
[Repolarisation anomalies simulating anterior myocardial infarction during ischemic cerebrovascular accident].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Cerebral Cortex; Cerebrovascular Disorder | 1997 |
On reaching the tunnel at the end of the light.
Topics: Adrenergic beta-Antagonists; Data Interpretation, Statistical; Humans; Multicenter Studies as Topic; | 1997 |
On wisdom after the event.
Topics: Adrenergic beta-Antagonists; Chi-Square Distribution; Data Interpretation, Statistical; Humans; Meta | 1997 |
[Comparative evaluation of the effect of dimebon, obzidan, finoptin, and cordarone on the functional state of the ischemic focus and the size of necrosis zone during experimental myocardial infarction].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cats; Histamine H1 Antagonists; Indoles; Myocardial Inf | 1996 |
Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Captopril; Dilatation, Pathologic; Heart Ventricles; Hemodynam | 1997 |
Myocardial functional preservation during ischemia: influence of beta blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Heart; Heart Function Tests; Male; Myocardial Infarction; Myoc | 1997 |
Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
Topics: Adrenergic beta-Antagonists; Biometry; Clinical Trials as Topic; Diastole; Double-Blind Method; Huma | 1998 |
Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Blood Pressure; Ca | 1998 |
Current insights and new treatment options in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Coronary Disease; Heart Failure; Humans; | 1998 |
Construction of a continuous stopping boundary from an alpha spending function.
Topics: Adrenergic beta-Antagonists; AIDS-Related Opportunistic Infections; Biometry; Clinical Trials as Top | 1998 |
Effects of propranolol on beta-adrenergic receptor of experimental acute myocardial infarction in rats.
Topics: Adrenergic beta-Antagonists; Animals; Autoradiography; Female; Male; Myocardial Infarction; Proprano | 1997 |
[The objective assessment of treatment efficacy in microfocal myocardial infarct using paired stress tests].
Topics: Acebutolol; Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiac Pacing, Artificial; Dilti | 1998 |
Reduced periinfarction mortality as a result of long-term therapy with captopril but not hydralazine or propranolol in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Collagen; Electric Stimulation; Heart R | 1998 |
Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity.
Topics: Adrenergic beta-Antagonists; Animals; Arteries; Atropine; Constriction, Pathologic; Coronary Vessels | 1999 |
Age- and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Atenolol; Chlorthalidone; Confide | 1999 |
Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure.
Topics: Adrenergic beta-Antagonists; Aequorin; Animals; Calcium; Cardiotonic Agents; Coronary Circulation; E | 1999 |
Protective effect of FR168888, a new Na+/H+ exchange inhibitor, on ischemia and reperfusion-induced arrhythmia and myocardial infarction in rats: in comparison with other cardioprotective compounds.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Benzyl Alcohol; Benzyl Alcohols; Diltiazem; Dose-Response | 1999 |
Pulmonary morphofunctional effects of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Blood Gas Analysis; Disease Models, Animal; Elasticity; Lung; | 1999 |
Experimental studies of electroacupuncture on ventricular fibrillation threshold in rats with acute ischemic myocardium.
Topics: Adrenergic beta-Antagonists; Animals; Electroacupuncture; Female; Male; Myocardial Infarction; Propr | 1998 |
Effects of prolonged propranolol treatment on left ventricular remodeling and oxidative stress after myocardial infarction in rats.
Topics: Animals; Anti-Arrhythmia Agents; Heart Failure; Male; Muscle Contraction; Myocardial Infarction; Oxi | 2000 |
[When generic non-prescription drugs are administered and yet everything goes well.... The problem of medical studies on infants and children].
Topics: Adrenergic beta-Antagonists; Age Factors; Child; Child, Preschool; Germany; Humans; Infant; Infant, | 2000 |
Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Baltimore; Female; Humans; Male; Medical Records; Metop | 2001 |
Estimation of a secondary parameter in a group sequential clinical trial.
Topics: Adrenergic beta-Antagonists; Biometry; Clinical Trials as Topic; Female; Humans; Male; Myocardial In | 2001 |
Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Drug Costs; Evidence-Based Medicine; Female; Humans; Ma | 2001 |
Electroplegia: an alternative to blood cardioplegia for arresting the heart during conventional (on-pump) cardiac operation.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Blood; Blood Pressure; Body Water; Cardiac Surgical | 2001 |
Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Azocines; Coronary Disease; Electrocardiography; Iso | 2002 |
Effect of beta blockers on new congestive heart failure in older persons with healed myocardial infarcts.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Heart Failure; Humans; Myocardial Infarct | 2002 |
The effect of beta-blockade on ST segment elevation after acute myocardial infarction in man with some experimental observations.
Topics: Acute Disease; Adrenergic beta-Antagonists; Coronary Circulation; Heart Rate; Humans; Isoproterenol; | 1976 |
Effects of allopurinol, propranolol and methylprednisolone on infarct size in experimental myocardial infarction.
Topics: Allopurinol; Animals; Blood; Coronary Disease; Disease Models, Animal; Dogs; Heart; Hemodynamics; Hy | 1976 |
Editorial: Beta adrenergic blockade for prophylaxis against recurrent myocardial infarction and sudden death.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Death, Sudden; Humans; Myocardial Infarction; Practol | 1976 |
Interaction of anesthesia, beta-receptor blockade, and blood loss in dogs with induced myocardial infarction.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Anesthesia, General; Animals; Coronary Circulation; Dogs | 1976 |
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Animals; Coronary Disease; Dogs; Follow-Up | 1976 |
[Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Catecholamines; Diuretics; Humans; | 1976 |
Beta adrenergic blockade, regional left ventricular blood flow and ST-segment elevation in canine experimental myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Dogs; Electrocardiography; Female; Hemod | 1978 |
[An inverse reaction of the ST-T complex in the elctrocardiogram due to beta receptor inhibition].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Electrocardiography; Heart Valve | 1978 |
[Therapy using beta-receptor blockaders in coronary disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Glycosides; Coronary Disease; Humans; Myocardi | 1978 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
Haemodynamic setting of essential hypertension as a guide to management.
Topics: Antihypertensive Agents; Arteries; Blood Pressure; Cardiac Output; Clonidine; Diazoxide; Diuretics; | 1975 |
Letter: Role of catecholamines in arrhythmias after acute myocardial infarction.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; Heart; Humans; Myocardial Infarc | 1975 |
Arrhythmias in myocardial infarction.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac Complexes, Premature; D | 1976 |
Should premature ventricular beats be treated in the ambulatory patient? An antagonist's view.
Topics: Adult; Aged; Cardiac Complexes, Premature; Coronary Disease; Death, Sudden; Electrocardiography; Fol | 1977 |
Unstable angina: comparison of medical and surgical management.
Topics: Angina Pectoris; Clinical Enzyme Tests; Coronary Angiography; Coronary Artery Bypass; Electrocardiog | 1977 |
Serum enzymes and myocardial infarct size: the effect of drugs.
Topics: Animals; Creatine Kinase; Dogs; Humans; Myocardial Infarction; Propranolol | 1978 |
Propranolol in threatened myocardial infarction.
Topics: Administration, Oral; Humans; Injections, Intravenous; Myocardial Infarction; Propranolol; Time Fact | 1979 |
Surgical approach for patients with unstable angina pectoris: role of the response to initial medical therapy and intraaortic balloon pumping in perioperative complications after aortocoronary bypass grafting.
Topics: Administration, Oral; Angina Pectoris; Assisted Circulation; Cardiac Catheterization; Coronary Arter | 1978 |
Effect of propranolol and nitroglycerin plus methoxamine on transmural creatine kinase activity after acute coronary occlusion.
Topics: Acute Disease; Animals; Creatine Kinase; Dogs; Drug Evaluation, Preclinical; Female; Hemodynamics; I | 1978 |
[Protection of the ischemial myocardium during myocardial infarction (author's transl)].
Topics: Coronary Circulation; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Myocardial Infarction; Nit | 1978 |
Recurrent chest pain with transient ST-segment elevation and acute myocardial infarction in a patient with normal coronary arteries.
Topics: Adult; Aspartate Aminotransferases; Coronary Angiography; Creatine Kinase; Electrocardiography; Huma | 1979 |
Variant angina. Clinical spectrum and results of medical and surgical therapy.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Angiography; Coronary Artery Bypass; Electrocard | 1979 |
[Results of prospective studies of patients with unstable angina pectoris treated by conservative methods].
Topics: Adult; Aged; Angina Pectoris; Death, Sudden; Female; Follow-Up Studies; Humans; Male; Middle Aged; M | 1979 |
A guide to the use of propranolol in five cardiac conditions.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Biological Availability; Cardiomegaly; Dose-Response Relation | 1978 |
Myocardial and plasma levels of adenosine 3':5'-cyclic phosphate. Studies in experimental myocardial ischemia.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Coronary Disease; Coronary Vessels; Cyclic AMP; Depression | 1975 |
Alterations in myocardial and plasma cyclic adenosine monophosphate in experimental myocardial ischemia.
Topics: Animals; Coronary Disease; Coronary Vessels; Cyclic AMP; Dogs; Myocardial Infarction; Myocardium; Pr | 1975 |
Significance and treatment of nocturnal angina preceding myocardial infarction.
Topics: Acute Disease; Angina Pectoris; Cardiomegaly; Digitalis Glycosides; Electrocardiography; Female; Hea | 1977 |
Long-term beta blockade: possible protection from myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; Cor | 1975 |
Beta blocking drugs as anti-arrhythmic agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anura; Arrhythmias, Cardiac; Atrial Fibrill | 1975 |
Hemodynamic effects of procainamide and quinidine and the influence of beta-blockade before and after experimental myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Coronary Vessels; Dogs; Drug I | 1975 |
Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part B.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Arrhythmia, Sin | 1975 |
Helping the client with unstable angina.
Topics: Angina Pectoris; Electrocardiography; Humans; Life Style; Myocardial Infarction; Nitrates; Patient E | 1978 |
Treatment of impending myocardial infarction (medical viewpoint).
Topics: Angina Pectoris; Coronary Artery Bypass; Coronary Vessels; Humans; Myocardial Infarction; Nitrates; | 1977 |
Integrated medical-surgical treatment of pre-infarction syndrome.
Topics: Adult; Aged; Angina Pectoris; Angiocardiography; Aortic Valve Stenosis; Coronary Artery Bypass; Deci | 1977 |
Chronic stable inferior myocardial infarction: unsuspected harbinger of high-risk proximal left coronary arterial obstruction amenable to surgical revascularization.
Topics: Coronary Artery Bypass; Coronary Disease; Coronary Vessels; Female; Humans; Male; Middle Aged; Myoca | 1977 |
Incidence and mortality of perioperative myocardial infarction in patients undergoing coronary artery bypass grafting.
Topics: Adult; Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Myoc | 1977 |
Management of sudden coronary death.
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Female; | 1977 |
Changing indications for the surgical treatment of unstable angina.
Topics: Adult; Aged; Angina Pectoris; Boston; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Humans | 1978 |
Clinical predictors of angina following myocardial infarction.
Topics: Acute Disease; Aged; Angina Pectoris; Coronary Artery Bypass; Exercise Test; Female; Follow-Up Studi | 1979 |
Coronary bypass grafting in early stages of acute myocardial infarction.
Topics: Adult; Coronary Artery Bypass; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarctio | 1979 |
Observations on unstable angina pectoris with particular respect to management.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Bypass; Female; Follow-Up Studie | 1979 |
Beneficial effect of continuation of propranolol through coronary bypass surgery.
Topics: Adult; Coronary Artery Bypass; Depression, Chemical; Epinephrine; Heart Rate; Humans; Middle Aged; M | 1979 |
[Coronary disease. Introduction].
Topics: Angiography; Coronary Angiography; Coronary Disease; Creatine Kinase; Glucose; Humans; Insulin; Myoc | 1977 |
Perioperative infarction: pathogenesis and prevention.
Topics: Animals; Dogs; Electrocardiography; Myocardial Infarction; Myocardial Reperfusion Injury; Propranolo | 1978 |
Preservation of the ischemic myocardium: a review of new concepts in the treatment of acute myocardial infarction and unstable angina.
Topics: Acute Disease; Angina Pectoris; Coronary Disease; Humans; Myocardial Infarction; Nitroglycerin; Nitr | 1977 |
The elderly patient in the coronary care unit. II. Incidence and treatment of arrhythmias.
Topics: Aged; Arrhythmias, Cardiac; Atropine; Cardiac Pacing, Artificial; Coronary Care Units; Digoxin; Elec | 1979 |
The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs.
Topics: Animals; Arterial Occlusive Diseases; Cardiac Output; Coronary Vessels; Dogs; Electrocardiography; H | 1979 |
Exercise stress testing and systolic time intervals.
Topics: Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; Heart Rate; Humans; Infusions | 1979 |
Combined effects of paired ventricular pacing and propranolol on ischemic myocardial injury.
Topics: Acute Disease; Animals; Cardiac Pacing, Artificial; Coronary Vessels; Dogs; Female; Ligation; Male; | 1979 |
Propranolol in acute myocardial infarction.
Topics: Biological Availability; Coronary Circulation; Creatine Kinase; Humans; Myocardial Infarction; Oxyge | 1979 |
When cardiac patients become surgical patients.
Topics: Aged; Anesthesia; Anti-Bacterial Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Bundle-Branch Bl | 1979 |
Propranolol in acute myocardial infarction.
Topics: Humans; Myocardial Infarction; Propranolol | 1979 |
On significance of plasma fibrinogen level to assess severity of myocardial damage--an experimental study.
Topics: Animals; Cardiomyopathies; Female; Fibrinogen; Isoproterenol; Male; Myocardial Infarction; Myocardiu | 1979 |
[The comparative studies of hemodynamic effects of verapamil and propranolol in patients with acute myocardial infarction (author's transl)].
Topics: Adult; Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Ve | 1979 |
Propranolol during the evolution and subsequent ten days of myocardial infarction in man: hemodynamic, initial cardiac energetic, and neurohumoral responses.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Epinephrine; Female; Heart Rate; Hemody | 1979 |
Characteristics of ventricular tachycardia in ambulatory patients.
Topics: Ambulatory Care; Cardiomyopathy, Hypertrophic; Coronary Disease; Digitalis Glycosides; Electrocardio | 1977 |
The present status of propranolol.
Topics: Adrenal Gland Neoplasms; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 1979 |
Caution in propranolol withdrawal.
Topics: Acute Disease; Angina Pectoris; Humans; Myocardial Infarction; Propranolol; Substance Withdrawal Syn | 1977 |
Effects of dimethyl propranolol (UM-272; SC-27761) on myocardial ischemic injury in the canine heart after temporary coronary artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Creatine Kinase; Dogs; Electrocardiography; Heart Injuries; He | 1978 |
Propranolol in the treatment of cardiovascular disease.
Topics: Angina Pectoris; Aortic Aneurysm; Aortic Dissection; Arrhythmias, Cardiac; Cardiomyopathies; Cardiov | 1978 |
Propranolol rebound--a retrospective study.
Topics: Adult; Aged; Cardiac Catheterization; Coronary Disease; Female; Hospitalization; Humans; Male; Middl | 1978 |
Effect of propranolol on mitochondrial morphology during acute myocardial ischemia.
Topics: Animals; Cell Nucleus; Glycogen; Mitochondria, Heart; Mitochondrial Swelling; Myocardial Infarction; | 1978 |
[The rational basis of the beta blockader-nitroderivative combination in the treatment of late postinfarction angina].
Topics: Adult; Aged; Angina Pectoris; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Isosorbide | 1978 |
[Effect of propranolol on the fibrillation threshold and the period of vulnerability of cardiac ventricles under normal conditions and during acute coronary occlusion].
Topics: Animals; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Heart Conduction System; Heart Ve | 1978 |
Beneficial effects of propranolol and digitalis on contraction and S-T segment elevation after acute coronary occlusion.
Topics: Animals; Dogs; Drug Therapy, Combination; Electrocardiography; Heart; Myocardial Contraction; Myocar | 1978 |
Metabolic response of the heart in acute myocardial infarction in man.
Topics: Adult; Aged; Blood Glucose; Carbohydrate Metabolism; Catecholamines; Epinephrine; Fatty Acids, Nones | 1978 |
Vasodilator and inotropic therapy of heart failure [panel discussion].
Topics: Animals; Cardiac Output; Coronary Circulation; Dobutamine; Dogs; Dose-Response Relationship, Drug; H | 1978 |
A simple micromethod for simultaneous determination of plasma propranolol and 4-hydroxypropranolol.
Topics: Drug Interactions; Humans; Hydroxylation; Methods; Microchemistry; Myocardial Infarction; Propranolo | 1978 |
Experimental catecholamine-induced acute myocardial necrosis.
Topics: Acute Disease; Animals; Catecholamines; Dogs; Heart; Hemodynamics; Infusions, Parenteral; Isoprotere | 1978 |
Protection from morbidity and mortality from first infarcts: the case for beta-blockade.
Topics: Aged; Angina Pectoris; Coronary Disease; Humans; Hypertension; Myocardial Infarction; Propranolol | 1978 |
Myocardial damage following infarction.
Topics: Creatine Kinase; Electrocardiography; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Myocardial | 1978 |
Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Male; Myocard | 1978 |
Intravenous therapy with propranolol in acute myocardial infarction: effects on changes in the S-T segment and hemodynamics.
Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Electrocardiography; Female; Heart; Heart Rate; | 1978 |
Propranolol and enzyme levels.
Topics: Creatine Kinase; Humans; Methods; Models, Biological; Myocardial Infarction; Prognosis; Propranolol | 1979 |
Propranolol and threatened myocardial infarction.
Topics: Animals; Coronary Circulation; Coronary Disease; Coronary Vessels; Heart; Humans; Myocardial Contrac | 1979 |
Debate on coronary artery disease. Con: surgery is treatment of choice in preinfarction angina.
Topics: Angina Pectoris; Angiocardiography; Follow-Up Studies; Humans; Myocardial Infarction; Myocardial Rev | 1976 |
Medical versus surgical treatment of unstable angina.
Topics: Acute Disease; Angina Pectoris; Angiocardiography; Coronary Disease; Follow-Up Studies; Humans; Myoc | 1976 |
The syndromes of cardiac pain.
Topics: Angina Pectoris; Angina Pectoris, Variant; Cardiomyopathies; Coronary Angiography; Coronary Circulat | 1976 |
The effects of heart rate, myocardial ischemia and vagal stimulation on the threshold for ventricular fibrillation.
Topics: Animals; Coronary Disease; Dogs; Electric Stimulation; Female; Heart; Heart Rate; Male; Myocardial I | 1977 |
[Cardiovascular collapse in a damaged heart following 10 mg of propranolol or 1,25 mg of pindolol].
Topics: Adult; Humans; Male; Myocardial Infarction; Pindolol; Propranolol; Syncope | 1977 |
Automated mapping of body surface and pericardial potentials in experimental myocardial infarction. Reduction of infarct size by means of a new beta-adrenolytic compound.
Topics: Animals; Dogs; Electrocardiography; Heart Conduction System; Myocardial Infarction; Pericardium; Pro | 1977 |
Resistant ventricular tachycardias and recurrent cardiac arrests. 96 episodes.
Topics: Aged; Disopyramide; Electric Countershock; Heart Aneurysm; Humans; Male; Myocardial Infarction; Prop | 1977 |
Impending myocardial infarction: medical management.
Topics: Angina Pectoris; Coronary Angiography; Coronary Disease; Humans; Myocardial Infarction; Myocardial R | 1977 |
[Sympathetic nervous activity and ischemic cardiopathy].
Topics: Aged; Angina Pectoris; Catecholamines; Coronary Disease; Heart Failure; Humans; Male; Middle Aged; M | 1977 |
Prevention of ventricular arrhythmias after myocardial infarction.
Topics: Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Procainamide; Propranolol; Quini | 1977 |
Irreversible myocardial damage resembling catecholamine necrosis secondary to acute coronary occlusion in dogs: its prevention by propranolol.
Topics: Animals; Dogs; Myocardial Infarction; Myocardium; Necrosis; Propranolol | 1977 |
Infarct size reduction by propranolol before and after coronary ligation in dogs.
Topics: Animals; Disease Models, Animal; Dogs; Electrocardiography; Female; Hemodynamics; Male; Myocardial I | 1977 |
Effects of long-term therapy of propranolol and practolol on plasma-lipids after acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Female; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Practo | 1977 |
Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction.
Topics: Animals; Body Temperature; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; Female; Hemod | 1976 |
Acute coronary syndromes following abrupt cessation of oral propranolol therapy.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Angina Pectoris; Coronary Disease; Dose-Response R | 1976 |
Letter: Hypothermia in acute myocardial infarction defended.
Topics: Animals; Dogs; Humans; Hypothermia, Induced; Myocardial Infarction; Myocardium; Oxygen Consumption; | 1976 |
[Effect of propranolol on haemaodynamics and extent of ischaemic damage of the myocardium in experimental infarction (author's transl)].
Topics: Animals; Disease Models, Animal; Dogs; Hemodynamics; Myocardial Infarction; Propranolol | 1976 |
Cardiology: preinfarction angina. Defining the syndrome and the risk.
Topics: Angina Pectoris; Humans; Myocardial Infarction; Propranolol; Risk; Time Factors; Vasodilator Agents | 1976 |
Chronic propranolol administration and acute myocardial infarction.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Shock, Cardiogen | 1976 |
Propranolol in experimental myocardial ischemia: dissociation of effects on contraction and epicardial ST segments.
Topics: Animals; Blood Pressure; Depression, Chemical; Disease Models, Animal; Dogs; Electrocardiography; He | 1976 |
Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion.
Topics: Animals; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Fe | 1976 |
Electrocardiographic surface mapping of the heart following myocardial infarction and the influence of beta-blockade.
Topics: Heart Rate; Humans; Male; Myocardial Infarction; Propranolol | 1976 |
Propranolol in acute myocardial infarction in man: effects of haemodynamics and myocardial oxygenation.
Topics: Adult; Aged; Animals; Coronary Circulation; Dogs; Female; Heart; Hemodynamics; Humans; Male; Middle | 1976 |
Propranolol in patients with acute myocardial infarction at the Royal Melbourne Hospital from 1965: a review.
Topics: Arrhythmias, Cardiac; Atropine; Drug Therapy, Combination; Humans; Myocardial Infarction; Propranolo | 1976 |
Role of the nervous system in experimentally induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Atropine; Cats; Coronary Circulation; Denervation; Electric Stimulati | 1976 |
Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
Topics: Animals; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease; Disease Models, Ani | 1976 |
The effect of a potent inhibitor of platelet aggregation, BL-3459, on adrenaline-induced myocardial necrosis in beagle dogs.
Topics: Animals; Aspirin; Blood Pressure; Disease Models, Animal; Dogs; Epinephrine; Female; Imidazoles; Mal | 1976 |
Prolonged epicardial mapping in myocardial infarction: the effects of propranolol and intra-aortic balloon pumping following coronary artery occlusion.
Topics: Animals; Assisted Circulation; Collateral Circulation; Coronary Vessels; Dogs; Electrocardiography; | 1976 |
Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction.
Topics: Acute Disease; Animals; Coronary Circulation; Electrocardiography; Hemodynamics; Humans; Myocardial | 1976 |
Propranolol therapy in patients undergoing myocardial revascularization.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiac Output; Cardiopulmonary Bypass; Coronary | 1976 |
Geriatric cardiovascular problems.
Topics: Aged; Aging; Anesthesia; Arrhythmias, Cardiac; Blood Circulation; Cardiovascular Physiological Pheno | 1976 |
Propranolol in acute myocardial infarction in man. Effects of hemodynamics and myocardial oxygenation.
Topics: Acute Disease; Adult; Aged; Coronary Circulation; Female; Heart Rate; Hemodynamics; Humans; Lactates | 1976 |
Compared incidence of first myocardial infarction in hypertensive patients under treatment containing propranolol or excluding beta-receptor blockade.
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Propranolol | 1976 |
The rationale for surgery in preinfarction angina.
Topics: Adult; Aged; Angina Pectoris; Angiography; Cardiac Catheterization; Cardiopulmonary Bypass; Coronary | 1975 |
The value of exercise stress testing.
Topics: Adult; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Energy Metabolism; | 1975 |
A practical approach to coronary artery disease, with special reference to coronary bypass surgery.
Topics: Adult; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Electrocardiography; Exercis | 1976 |
Effect of autonomic neural influences on the cardiovascular changes induced by coronary occlusion.
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Cats; Electric Stimulation; | 1975 |
Ventricular fibrillation threshold; its physiological and pharmacological importance.
Topics: Acidosis, Respiratory; Action Potentials; Aminophylline; Animals; Digitalis Glycosides; Dogs; Electr | 1975 |
Evaluation of haemodynamic effects of intravenous propranolol at low dosage (1 and 2 mg) in acute myocardial infarction.
Topics: Dose-Response Relationship, Drug; Female; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; | 1975 |
Diagnosis and therapy in the critically ill.
Topics: Acute Disease; Aged; Assisted Circulation; Cardiac Output; Coronary Disease; Diagnosis, Differential | 1975 |
Intra-aortic ballon pump assistance and early surgery in cardiogenic shock.
Topics: Animals; Assisted Circulation; Boston; Coronary Circulation; Electrocardiography; Humans; Myocardial | 1975 |
Management of acute myocardial infarction. Pathophysiological considerations.
Topics: Acute Disease; Adenosine Triphosphate; Animals; Assisted Circulation; Cardiac Output; Coronary Circu | 1975 |
Intrapartum anesthetic management of the pregnant patient with heart disease.
Topics: Anesthesia, Epidural; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Local; Anesthesia, Ob | 1975 |
Modification of ventricular fibrillation latency following coronary artery occlusion in the conscious pig.
Topics: Adaptation, Physiological; Animals; Coronary Vessels; Electrocardiography; Heart Conduction System; | 1975 |
Refractory paroxysmal supraventricular tachycardia incited by multiple mechanisms.
Topics: Atrioventricular Node; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Male; Middl | 1975 |
[Experimental studies on the use of beta-sympatholytics in infarct-induced ventricular fibrillation].
Topics: Animals; Dogs; Drug Combinations; Myocardial Infarction; Practolol; Propranolol; Sympatholytics; Ven | 1975 |
Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system.
Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Chlordiaz | 1975 |
Drug action, reaction, and interaction. II. Iatrogenic cardiopathies.
Topics: Anesthetics; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Arrhythmias, Cardiac; Barbit | 1975 |
[Treatment of arrhythmia in general practice].
Topics: Ajmaline; Anti-Arrhythmia Agents; Aprindine; Arrhythmia, Sinus; Arrhythmias, Cardiac; Bradycardia; H | 1975 |
[Use of small doses of obsidan in physical rehabilitation of patients with myocardial infarct].
Topics: Drug Evaluation; Hemodynamics; Humans; Myocardial Infarction; Propranolol; Respiration | 1975 |
[The use of beta-blocking agents in acute cardiac infarct].
Topics: Adult; Aged; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Practol | 1975 |
[Pharmacology of cornary dilator agent, trapymin. (2) Analysis of its mode of action].
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Blood Glucose; Calcium Chloride; Catecholamin | 1975 |
[The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
Topics: Animals; Atenolol; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Dose-Response Relatio | 1975 |
Editorial: Discontinuation of propranolol therapy. Cause of rebound angina pectoris and acute coronary events.
Topics: Angina Pectoris; Coronary Disease; Humans; Myocardial Infarction; Propranolol; Substance Withdrawal | 1976 |
On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs.
Topics: Animals; Coronary Disease; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electroca | 1976 |
Metabolic evaluation of agents designed to protect the ischemic myocardium and to reduce infarct size.
Topics: Animals; Coronary Circulation; Coronary Disease; Disease Models, Animal; Heart; Hemodynamics; Lysoso | 1976 |
Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs.
Topics: Acute Disease; Animals; Blood Pressure; Catecholamines; Chronic Disease; Coronary Circulation; Coron | 1976 |
Comparison of the effects of halothane and propranolol on the effective refractory period and the ventricular activation in a canine myocardial infarction model.
Topics: Animals; Dogs; Electrocardiography; Halothane; Heart; Hemodynamics; Models, Cardiovascular; Myocardi | 1992 |
Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction.
Topics: Adenylyl Cyclases; Animals; Heart Failure; Male; Myocardial Contraction; Myocardial Infarction; Papi | 1992 |
The mechanisms of free-radical lipids and antioxidant heart protection in experimental ischaemia and infarction.
Topics: Animals; Female; Free Radicals; Lipid Peroxidation; Male; Malondialdehyde; Microscopy, Electron; Myo | 1992 |
Propranolol reduces myocardial hypertrophy in the right cardiac chambers after infarction in rats.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Heart; Hypertro | 1992 |
Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilo | 1992 |
The prognostic significance of very low frequency ventricular ectopic activity in survivors of acute myocardial infarction. BHAT Study Group.
Topics: Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Follow-Up Studies; Humans; Myocardial | 1992 |
Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Dihydropyridines; Hemodynamics; Myocardial Infarction | 1992 |
[Effects of m-nifedipine on experimental myocardial metabolism and infarct size in rabbits].
Topics: Animals; Dose-Response Relationship, Drug; Isomerism; Lactates; Male; Myocardial Infarction; Myocard | 1992 |
Global depletion of myocardial norepinephrine and ATP after left coronary artery occlusion in rats.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Epinephrine; Female | 1992 |
Alpha 1-adrenoceptor regulation of delayed afterdepolarizations and triggered activity in subendocardial Purkinje fibers surviving 1 day of myocardial infarction.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Dogs; Heart; Myocardial Infarction; Myocardium | 1991 |
Chronic propranolol treatment promotes left ventricular dilation without altering systolic function after large myocardial infarction in rats.
Topics: Analysis of Variance; Animals; Cardiomegaly; Chronic Disease; Dose-Response Relationship, Drug; Hear | 1990 |
[Endogenous intoxication of the body in acute myocardial infarct during lymph stimulation].
Topics: Animals; Dextrans; Dogs; Drug Combinations; Heparin; Lymph; Mannitol; Myocardial Infarction; Paramec | 1990 |
Time course of changes in heart rate and sympathetic tone after coronary artery ligation in rats.
Topics: Animals; Atropine; Autonomic Nerve Block; Blood Pressure; Coronary Vessels; Heart Rate; Ligation; Ma | 1991 |
[Effects of sympathetic block on post-infarction cardiac hypertrophy and their impact on myocardial contractility].
Topics: Animals; Autonomic Nerve Block; Cardiomegaly; Male; Myocardial Contraction; Myocardial Infarction; P | 1991 |
Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1.
Topics: Adult; Circadian Rhythm; Death, Sudden, Cardiac; Delayed-Action Preparations; Female; Humans; Incide | 1991 |
[Beta-adrenergic reactivity in patients with myocardial infarct according to the antihemolytic test].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Dose-Response Relationship, Drug; Erythrocyte Membrane; Er | 1990 |
Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs.
Topics: Animals; Atropine; Dogs; Electric Stimulation; Heart Rate; Myocardial Infarction; Parasympathetic Ne | 1991 |
[Effect of obsidan on metabolic processes in the blood and lymph in acute myocardial infarction].
Topics: Acid-Base Equilibrium; Animals; Disease Models, Animal; Dogs; Electrolytes; Glucose; Lactates; Lymph | 1991 |
[Immediate and late prognosis in patients with unstable angina under medical treatment].
Topics: Adult; Aged; Angina, Unstable; Calcium Channel Blockers; Death, Sudden; Electrocardiography; Female; | 1990 |
[Expediency of long-term anti-angina therapy and physical exercises in patients with angina pectoris and a history of myocardial infarction].
Topics: Adult; Angina Pectoris; Aspirin; Exercise Therapy; Humans; Male; Middle Aged; Myocardial Infarction; | 1990 |
Lack of significant effect of therapeutic propranolol on measurable platelet function in healthy subjects.
Topics: Coronary Disease; Humans; Myocardial Infarction; Platelet Aggregation; Propranolol | 1990 |
[The use of labetalol and propranolol in patients who have had a myocardial infarct].
Topics: Adult; Drug Evaluation; Exercise Test; Humans; Labetalol; Middle Aged; Myocardial Infarction; Physic | 1990 |
[Correction of metabolic disorders of the myocardium in acute myocardial infarct as an important factor in preventing the development of circulatory insufficiency].
Topics: Animals; Aprotinin; Ascorbic Acid; Drug Therapy, Combination; Glutamates; Glutamic Acid; Heart Failu | 1985 |
[Blood endorphin levels in myocardial infarction].
Topics: Adult; Aged; Endorphins; Female; gamma-Endorphin; Humans; Male; Middle Aged; Myocardial Infarction; | 1987 |
Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Coronary Disease; Coronary Vessels; Heart Rate; | 1989 |
[The significance of a staged diagnostic-therapeutic program for the disease course in patients following unstable angina pectoris during a follow-up period of 3 1/2 years].
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Combined Modality Therapy; Coronary Disease | 1989 |
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coron | 1989 |
Autonomic response to coronary occlusion in animals susceptible to ventricular fibrillation.
Topics: Animals; Autonomic Nervous System; Blood Pressure; Coronary Disease; Coronary Vessels; Death, Sudden | 1989 |
Biochemical and morphological changes in myocardium during coronary occlusion and reperfusion in canine hearts: effects of propranolol on myocardial damage.
Topics: Animals; Dogs; Female; Heart; Intracellular Membranes; Lysosomes; Male; Mitochondria, Heart; Myocard | 1989 |
[Actual problems of the treatment of acute myocardial infarction].
Topics: Aged; Cardiomyopathy, Dilated; Drug Evaluation; Drug Therapy, Combination; Hemodynamics; Humans; Mid | 1989 |
[Mechanisms of the effect of obsidan on the clinical picture of myocardial infarction at the early stage of the disease].
Topics: Adult; Aged; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Sym | 1989 |
Assessing efficacy of therapeutic intervention on myocardial infarction process by enzymatic prediction method.
Topics: Creatine Kinase; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Predictive Value of Tests; | 1989 |
Changes in phase analysis patterns of radionuclide ventriculograms obtained from baboons during atrial pacing, septic shock, and induced myocardial infarction.
Topics: Animals; Cardiac Pacing, Artificial; Cardiac Volume; Electrocardiography; Fourier Analysis; Heart; M | 1989 |
[Epidural analgesia with obzidan in the acute period of myocardial infarct].
Topics: Analgesia, Epidural; Drug Evaluation; Hemodynamics; Humans; Myocardial Infarction; Prognosis; Propra | 1989 |
Myocardial dysfunction in diabetic rats: influence of beta-adrenoceptor blockade (propranolol).
Topics: Animals; Diabetes Mellitus, Experimental; Female; Isoenzymes; Male; Myocardial Infarction; Oxidoredu | 1989 |
Infarct-sparing effect of propranolol in an occlusion-reperfusion dog model.
Topics: Animals; Blood Pressure; Dogs; Female; Heart Rate; Ligation; Male; Myocardial Infarction; Myocardial | 1989 |
Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study).
Topics: Adult; Aged; Death, Sudden; Double-Blind Method; Humans; Middle Aged; Myocardial Infarction; Posture | 1989 |
Exercise training after experimental myocardial infarction increases the ventricular fibrillation threshold before and after the onset of reinfarction in the isolated rat heart.
Topics: Animals; Coronary Disease; Differential Threshold; Epinephrine; In Vitro Techniques; Male; Myocardia | 1989 |
The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models.
Topics: Animals; Cardiac Pacing, Artificial; Cats; Electric Stimulation; Female; Male; Myocardial Infarction | 1989 |
Treatment-induced blood pressure reduction and the risk of myocardial infarction.
Topics: Blood Pressure; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle A | 1989 |
[Use of obsidan in patients with myocardial infarction].
Topics: Adult; Aged; Arrhythmias, Cardiac; Depression, Chemical; Heart Conduction System; Hemodynamics; Huma | 1989 |
Intravenous propranolol in acute myocardial infarction.
Topics: Humans; Myocardial Infarction; Propranolol; Ventricular Fibrillation | 1985 |
Exercise training during chronic beta blockade in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Coronary Artery Bypass; Female; Heart Rate; Humans; Male; Met | 1985 |
[Efficacy of fenigidin, senzit and trazikor in the treatment of patients with angina pectoris].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium; Cardiac Glycosides; Drug Therapy, Combi | 1985 |
Beta-blocker therapy after myocardial infarction: secondary prevention in all patients?
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Electrocardiography; Exercise Test; Heart; Humans | 1985 |
Exercise tolerance and compensatory sympathetic tone during beta-blockade after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Blood Pressure; Dogs; Exercise Test; Hear | 1986 |
Cardiac rhythm in cats during physiological sleep in experimental myocardial infarction and beta-adrenergic receptor blockade.
Topics: Adrenergic beta-Antagonists; Animals; Cats; Diazepam; Heart Rate; Myocardial Infarction; Propranolol | 1986 |
[Contractile function of the myocardium and central hemodynamics in acute myocardial infarct patients after a single intravenous injection of adrenergic beta receptor blockaders].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Coronary Artery Bypass; Hemodynamics; Humans; Int | 1986 |
Effect of beta-blockers on the relation between QT-interval and heart rate in exercise ECG.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; | 1987 |
[ST elevation in the initial phase of myocardial infarct--a sequela of acute coronary occlusion of an expression of neurohumorally-induced metabolic processes?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Electrocardiography; Female; Heart Conduction System; Huma | 1987 |
Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Cost-Benefit Analysis; Costs and Cost Analysis; Humans; | 1988 |
Islet cell damage and cardiac enzyme and isoenzyme changes in isoproterenol treated rats.
Topics: Animals; Female; Heart; Hexokinase; Insulin; Islets of Langerhans; Isoenzymes; Isoproterenol; L-Lact | 1985 |
[Influence of propranolol withdrawal on the induction of sudden death in chronically infarcted rats by isoproterenol challenge].
Topics: Animals; Death, Sudden; Mice; Myocardial Infarction; Propranolol; Rats; Substance Withdrawal Syndrom | 1987 |
[Relationship among myocardial norepinephrine, cyclic AMP and ventricular fibrillation in experimental infarction].
Topics: Animals; Cyclic AMP; Dogs; Myocardial Infarction; Myocardium; Norepinephrine; Propranolol; Ventricul | 1985 |
On the mechanism of renin release during experimental myocardial ischaemia.
Topics: Animals; Coronary Disease; Disease Models, Animal; Dogs; Female; Hemodynamics; Kidney; Male; Myocard | 1985 |
Protective metabolic effects of propranolol during total myocardial ischemia.
Topics: Adenine Nucleotides; Animals; Blood Pressure; Dogs; Energy Metabolism; Heart Rate; Lactates; Myocard | 1986 |
[The effect of obsidan on the content of catecholamines and renin in the blood in myocardial infarct].
Topics: Adult; Epinephrine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Propra | 1988 |
[Effect of dalargin on morphologic and functional indices in experimental myocardial infarct].
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enkephalin, Leucine; | 1986 |
Effects of beta-adrenergic blockade on the natural progression of myocardial infarct size and compensatory hypertrophy.
Topics: Animals; Blood Pressure; Cardiomegaly; Dogs; Heart; Heart Rate; Myocardial Infarction; Propranolol; | 1985 |
Alterations in isoproterenol-induced cardiac metabolic changes by a quaternary analog of propranolol, UM-272.
Topics: Animals; Anti-Arrhythmia Agents; Creatine Kinase; Dose-Response Relationship, Drug; Energy Metabolis | 1985 |
Effects of 10- to 12-day treatment with L-thyroxine in rats with myocardial infarction.
Topics: Animals; Blood Pressure; Diastole; Dose-Response Relationship, Drug; Heart; Heart Rate; Male; Myocar | 1988 |
[Effects of protocatechuic acid and propranolol on myocardial metabolism and infarct size in dogs with acute myocardial infarction].
Topics: Animals; Dogs; Female; Heart Rate; Hydroxybenzoates; Male; Myocardial Infarction; Myocardium; Oxygen | 1988 |
[Effect of obzidan on coronary blood flow in patients with the hyperkinetic type of hemodynamics in the acute period of myocardial infarct].
Topics: Adult; Coronary Circulation; Drug Evaluation; Hemodynamics; Humans; Male; Middle Aged; Myocardial In | 1988 |
[Effect of the beta-blocker propranolol (obzidan) on the content of macroergic phosphates and the development of the size of necrotic areas in the myocardium in experimental acute coronary occlusion].
Topics: Acute Disease; Animals; Coronary Disease; Drug Evaluation, Preclinical; Energy Metabolism; Male; Myo | 1988 |
[A case of recurrent myocardial infarction after discontinuation of the treatment with beta adrenergic receptor blockaders].
Topics: Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Recurrence | 1988 |
Inhibitory effect of KW-3049, a new 1,4-dihydropyridine calcium antagonist, on the reduction of myocardial creatine kinase activity and high-energy phosphate content in rats subjected to coronary artery ligation.
Topics: Adenosine Triphosphate; Animals; Calcium Channel Blockers; Coronary Circulation; Creatine Kinase; Li | 1988 |
[Pharmacodynamic characteristics of a test using intravenous obzidan administration in patients with myocardial infarct].
Topics: Adult; Aged; Drug Evaluation; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Age | 1988 |
The effects of trapidil and propranolol on platelet aggregation and prostacyclin-thromboxane balance following acute myocardial infarction in rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Female; Male; Myocardial Infarction; Platelet Aggregation; Pr | 1988 |
MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
Topics: Acidosis; Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Vessels; Dogs; Fe | 1988 |
The B-value: a tool for monitoring data.
Topics: Biometry; Clinical Trials as Topic; Myocardial Infarction; Probability; Propranolol; Research Design | 1988 |
The B-value: a tool for monitoring data.
Topics: Biometry; Clinical Trials as Topic; Myocardial Infarction; Probability; Propranolol; Research Design | 1988 |
The B-value: a tool for monitoring data.
Topics: Biometry; Clinical Trials as Topic; Myocardial Infarction; Probability; Propranolol; Research Design | 1988 |
The B-value: a tool for monitoring data.
Topics: Biometry; Clinical Trials as Topic; Myocardial Infarction; Probability; Propranolol; Research Design | 1988 |
The B-value: a tool for monitoring data.
Topics: Biometry; Clinical Trials as Topic; Myocardial Infarction; Probability; Propranolol; Research Design | 1988 |
The B-value: a tool for monitoring data.
Topics: Biometry; Clinical Trials as Topic; Myocardial Infarction; Probability; Propranolol; Research Design | 1988 |
The B-value: a tool for monitoring data.
Topics: Biometry; Clinical Trials as Topic; Myocardial Infarction; Probability; Propranolol; Research Design | 1988 |
The B-value: a tool for monitoring data.
Topics: Biometry; Clinical Trials as Topic; Myocardial Infarction; Probability; Propranolol; Research Design | 1988 |
The B-value: a tool for monitoring data.
Topics: Biometry; Clinical Trials as Topic; Myocardial Infarction; Probability; Propranolol; Research Design | 1988 |
[The status of oxygen supply in patients with acute myocardial infarction during treatment with nitrates and nitrates combined with beta-blockaders].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardia | 1988 |
[Effectiveness of obzidan in patients with a history of myocardial infarct].
Topics: Adult; Drug Evaluation; Echocardiography; Exercise Test; Follow-Up Studies; Hemodynamics; Humans; Mi | 1988 |
Long-term propranolol administration alters myocyte and ventricular geometry in rat hearts with and without infarction.
Topics: Analysis of Variance; Animals; Female; Heart Ventricles; Myocardial Infarction; Myocardium; Organ Si | 1988 |
Combined effect of propranolol and nifedipine on infarct size in dogs.
Topics: Animals; Dogs; Drug Therapy, Combination; Female; Hemodynamics; Male; Myocardial Infarction; Nifedip | 1986 |
Beta-blockade after myocardial infarction: is prolonged treatment feasible?
Topics: Adult; Aged; Atenolol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Time F | 1987 |
[Definition and significance of the area at risk in myocardial infarct and the ischemic border zone in acute myocardial infarct].
Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Dogs; Electrolytes; Energy | 1986 |
[Evaluation of the mechanisms of exercise induced ST elevation in old anterior myocardial infarction by cardiac blood pool scan].
Topics: Electrocardiography; Female; Heart; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infa | 1987 |
[Effect of obsidan on the functional status of the cardiovascular system of patients with acute myocardial infarction].
Topics: Cardiovascular System; Humans; Myocardial Infarction; Propranolol | 1987 |
Relationship between the prolonged QTc interval and ventricular fibrillation.
Topics: Analysis of Variance; Death, Sudden; Electrocardiography; Female; Humans; Hypokalemia; Male; Middle | 1986 |
[Peripheral circulatory and tissue oxygen regimen functions in acute myocardial infarct patients being treated with obzidan].
Topics: Adult; Aged; Blood Circulation; Cardiac Catheterization; Drug Therapy, Combination; Female; Humans; | 1986 |
The long-term outcome of patients who suffered and survived an acute myocardial infarction in the midst of recurrent attacks of variant angina.
Topics: Angina Pectoris, Variant; Cardiac Catheterization; Drug Therapy, Combination; Electrocardiography; F | 1986 |
The effect of lidocaine compared with verapamil on the enhanced ventricular rhythm in the infarcted canine heart.
Topics: Animals; Dogs; Female; Heart; Heart Block; Heart Rate; Heart Ventricles; Lidocaine; Male; Myocardial | 1986 |
Diuretics and myocardial infarction or sudden death.
Topics: Chlorothiazide; Death, Sudden; Humans; Hypertension; Male; Methyldopa; Middle Aged; Myocardial Infar | 1986 |
[Inderal in the acute and post-myocardial infarct periods].
Topics: Aged; Death, Sudden; Drug Evaluation; Electrocardiography; Female; Heart; Humans; Male; Middle Aged; | 1986 |
Non-invasive evaluation of autonomic tone changes during isometric exercise in normal subjects and in patients with coronary artery disease.
Topics: Adult; Autonomic Nervous System; Blood Pressure; Coronary Disease; Electrocardiography; Female; Hear | 1986 |
Fatal nonatherosclerotic myocardial infarction in a young man with allergic bronchial asthma.
Topics: Adult; Asthma; Coronary Disease; Heart Arrest; Humans; Lung; Male; Myocardial Infarction; Myocardium | 1986 |
Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Female; Heart; Heart Ventricles; Male; | 1987 |
[Effect of nitrates and obsidan on myocardial infarction].
Topics: Adult; Aged; Drug Synergism; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Male; Middle A | 1985 |
[Effect of nitroprusside, nitroglycerin, propranolol and mannitol on the size of a myocardial infarct].
Topics: Cardiac Catheterization; Drug Evaluation; Electrocardiography; Ferricyanides; Hemodynamics; Humans; | 1985 |
[Effect of obzidan and nitroglycerin on heart chamber function in acute myocardial infarct (based on echocardiographic data)].
Topics: Drug Evaluation; Drug Therapy, Combination; Echocardiography; Heart Ventricles; Hemodynamics; Humans | 1985 |
[Effect of lidocaine and pyromecaine on the size of an experimental myocardial infarct].
Topics: Animals; Anti-Arrhythmia Agents; Coronary Circulation; Dogs; Drug Evaluation, Preclinical; Electroca | 1986 |
[Use of obsidan in different hemodynamic variants of acute myocardial infarction].
Topics: Acute Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol | 1986 |
Effects of propranolol on myocardial damage resulting from coronary artery occlusion followed by reperfusion.
Topics: Animals; Arterial Occlusive Diseases; Calcium; Creatine Kinase; Dogs; Hemodynamics; Lactates; Lactic | 1986 |
[Experimental myocardial infarction in atherosclerosis--various methods of pharmacological correction].
Topics: Administration, Oral; Animals; Aortic Diseases; Arteriosclerosis; Barbiturates; Coronary Disease; Dr | 1985 |
Participation in a clinical trial: the patients' point of view.
Topics: Adult; Aged; Altruism; Aspirin; Attitude to Health; Clinical Trials as Topic; Double-Blind Method; F | 1985 |
[Combined use of nitrates and beta-adrenergic blockaders in patients with acute myocardial infarct].
Topics: Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Hemodynamics; Humans; | 1985 |
[Lipid peroxidation in the myocardium in experimental infarct].
Topics: Animals; Butylated Hydroxytoluene; Catalase; Drug Evaluation, Preclinical; Glutathione Peroxidase; L | 1985 |
Prolonged protective effects following propranolol withdrawal against isoproterenol-induced myocardial infarction in normotensive and hypertensive rats.
Topics: Animals; Blood Pressure; Corticosterone; Creatine Kinase; Female; Humans; Isoproterenol; L-Lactate D | 1985 |
Pharmacological interventions and myocardial infarct size in rat.
Topics: Animals; Imidazoles; Myocardial Infarction; Nitroblue Tetrazolium; Oxidoreductases; Propranolol; Rat | 1985 |
[Dose-effect relationship and duration of the effect of diltiazem in stable effort angina. Comparison with propranolol].
Topics: Aged; Angina Pectoris; Benzazepines; Diltiazem; Dose-Response Relationship, Drug; Exercise Test; Hea | 1985 |
[Effect of obzidan on cell membrane permeability in myocardial infarct patients].
Topics: Adult; Aged; Cell Membrane Permeability; Drug Evaluation; Erythrocyte Membrane; Female; Heart; Human | 1985 |
[Changes in the oxygen transport function of the blood of patients with myocardial infarcts during treatment with obzidan].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen; Oxyhemoglobins; Propr | 1985 |
Reduction of infarct size by early use of oral propranolol and verapamil in acute myocardial infarction.
Topics: Administration, Oral; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infar | 1985 |
Effects of propranolol on infarct size and the impaired hemodynamics in experimental myocardial infarcted dogs.
Topics: Administration, Oral; Animals; Dogs; Dose-Response Relationship, Drug; Female; Heart; Heart Rate; He | 1985 |
Beta blocking agents and antithyroid drugs as adjuncts to radioiodine therapy.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Carbimazole; Chemical Phenomena; Chemistry; Humans; | 1971 |
[Treatment of cardiac rhythm disorders with beta-adrenergic blockaders, propranolol, benzodixin, visken, eraldin and trazikor].
Topics: Adolescent; Adult; Aged; Arrhythmia, Sinus; Arrhythmias, Cardiac; Arteriosclerosis; Atrial Fibrillat | 1971 |
Effect of propranolol, procainamide, and lidocaine on ventricular automaticity and reentry in experimental myocardial infarction.
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cats; Coronary Vessels; | 1972 |
Post-extrasystolic T and U wave changes in diseased and normal hearts.
Topics: Adult; Arrhythmia, Sinus; Atrial Fibrillation; Cardiac Complexes, Premature; Electrocardiography; He | 1972 |
Withdrawal of propranolol and myocardial infarction.
Topics: Angina Pectoris; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol | 1973 |
Withdrawal of propranolol and myocardial infarction.
Topics: Humans; Myocardial Infarction; Propranolol | 1973 |
Withdrawal of propranolol and myocardial infarction.
Topics: Aged; Angina Pectoris; Humans; Male; Myocardial Infarction; Propranolol | 1973 |
Modification of myocardial infarct volume. An experimental study in the dog.
Topics: Animals; Arrhythmias, Cardiac; Arteries; Blood Pressure; Body Weight; Coronary Vessels; Disease Mode | 1973 |
Aneurysmectomy in treatment of ventricular and supraventricular tachyarrhythmias in patients with postinfarction and traumatic ventricular aneurysms.
Topics: Angiocardiography; Atrial Flutter; Cardiac Complexes, Premature; Digoxin; Electrocardiography; Heart | 1973 |
[Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)].
Topics: Administration, Oral; Ajmaline; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Cardiac Complexe | 1974 |
Editorial: Beta-blockade and size of acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Animals; Dogs; Heart; Humans; Injections, Intravenous; Myocardi | 1974 |
[Sino-atrial block in inderal and digoxin treatment].
Topics: Adrenergic beta-Antagonists; Blood Circulation; Cardiac Glycosides; Digoxin; Heart Block; Humans; Ma | 1973 |
Editorial: Intermediate coronary syndrome.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiography; Blood Pressure; Heart Rate; Humans; Myoca | 1973 |
Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiovascular Disea | 1974 |
[Exercise test in the evaluation of effectiveness of 4 antianginal drugs (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Exercise Test; Humans; Isosorbide Dinitrate; Ma | 1974 |
Propranolol and myocardial infarction.
Topics: Humans; Myocardial Infarction; Propranolol | 1966 |
Propranolol in myocardial infarction.
Topics: Animals; Coronary Vessels; Dogs; Humans; Myocardial Infarction; Propranolol; Sympathetic Nervous Sys | 1967 |
Propranolol in myocardial infarction.
Topics: Animals; Coronary Vessels; Dogs; Humans; Myocardial Infarction; Propranolol; Sympathetic Nervous Sys | 1967 |
A new beta-adrenergic receptor blocking agent, H 56/28, in the treatment of cardiac arrhythmias.
Topics: Atrial Fibrillation; Blood Pressure; Cardiac Complexes, Premature; Electric Countershock; Female; Hu | 1967 |
[Clinical use of propranolol (Inderal)].
Topics: Adolescent; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 1967 |
[Sodium diphenylhydantoin in cardiac arrhythmias].
Topics: Animals; Atrial Fibrillation; Blood Pressure; Cardiac Complexes, Premature; Cats; Depression, Chemic | 1969 |
[Clinical significance and treatment of disorders of the cardiac rhythm in patients with myocardial infarct].
Topics: Adult; Aged; Amides; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, P | 1969 |
Treatment of premature cardiac contractions.
Topics: Bretylium Compounds; Cardiac Complexes, Premature; Digitalis Glycosides; Digoxin; Humans; Lidocaine; | 1970 |
Unstable angina.
Topics: Angina Pectoris; Anticoagulants; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Ele | 1973 |
What constitutes adequate medical therapy for the patient with angina pectoris?
Topics: Aged; Angina Pectoris; Arteriosclerosis; Delayed-Action Preparations; Drug Synergism; Drug Therapy, | 1974 |
Exercise electrocardiography: recognition of the ischemic response, false positive and negative patterns.
Topics: Action Potentials; Angina Pectoris; Arteriosclerosis; Chlorothiazide; Coronary Disease; Diagnostic E | 1974 |
Coronary artery syndromes after sudden propranolol withdrawal.
Topics: Adult; Aged; Angina Pectoris; Death, Sudden; Electrocardiography; Humans; Male; Middle Aged; Myocard | 1974 |
Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog.
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Heart; Heart Rate; Hemodynamics; Isoproterenol; Myo | 1974 |
[Differential treatment of coronary heart disease].
Topics: Angina Pectoris; Aspirin; Cardiac Glycosides; Coronary Disease; Dipyridamole; Furosemide; Heparin; H | 1974 |
The "natural" history of severe angina pectoris with intensive medical therapy alone: a five year prospective study of 133 patients.
Topics: Adult; Aged; Aging; Angina Pectoris; Atrial Fibrillation; Cardiomegaly; Cerebrovascular Disorders; D | 1974 |
Editorial: Calcium responses ("calcium spikes").
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Caffeine; Calcium; Coronary Disease; Cyclic AMP; E | 1974 |
Effect of various types of sympathicolytics on isoproterenol-induced myocardial lesions.
Topics: Animals; Dibenzylchlorethamine; Ethanolamines; Guanethidine; Heart; Isoproterenol; Myocardial Infarc | 1966 |
Beta adrenergic blocking agents with review of current literature.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Ethanolamines; Humans; Myocardial Infarction; Propranolol; Sy | 1968 |
Haemodynamic effects of dextro-propranolol in acute myocardial infarction.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiac Output; Female; Hea | 1970 |
Anti-arrhythmic effect of DL-propranolol, D-propranolol and I. C. I. 50 172 in experimental myocardial infarction in the dog.
Topics: Acetanilides; Acute Disease; Adrenergic beta-Antagonists; Amino Alcohols; Animals; Arrhythmias, Card | 1970 |
[Beta receptor blockaders in heart therapy].
Topics: Adrenergic beta-Antagonists; Atrial Flutter; Cardiac Output; Cardiomyopathy, Hypertrophic; Heart; He | 1970 |
Value of electrical pacing and beta adrenergic blockers in the prevention of fatal ventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Dogs; Ligation; Myocardial Infarction; Pacem | 1971 |
The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Anura; Arrhythmias, Cardiac; Cardanolides; | 1973 |
Preservation of ischemic myocardium.
Topics: Acute Disease; Blood Pressure; Cardiac Output; Coronary Circulation; Depression, Chemical; Digitalis | 1974 |
Treatment of cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Digitalis; Digoxin; Electric Countershock | 1974 |
[Effect of propranolol on left ventricular function at rest and during exercise in patients with ischemic heart disease (author's transl)].
Topics: Coronary Disease; Heart; Heart Ventricles; Humans; Myocardial Infarction; Physical Exertion; Propran | 1974 |
Corticosteroids in ventricular tachycardia.
Topics: Adult; Aged; Coronary Disease; Dexamethasone; Female; Heart Ventricles; Humans; Hypertension; Inject | 1974 |
[Certain problems of antiarrhythmia therapy in myocardial infarct].
Topics: Administration, Oral; Adult; Aged; Ajmaline; Arrhythmias, Cardiac; Drug Therapy, Combination; Female | 1974 |
[A new method of evaluation of ventricular contractility].
Topics: Adolescent; Adult; Cardiomyopathies; Child; Female; Heart Function Tests; Heart Valve Diseases; Hear | 1974 |
Effects of isoproterenol, propranolol and artificial pacing on hemodynamics and energy liberation of the infarcted heart in dogs.
Topics: Animals; Blood Pressure; Coronary Vessels; Depression, Chemical; Dogs; Dose-Response Relationship, D | 1974 |
Letter: Infarction in patients treated with propranolol.
Topics: Angina Pectoris; Atropine; Heart Rate; Humans; Injections; Myocardial Infarction; Propranolol; Shock | 1974 |
Propranolol vs. saphenous vein graft bypass for impending infarction (preinfarction syndrome).
Topics: Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Evaluation Studies as Topic; Female | 1974 |
Improved coronary vein graft patency rates with side-to-side anastomoses.
Topics: Age Factors; Aged; Angiography; Anticoagulants; Blood Flow Velocity; Body Weight; Coronary Artery By | 1974 |
Coronary revascularization in patients receiving propranolol.
Topics: Angina Pectoris; Coronary Artery Bypass; Emergencies; Heart Rate; Heart Ventricles; Humans; Isoprote | 1974 |
Clinical applications of His bundle electrography.
Topics: Adult; Arrhythmias, Cardiac; Atropine; Bundle-Branch Block; Cardiac Catheterization; Digitalis Glyco | 1973 |
Effects of intravenously administered propranolol on wall motion abnormalities.
Topics: Adult; Aged; Angina Pectoris; Female; Heart; Heart Rate; Humans; Male; Methods; Middle Aged; Myocard | 1973 |
[The possible relationship between the antifibrillatory effect of inderal in experimental myocardial infarct and its effect on cardiac oxidation reduction processes and blood supply].
Topics: Animals; Coronary Vessels; Dogs; Myocardial Infarction; Myocardium; Oxidation-Reduction; Oxygen Cons | 1973 |
[Assisted circulation by intra-aortic counter-pulsation. Experimental study].
Topics: Animals; Aorta; Assisted Circulation; Blood Pressure; Catheterization; Dogs; Electrocardiography; He | 1973 |
Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Arteries; Coronary Vessels; Creatine Kinase; Do | 1973 |
Prophylactic uses of antiarrhythmic drugs in acute myocardial infarction.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Humans; Injections, Intravenous; Isoproteren | 1973 |
Investigations on protection of the ischemic myocardium.
Topics: Animals; Assisted Circulation; Creatine Kinase; Digitalis Glycosides; Dogs; Electrocardiography; Glu | 1973 |
Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs.
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Female; Heart; Heart Rate; Male; Myocardial Infarct | 1973 |
[Infarction following sudden withdrawal of propranolol].
Topics: Angina Pectoris; Humans; Myocardial Infarction; Propranolol; Substance Withdrawal Syndrome | 1973 |
[Possible dependence of the antifibrillatory action of inderal in experimental myocardial infarct on its effect on oxidation-reduction processes and the blood supply of the heart].
Topics: Animals; Arrhythmia, Sinus; Coronary Vessels; Dogs; Heart; Injections, Intravenous; Ligation; Myocar | 1973 |
Combined use of glucagon and beta-adrenoceptor antagonists in ventricular arrhythmias accompanying myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Drug Synergism; Glucagon; Myocardial Infarction; Practolol; Pro | 1973 |
Proceedings: A comparison of the effects of practolol and propranolol on the response to haemorrhage in anaesthetized dogs after myocardial infarction.
Topics: Animals; Dogs; Hemodynamics; Hemorrhage; Myocardial Infarction; Practolol; Propranolol | 1973 |
Systemic and renal haemodynamics during antihypertensive treatment with propranolol.
Topics: Blood Pressure; Cardiac Output; Hemodynamics; Humans; Hypertension; Kidney; Myocardial Infarction; P | 1973 |
Effects of submaximal isometric handgrip on left ventricular size and wall motion.
Topics: Adult; Aged; Digoxin; Electrocardiography; Female; Fluoroscopy; Hand; Heart Rate; Heart Ventricles; | 1974 |
Cardiac migraine--report of twelve cases.
Topics: Adolescent; Adult; Angina Pectoris; Angiocardiography; Coronary Disease; Diazepam; Diet Therapy; Ele | 1974 |
Ventricular function following experimental coronary artery bypass grafting: the relationship of functional improvement to haemodynamics in the graft.
Topics: Animals; Blood Pressure; Blood Volume; Cardiac Catheterization; Cardiac Output; Collateral Circulati | 1974 |
Prevention of gross myocardial infarction in the canine heart.
Topics: Animals; Assisted Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Heart Ventricles; Hyp | 1974 |
Sudden death and the ballooning posterior leaflet syndrome. Detailed anatomic and histochemical investigation.
Topics: Adult; Aorta; Autopsy; Coronary Vessels; Death, Sudden; Electrocardiography; Female; Heart Auscultat | 1974 |
Myocardial infarction after propranolol withdrawal.
Topics: Angina Pectoris; Animals; Arteriosclerosis; Coronary Disease; Dogs; Humans; Myocardial Infarction; N | 1974 |
[Clinical use of propranolol].
Topics: Alcoholism; Angina Pectoris; Aortic Aneurysm; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flut | 1974 |
[Continuous surveillance of patients in the initial stages of myocardial infarct].
Topics: Aged; Arrhythmias, Cardiac; Female; Heart Block; Humans; Intensive Care Units; Male; Middle Aged; My | 1968 |
[Significance of the a-wave for the evaluation of end-diastolic filling of the ventricle. Apex-cardiographic studies on subjects with coronary disease and with normal hearts].
Topics: Cardiac Output; Exercise Test; Female; Heart Ventricles; Humans; Kinetocardiography; Male; Middle Ag | 1968 |
[Conservative therapy of angina pectoris].
Topics: Acute Disease; Amyl Nitrite; Angina Pectoris; Anticoagulants; Coronary Disease; Digitalis Glycosides | 1970 |
An internist looks at myocardial revascularization.
Topics: Angina Pectoris; Angiography; Chlordiazepoxide; Collateral Circulation; Coronary Disease; Diazepam; | 1971 |
'Progress' in the treatment and prevention of coronary heart disease.
Topics: Adolescent; Adult; Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Ar | 1971 |
Left ventricular performance and coronary flow after coronary embolization with plastic microspheres.
Topics: Animals; Atropine; Blood Pressure; Cardiac Output; Coronary Circulation; Disease Models, Animal; Dog | 1971 |
Clinical studies on apexcardiogram. II. Cardiac movement in thyroid dysfunction and coronary heart disease from the point of apexcardiogram.
Topics: Adolescent; Adult; Angina Pectoris; Arteriosclerosis; Coronary Disease; Electrocardiography; Female; | 1971 |
Acute coronary insufficiency. Course and follow-up.
Topics: Adult; Aged; Angina Pectoris; Aspartate Aminotransferases; Coronary Disease; Creatine Kinase; Electr | 1972 |
Ventricular fibrillation and myocardial necrosis after transient ischemia. Effect of treatment with oxygen, procainamide, reserpine, and propranolol.
Topics: Animals; Coronary Disease; Dogs; Injections, Intra-Arterial; Injections, Intramuscular; Injections, | 1972 |
Propranolol-induced hypoglycaemia and myocardial infarction.
Topics: Aged; Angina Pectoris; Humans; Hypoglycemia; Male; Myocardial Infarction; Propranolol | 1972 |
Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion.
Topics: Animals; Coronary Disease; Coronary Vessels; Creatine Kinase; Disease Models, Animal; Dogs; Drug Com | 1972 |
Ventricular aneurysm due to cardiac sarcoidosis with surgical cure of refractory ventricular tachycardia.
Topics: Adult; Angiocardiography; Cardiac Catheterization; Cardiomyopathies; Cineangiography; Electrocardiog | 1972 |
Effects of glucagon on a multistressed circulation.
Topics: Animals; Aorta, Thoracic; Blood Circulation; Blood Pressure; Cardiac Output; Coronary Vessels; Dogs; | 1972 |
Prognosis in severe angina pectoris: medical versus surgical therapy.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Drug Combinations; Electrocardiography; Female; Humans; I | 1972 |
Myocardial lesions following experimental intracranial hemorrhage: prevention with propranolol.
Topics: Animals; Cerebral Hemorrhage; Electrocardiography; Heart; Heart Ventricles; Male; Myocardial Infarct | 1972 |
Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions.
Topics: Animals; Arteries; Blood Pressure; Coronary Vessels; Dogs; Electrocardiography; Female; Heart Rate; | 1972 |
[Experimental study on drugs for the treatment of myocardial infarction].
Topics: Angiography; Animals; Benzyl Compounds; Body Weight; Carboxylic Acids; Dipyridamole; Disease Models, | 1972 |
Effect of caffeine on the ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction.
Topics: Animals; Benzoates; Caffeine; Dogs; Heart; Myocardial Infarction; Propranolol; Sodium; Ventricular F | 1972 |
Shortening of electromechanical systole as a manifestation of excessive adrenergic stimulation in acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Electrocardiography; Epinephrine; Female; Heart; H | 1972 |
Calcium as mediator of isoproterenol-induced myocardial necrosis.
Topics: Animals; Calcium; Heart; Injections, Intraperitoneal; Isoproterenol; Myocardial Infarction; Myocardi | 1972 |
[The hemodynamic effects of alpha- and beta-adrenergic blockaders in experimental myocaedial infarct].
Topics: Animals; Cardiac Output; Dogs; Ergotamine; Heart Rate; Myocardial Infarction; Propranolol; Stellate | 1971 |
Effect of propranolol on catecholamine content of injured cardiac tissue.
Topics: Animals; Catecholamines; Coronary Vessels; Depression, Chemical; Dogs; Dopamine; Electrocardiography | 1971 |
Treatment of arrhythmias associated with acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atropine; Bradycardia; Digitalis Glycosides; Humans; Isoproterenol; Lidocaine; | 1971 |
Management of dysrhythmias associated with acute myocardial infarction. 2.
Topics: Arrhythmias, Cardiac; Digitalis Glycosides; Electric Countershock; Electrocardiography; Humans; Myoc | 1971 |
Experimental graded "pump failure" of the left ventricle.
Topics: Animals; Aorta, Thoracic; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Cardiac Output; Cardi | 1971 |
Effects of propranolol on the ischemic heart muscles in dogs.
Topics: Action Potentials; Animals; Coronary Disease; Dogs; Electrocardiography; Heart; Myocardial Infarctio | 1969 |
Acute coronary care.
Topics: Electric Countershock; Electrocardiography; Facility Design and Construction; Heart Massage; Humans; | 1968 |
A new look at ventricular tachycardia.
Topics: Age Factors; Digitalis Glycosides; Electric Countershock; Electrocardiography; Heart Ventricles; Hum | 1967 |
Artificial pacemaker-induced true vs. pseudo-electrical alternans.
Topics: Aged; Arrhythmias, Cardiac; Digitalis Glycosides; Electric Countershock; Electrocardiography; Humans | 1971 |
[A case of ventricular fibrillation treated by electric defibrillation associated with intracardial administration of inderal].
Topics: Adult; Electric Countershock; Humans; Male; Myocardial Infarction; Propranolol; Sympatholytics; Vent | 1969 |
Comparison of drugs used in management of arrhythmias developing after acute myocardial infarction.
Topics: Acetanilides; Arrhythmias, Cardiac; Humans; Lidocaine; Myocardial Infarction; Phenytoin; Procainamid | 1969 |
The clinical significance of an ST-segment depression in the electrocardiogram. A seven-year longitudinal study.
Topics: Adult; Aged; Angina Pectoris; Blood Circulation; Body Weight; Cholesterol; Coronary Disease; Coronar | 1969 |
Hemodynamic effects of propranolol (Inderal) and H 56-28 (Aptin) in patients with acute myocardial infarction. A comparative study.
Topics: Amino Alcohols; Blood Circulation; Blood Pressure; Heart Rate; Humans; Middle Aged; Myocardial Infar | 1969 |
[Ventricular fibrillation in acute myocardial infarct. Apropos of 7 cases with recovery].
Topics: Acute Disease; Aged; Electric Countershock; Female; Humans; Lidocaine; Male; Middle Aged; Myocardial | 1969 |
The circulatory effects of practolol (ICI 50172) in patients with acute myocardial infarction.
Topics: Acetanilides; Acute Disease; Aged; Depression, Chemical; Heart Rate; Humans; Male; Middle Aged; Myoc | 1970 |
[Increase of contractility of the intact portions of the myocardium in the course of acute focal ischemia of the left ventricle in the dog].
Topics: Animals; Blood Pressure; Dogs; Heart; Muscle Contraction; Myocardial Infarction; Propranolol; Reserp | 1970 |
Antiarrhythmic drugs in the prevention of ventricular arrhythmias related to paired pacing.
Topics: Animals; Bretylium Compounds; Coronary Vessels; Dogs; Lidocaine; Myocardial Infarction; Pacemaker, A | 1970 |
The use of ventricular pacing for suppression of ectopic ventricular activity.
Topics: Arrhythmias, Cardiac; Cardiac Catheterization; Cardiac Surgical Procedures; Digitalis Glycosides; El | 1970 |
Mixed reception for myocardial revascularization.
Topics: Angina Pectoris; Cardiac Surgical Procedures; Carotid Sinus; Coronary Vessels; Electric Countershock | 1970 |
The use of propranolol in arrhythmias complicating acute myocardial infarction.
Topics: Aged; Arrhythmia, Sinus; Arrhythmias, Cardiac; Blood Pressure; Bradycardia; Electrocardiography; Fem | 1970 |
[Effect of intravenous propranolol on the electrocardiographic curve].
Topics: Adult; Aged; Electrocardiography; Female; Heart; Humans; Injections, Intravenous; Male; Middle Aged; | 1970 |
[Treatment of acute arrhythmia with propranolol].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Female; Humans; | 1970 |
Factors influencing infarct size following experimental coronary artery occlusions.
Topics: Animals; Blood Pressure; Bretylium Compounds; Coronary Disease; Creatine Kinase; Dogs; Electric Stim | 1971 |
Experimental evaluation of pentazocine: effect on myocardial contractility and peripheral vascular resistance.
Topics: Animals; Aorta; Blood Flow Velocity; Blood Pressure; Catecholamines; Coronary Vessels; Dogs; Heart; | 1971 |
Coronary care unit--report on a year's experience.
Topics: Adult; Aged; Anticoagulants; Arrhythmias, Cardiac; Atropine; Coronary Care Units; Coronary Disease; | 1971 |
Bretylium tosylate in the management of refractory ventricular fibrillation.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Aortic Valve Insufficiency; Aortic Valve Stenosis; Bretyl | 1971 |
Use of propranolol in preinfarction angina.
Topics: Aged; Angina Pectoris; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction | 1971 |
[Therapy of acute myocardial infarct with particular reference to arrhythmia and myocardial contractibility disorders].
Topics: Adult; Aged; Aging; Arrhythmias, Cardiac; Atropine; Cardiac Glycosides; Cortisone; Electric Counters | 1971 |
[Recurrent ventricular fibrillation after myocardial infarct treated with propranolol (Inderal)].
Topics: Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; Ventricular Fibrillation | 1971 |
[Possibilities of drug therapy of arrhythmias in myocardial infarct].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Care Units; Digitalis Glycosides; Lidocaine; | 1971 |
Cardiac effects of cold-induced hyperthyroidism and the seasonal variation in incidence of myocardial infarction.
Topics: Animals; Atropine; Cold Temperature; Heart; Heart Rate; Hyperthyroidism; Male; Myocardial Infarction | 1971 |
[Risk factors, prognosis, treatment and rehabilitation in myocardial infarct].
Topics: Adult; Age Factors; Aged; Angina Pectoris; Anticoagulants; Cholesterol; Female; Humans; Hypertension | 1967 |
Adams-Stokes attacks and corticosteroids.
Topics: Adams-Stokes Syndrome; Electric Countershock; Electrocardiography; Female; Humans; Middle Aged; Myoc | 1968 |
Vasospastic elements in myocardial infarction following coronary occlusion in the dog.
Topics: Acetylcholine; Animals; Atropine; Blood Flow Velocity; Bretylium Compounds; Coronary Vessels; Dogs; | 1968 |
The haemodynamic effects of atropine combined with propranolol in acute myocardial infarction.
Topics: Atropine; Blood Pressure; Cardiac Catheterization; Cardiac Output; Drug Synergism; Electrocardiograp | 1968 |
Propranolol in persistent ventricular fibrillation complicating acute myocardial infarction.
Topics: Acute Disease; Aged; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; | 1968 |
Hospital mortality in acute myocardial infarction.
Topics: Acute Disease; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; E | 1968 |
Propranolol in myocardial infarction.
Topics: Arrhythmias, Cardiac; Humans; Myocardial Infarction; Propranolol | 1968 |
[Therapeutic use of beta-receptor blocking agents].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Atrial Flutter; Coronary Disease; Electrocardiog | 1968 |
Management of persistently recurring ventricular fibrillation with propranolol hydrochloride.
Topics: Electric Countershock; Electrocardiography; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarct | 1968 |
[Electroimpulse therapy of paroxysmal tachycardia in myocardial infarct].
Topics: Aged; Electric Countershock; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol; | 1968 |
Toxic effects of glucagon-induced acute lipid mobilization in geese.
Topics: Animals; Aspartate Aminotransferases; Blood Glucose; Coronary Disease; Electrocardiography; Fatty Ac | 1968 |
Indications and limits of cardiac beta-receptor blockase: physiopharmacological and clinical considerations on the subject of beta-adrenergic receptor blockade, pure and otherwise.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Heart; Humans; Myocardial Infarction; Propranolol; Sensory Re | 1968 |
Incidence and management of supraventirucular arrhythmias after acute myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Digitalis Glycosides; Electric Countershock; Electrocardiography; | 1969 |
Paired pacing after coronary artery ligation.
Topics: Animals; Blood Pressure; Cardiac Output; Coronary Disease; Coronary Vessels; Dogs; Heart Rate; Myoca | 1969 |
Arrhythmias in myocardial infarction. Diagnosis and treatment (No. 1).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diagnosis, Differential; Electrocardiography; Humans; | 1969 |
Glucagon: its enhancement of atrioventricular nodal pacemaker activity and failure to increase ventricular automaticity in dogs.
Topics: Animals; Dogs; Glucagon; Heart Block; Heart Conduction System; Heart Ventricles; Hemostasis; Isoprot | 1969 |
Reevaluation of the treatment of shock secondary to cardiac infarction.
Topics: Adrenal Cortex Hormones; Animals; Blood Flow Velocity; Blood Pressure; Blood Volume; Cardiac Output; | 1969 |
[On treatment of rhythmic disorders in recent myocardial infarct].
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Electrocardiography; Female; Heart | 1966 |
Treatment of acute myocardial infarction with propranolol.
Topics: Arrhythmias, Cardiac; Humans; Myocardial Infarction; Propranolol | 1966 |
Cardio-pulmonary resuscitation. A report on two years' experience.
Topics: Acidosis; Adolescent; Adult; Aged; Bicarbonates; Child; Child, Preschool; Electric Countershock; Hea | 1966 |
Correlation of myocardial and renal necrosis with tissue electrolyte changes.
Topics: Animals; Calcium, Dietary; Catecholamines; Electrolytes; Kidney Diseases; Magnesium; Male; Metaramin | 1966 |
A preliminary report of clinical trial of a new adrenergic B-receptor blocking agent--"Propranolol" (inderalX) in a few cases of arythmias, especially after myocardial infarction.
Topics: Aged; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol | 1966 |